<SEC-DOCUMENT>0001104659-25-085779.txt : 20250829
<SEC-HEADER>0001104659-25-085779.hdr.sgml : 20250829
<ACCEPTANCE-DATETIME>20250829170352
ACCESSION NUMBER:		0001104659-25-085779
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20250829
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250829
DATE AS OF CHANGE:		20250829

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Canopy Growth Corp
		CENTRAL INDEX KEY:			0001737927
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			Z4
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38496
		FILM NUMBER:		251281862

	BUSINESS ADDRESS:	
		STREET 1:		1 HERSHEY DRIVE
		CITY:			SMITH FALLS
		STATE:			A6
		ZIP:			K7A0A8
		BUSINESS PHONE:		855-558-9333

	MAIL ADDRESS:	
		STREET 1:		1 HERSHEY DRIVE
		CITY:			SMITH FALLS
		STATE:			A6
		ZIP:			K7A0A8
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2524672d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:CGC="http://canopygrowth.com/20250829">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_03A_CGC_canopygrowth.com_20250829 -->
<!-- Field: Set; Name: xdx; ID: xdx_045_20250829_20250829 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_054_edei%2D%2DEntityCentralIndexKey_0001737927 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000004" name="dei:EntityCentralIndexKey">0001737927</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-08-29" id="xdx2ixbrl0011" name="dei:EntityRegistrantName">Canopy Growth Corp</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-08-29" id="xdx2ixbrl0014" name="dei:EntityTaxIdentificationNumber">00-0000000</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="cgc-20250829.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-08-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001737927</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-08-29</xbrli:startDate>
        <xbrli:endDate>2025-08-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>



<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_902_edei--DocumentType_c20250829__20250829_zNzIRWmd97Q4"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PURSUANT TO SECTION&#160;13 OR 15(d)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OF THE SECURITIES EXCHANGE ACT OF 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
<span id="xdx_90C_edei--DocumentPeriodEndDate_c20250829__20250829_zWldGFAlC1va"><ix:nonNumeric contextRef="AsOf2025-08-29" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">August 29, 2025</ix:nonNumeric></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_907_edei--EntityRegistrantName_dxL_c20250829__20250829_zk9mgOIDjC1e" title="::XDX::Canopy%20Growth%20Corp"><span style="-sec-ix-hidden: xdx2ixbrl0011">Canopy Growth Corporation</span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its
charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityIncorporationStateCountryCode_c20250829__20250829_z01k3NF5dNs7"><ix:nonNumeric contextRef="AsOf2025-08-29" format="ixt-sec:edgarprovcountryen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Canada</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: top; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityFileNumber_c20250829__20250829_zZ5Zac28WVAa"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000013" name="dei:EntityFileNumber">001-38496</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: top; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityTaxIdentificationNumber_dxL_c20250829__20250829_zGnAGyeJ9vD" title="::XDX::00-0000000" style="font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0014">N/A</span></span></b></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction <br/>
    of incorporation)</span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission
    <br/>
    File Number)</span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
    Employer<br/>
    Identification No.)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: center; font-size: 10pt; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--EntityAddressAddressLine1_c20250829__20250829_z83fR1NYuRTe"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000015" name="dei:EntityAddressAddressLine1">1 Hershey Drive</ix:nonNumeric></span><br/>
<span id="xdx_909_edei--EntityAddressCityOrTown_c20250829__20250829_zrFjqqBxmuA1"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000016" name="dei:EntityAddressCityOrTown">Smiths Falls</ix:nonNumeric></span>, <span id="xdx_90D_edei--EntityAddressStateOrProvince_c20250829__20250829_zBfN7LtlfR9b"><ix:nonNumeric contextRef="AsOf2025-08-29" format="ixt-sec:stateprovnameen" id="Fact000017" name="dei:EntityAddressStateOrProvince">Ontario</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; text-align: center; font-size: 10pt; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--EntityAddressPostalZipCode_c20250829__20250829_zTBeUzfpBnyg"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000018" name="dei:EntityAddressPostalZipCode">K7A
0A8</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center; font-size: 10pt">(Address of principal executive offices)</td>
    <td style="text-align: center; font-size: 10pt">(Zip Code)</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(<span id="xdx_909_edei--CityAreaCode_c20250829__20250829_z91Jsk9wdm61"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000019" name="dei:CityAreaCode">855</ix:nonNumeric></span>) <span id="xdx_903_edei--LocalPhoneNumber_c20250829__20250829_zFEshgWqcySl"><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000020" name="dei:LocalPhoneNumber">558-9333</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number, including
area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Not Applicable</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Check the appropriate box below if the Form&#160;8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_906_edei--WrittenCommunications_c20250829__20250829_zFh5BZg4aTYa"><ix:nonNumeric contextRef="AsOf2025-08-29" format="ixt:booleanfalse" id="Fact000021" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_90C_edei--SolicitingMaterial_c20250829__20250829_zUEDvZEwXZ1b"><ix:nonNumeric contextRef="AsOf2025-08-29" format="ixt:booleanfalse" id="Fact000022" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_90D_edei--PreCommencementTenderOffer_c20250829__20250829_z24r195VuRyb"><ix:nonNumeric contextRef="AsOf2025-08-29" format="ixt:booleanfalse" id="Fact000023" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_90C_edei--PreCommencementIssuerTenderOffer_c20250829__20250829_zH4M8S7TrBLd"><ix:nonNumeric contextRef="AsOf2025-08-29" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-left: Black 1pt solid; width: 35%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; text-align: center; width: 32%"><b>Trading</b> <b><br/>
Symbol(s)</b></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; text-align: center; width: 33%"><b>Name of each exchange<br/>
</b> <b>on which registered</b></td></tr>
  <tr style="vertical-align: top">
    <td style="border: Black 1pt solid; font-size: 10pt; text-align: center"><span id="xdx_90B_edei--Security12bTitle_c20250829__20250829_zzpmI1i5UnJ4"><b><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000025" name="dei:Security12bTitle">Common
    Shares, no par value</ix:nonNumeric></b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span id="xdx_906_edei--TradingSymbol_c20250829__20250829_zM24T15tynfi"><b><ix:nonNumeric contextRef="AsOf2025-08-29" id="Fact000026" name="dei:TradingSymbol">CGC</ix:nonNumeric></b></span></td>
    <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><b><span id="xdx_903_edei--SecurityExchangeName_c20250829__20250829_z5Q57xPwJB5b"><ix:nonNumeric contextRef="AsOf2025-08-29" format="ixt-sec:exchnameen" id="Fact000027" name="dei:SecurityExchangeName">Nasdaq
    Global Select Market</ix:nonNumeric></span></b></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2 of the Securities
Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-size: 10pt">Emerging growth company&#160;&#160;&#160;&#160;<span style="font-family: Wingdings"><span id="xdx_901_edei--EntityEmergingGrowthCompany_c20250829__20250829_zXhHQaGukjSk"><ix:nonNumeric contextRef="AsOf2025-08-29" format="ixt:booleanfalse" id="Fact000028" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-size: 10pt">If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act.&#160;&#160;<span style="font-family: Wingdings">&#168;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0%"/><td style="width: 1in"><span style="font-size: 10pt"><b>Item 7.01.</b></span></td><td><b>Regulation FD Disclosure.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August&#160;29, 2025, Canopy
Growth Corporation (the &#8220;Company&#8221;) issued a press release announcing its new at-the-market equity program, which is attached
as Exhibit&#160;99.1 to this Current Report on Form&#160;8-K (this &#8220;Current Report&#8221;) and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 10pt">The information in
Item 7.01 of this Current Report, including Exhibit&#160;99.1 attached hereto, is being furnished and shall not be deemed &#8220;filed&#8221;
for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;</span>Exchange Act&#8221;), or otherwise
subject to the liabilities of such section. The information in Item 7.01 of this Current Report, including Exhibit&#160;99.1, shall not
be incorporated by reference into any filing under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) or the Exchange
Act, regardless of any incorporation by reference language in any such filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in"><span style="font-size: 10pt"><b>Item 8.01.</b></span></td><td><b>Other Events.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On August&#160;29, 2025, the Company entered into
an equity distribution agreement (the &#8220;Equity Distribution Agreement&#8221;) with BMO Capital Markets Corp. (the &#8220;U.S. Agent&#8221;)
and BMO Nesbitt Burns Inc. (the &#8220;Canadian Agent&#8221;, and together with the U.S. Agent, the &#8220;Agents&#8221; and each an &#8220;Agent&#8221;),
pursuant to which the Company may offer and sell, from time to time, up to an aggregate offering price of up to $200,000,000 of the Company&#8217;s
common shares (the &#8220;Common Shares&#8221;) through the U.S. Agent, less any amounts sold in Canada through the Canadian Agent pursuant
to the Concurrent Canadian Offering (as defined below); <i>provided, however,</i> that (i)&#160;in no event will the Company sell Common
Shares in the Concurrent Canadian Offering for aggregate gross sales proceeds exceeding $50,000,000 (the &#8220;Canadian Cap&#8221;) and
(ii)&#160;in no event will the combined gross sales proceeds of the U.S. Offering (as defined below) and the Concurrent Canadian Offering
exceed $200,000,000. The U.S. Agent may sell Common Shares only in the United States (the &#8220;U.S. Offering&#8221;), and the Canadian
Agent may sell Common Shares only on marketplaces in Canada (the &#8220;Concurrent Canadian Offering&#8221;), subject to the Canadian
Cap. The Equity Distribution Agreement replaces the equity distribution agreement, dated February&#160;28, 2025, as amended, among the
Company and the Agents, which terminated upon the Company&#8217;s entry into the Equity Distribution Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 10pt">In the U.S. Offering,
sales of Common Shares, if any, will be made by any method that is deemed to be an &#8220;at the market offering&#8221; as defined in
Rule&#160;415(a)(4)&#160;under the Securities Act, including, but not limited to, sales made directly on The Nasdaq Global Select Market
or any other trading market for the Common Shares in the United States or pursuant to any other sales method used by the U.S. Agent. In
the Concurrent Canadian Offering, sales of Common Shares, if any, will be made in transactions that are deemed to be &#8220;at-the-market
distributions&#8221; as defined in National Instrument 44-102 &#8212; </span><i>Shelf Distributions</i>, including sales made by the Canadian
Agent directly on the Toronto Stock Exchange or any other marketplace for the Common Shares in Canada or pursuant to any other sales method
used by the Canadian Agent. The Agents may also sell the Common Shares by any other method agreed by the Company and the applicable Agent
and permitted by applicable law, including, without limitation, as block transactions. Actual sales of Common Shares pursuant to the Equity
Distribution Agreement will depend on a variety of factors to be determined by the Company from time to time, including (among others)
market conditions, the trading price of the Common Shares, capital needs and determinations by the Company of the appropriate sources
of funding for the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Subject to the terms and conditions of the Equity
Distribution Agreement, the Agents will use their commercially reasonable efforts to sell the Common Shares from time to time, as sales
agents, based upon the Company&#8217;s instructions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company has no obligation to sell any of the
Common Shares and may at any time suspend offers under the Equity Distribution Agreement, and either the Company or the Agents may terminate
the Equity Distribution Agreement at any time. The Equity Distribution Agreement contains customary representations, warranties and covenants
of the Company, indemnification rights and obligations of the parties and termination provisions. <span style="background-color: white">The
representations, warranties and covenants contained in the Equity Distribution Agreement were made only for purposes of the Equity Distribution
Agreement and as of specific dates, were solely for the benefit of the parties to the Equity Distribution Agreement and are subject to
certain limitations contained in the Equity Distribution Agreement.</span> Accordingly, investors and security holders should not rely
on the representations and warranties in the Equity Distribution Agreement as characterizations of the actual state of facts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 10pt">The U.S. Offering
is being made pursuant to the Company&#8217;s shelf registration statement on Form&#160;S-3 (File No.&#160;333-279949), filed with the
Securities and Exchange Commission (the &#8220;SEC&#8221;) on June&#160;5, 2024, and amended on May&#160;29, 2025 and May&#160;30, 2025
(as amended, the &#8220;Registration Statement&#8221;), a base prospectus, dated June&#160;4, 2025, included as part of the Registration
Statement, and a prospectus supplement, dated August&#160;29, 2025 filed with the SEC pursuant to Rule&#160;424(b)(5)&#160;on August&#160;29,
2025. The Concurrent Canadian Offering is being made </span>pursuant to a preliminary short form base shelf prospectus dated May&#160;14,
2024, a (final) short form base shelf prospectus dated June&#160;5, 2024 and a prospectus supplement dated August&#160;29, 2025, filed
with the securities commissions or similar authorities in each of the provinces and territories of Canada.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Current Report shall not constitute an offer
to sell or the solicitation of an offer to buy the Common Shares nor shall there be any sale of the Common Shares in any state or jurisdiction
in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such
state or other jurisdiction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The foregoing description of the Equity Distribution
Agreement is not complete and is qualified in its entirety by reference to the full text of the Equity Distribution Agreement, a copy
of which is attached as Exhibit&#160;1.1 to this Current Report and is incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The legal opinion of Cassels Brock&#160;&amp; Blackwell
LLP relating to the Common Shares being offered pursuant to the Equity Distribution Agreement is filed as Exhibit&#160;5.1 to this Current
Report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0%"/><td style="text-align: justify; width: 1in"><b>Item 9.01 </b></td>
                                                                                    <td style="text-align: justify"><b>Financial Statements and Exhibits.</b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&#160;Exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit&#160;Number</b></span></td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; padding-bottom: 1pt; width: 83%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit&#160;Description</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top"><a href="tm2524672d1_ex1-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1*+</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="tm2524672d1_ex1-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity Distribution Agreement, dated as of August&#160;29, 2025, by and among Canopy Growth Corporation and BMO Capital Markets Corp. and BMO Nesbitt Burns Inc.</span></a></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top"><a href="tm2524672d1_ex5-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="tm2524672d1_ex5-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of Cassels Brock&#160;&amp; Blackwell LLP</span></a></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top"><a href="tm2524672d1_ex5-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="tm2524672d1_ex5-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Cassels Brock&#160;&amp; Blackwell LLP (included in Exhibit&#160;5.1)</span></a></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top"><a href="tm2524672d1_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="tm2524672d1_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release, dated August&#160;29, 2025</span></a></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page&#160;Interactive Data File (formatted in Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">*</td><td style="text-align: left">A non-material exhibit has been omitted pursuant to Item 601(a)(5)&#160;of Regulation S-K. The Company hereby undertakes to furnish
supplemental copies of the omitted exhibit upon request by the SEC.</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td style="width: 0"/><td style="width: 0.5in; text-align: left"><span style="font-size: 10pt">+</span></td><td style="text-align: justify">Portions of this exhibit have been omitted pursuant to Item
601(a)(6)&#160;of Regulation S-K.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
<td>&#160;</td>
<td colspan="2"><b>CANOPY GROWTH CORPORATION</b></td></tr>
<tr>
<td style="width: 50%">&#160;</td>
<td style="width: 3%">&#160;</td>
<td style="width: 47%">&#160;</td></tr>
<tr style="vertical-align: top">
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: August&#160;29, 2025</span></td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
<td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Thomas Stewart</span></td></tr>
<tr style="vertical-align: top">
<td>&#160;</td>
<td>&#160;</td>
<td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thomas Stewart</span></td></tr>
<tr>
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim Chief Financial Officer</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>




<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KgkAQhZ/Adxj2OkyX7MK7kpLIIiSi2y3HWNIdmd3+Hqm3bFOiYWAYzvnOEWIkclrqBhmO87KAPbZdoxxCiTUymjN6R7Zap+BviRdtHSvj+vcHZuQZ9EwSSnnyQm+9a4tVCtF0HCVjOYE4TmUCs40IvnpGptYVGqdVA8pUsGPqWKNT/BoS9upJhtpXX3VAtppMCnEYDfIbZBRL2NJdPYivFooiE8Gon0DkTLfOuxZPh+ZLwqLB1tfZgf5v8AH+VEp+ -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>tm2524672d1_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit&nbsp;1.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Execution Version</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>CANOPY
GROWTH CORPORATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B><U>US$200,000,000</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>EQUITY
DISTRIBUTION AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">August&nbsp;29, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">BMO Capital Markets Corp.<BR>
151 West 42nd Street<BR>
New York, New York, 10036</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">BMO Nesbitt Burns Inc.<BR>
First Canadian Place, 4<SUP>th</SUP> Floor<BR>
100 King Street West<BR>
Toronto, ON M5X 1H3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Canopy Growth Corporation,
a corporation incorporated under the federal laws of Canada (the &ldquo;<B>Corporation</B>&rdquo;), confirms its agreement (this &ldquo;<B>Agreement</B>&rdquo;)
with BMO Capital Markets Corp. (the &ldquo;<B>U.S. Agent</B>&rdquo;) and BMO Nesbitt Burns Inc. (the &ldquo;<B>Canadian Agent</B>&rdquo;,
and together with the U.S. Agent, the &ldquo;<B>Agents</B>&rdquo;) to issue and sell common shares of the Corporation (the &ldquo;<B>Shares</B>&rdquo;)
upon and subject to the terms and conditions contained herein. Capitalized terms used herein have the meanings given to them in Section&nbsp;24
hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>1.</B></TD><TD><B><U>Issuance and Sale of Shares</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">The Corporation agrees that, from time
                                            to time during the term of this Agreement, on the terms and subject to the conditions set
                                            forth herein, it may issue and sell Shares (i)&nbsp;through the Canadian Agent, having an
                                            aggregate sales price of up to US$50,000,000 (or the equivalent in Canadian currency) (the
                                            &ldquo;<B>Canadian Offering</B>&rdquo;); and (ii)&nbsp;through the U.S. Agent, having an
                                            aggregate sales price of up to US$200,000,000 (the &ldquo;<B>Maximum Amount</B>&rdquo;),
                                            less any amounts sold in the Canadian Offering (the &ldquo;<B>U.S. Offering</B>&rdquo;, and
                                            together with the Canadian Offering, the &ldquo;<B>Offerings</B>&rdquo;). The Shares will
                                            be sold on the terms set forth herein at such times and in such amounts as the Corporation
                                            and the Agents shall agree from time to time. The issuance and sale of the Shares through
                                            the Agents will be effected pursuant to the Canadian Prospectus and the U.S. Prospectus,
                                            in each case, as applicable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">When determining the aggregate value of
                                            the Placement Shares sold, the Corporation will use the daily exchange rate posted by the
                                            Bank of Canada on the date the applicable Placement Shares were sold to determine the United
                                            States dollar equivalent of any Placement Shares which were sold for Canadian dollars.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.</B></TD><TD><B><U>Placements</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><U>Placement Notice</U>. Each time that
                                            the Corporation wishes to issue and sell Shares hereunder (each, a &ldquo;<B>Placement</B>&rdquo;),
                                            it will notify the applicable Agent by telephone followed by e-mail notice (or other method
                                            mutually agreed to in writing by the parties) (a &ldquo;<B>Placement Notice</B>&rdquo;) containing
                                            the parameters within which the Corporation desires to sell the Shares, which shall at a
                                            minimum include (i)&nbsp;the number of Shares to be sold under the applicable Placement pursuant
                                            to this Agreement (the &ldquo;<B>Placement Shares</B>&rdquo;), (ii)&nbsp;the time period
                                            during which sales of the Placement Shares are requested to be made, (iii)&nbsp;any limitation
                                            on the number of Placement Shares that may be sold in any one Trading Day, (iv)&nbsp;whether
                                            the Corporation desires the Placement Shares to be sold on a particular stock exchange, and
                                            (v)&nbsp;any minimum price below which sales of the Placement Shares may not be made, with
                                            a copy to the other Agent. The Placement Notice shall originate from any of the individuals
                                            (each, an &ldquo;<B>Authorized Representative</B>&rdquo;) from the Corporation set forth
                                            on Schedule 1 hereto, and shall be addressed to each of the respective individuals from the
                                            applicable Agent set forth on Schedule 1 hereto (after contacting such individuals by telephone),
                                            as such Schedule 1 may be amended from time to time by notice given in accordance with Section&nbsp;14.
                                            The Placement Notice shall be effective upon delivery to the applicable Agent unless and
                                            until (A)&nbsp;the applicable Agent declines to accept the terms contained therein for any
                                            reason, in its sole discretion, in accordance with the notice requirements set forth in Section&nbsp;4,
                                            (B)&nbsp;the entire amount of the Placement Shares specified in the Placement Notice have
                                            been sold and all such Shares have settled in accordance with the terms and conditions of
                                            this Agreement, (C)&nbsp;the Corporation suspends or terminates the Placement Notice in accordance
                                            with the notice requirements set forth in Section&nbsp;4 or Section&nbsp;13, as applicable,
                                            (D)&nbsp;the Corporation issues a subsequent Placement Notice with parameters superseding
                                            those on the earlier Placement Notice, or (E)&nbsp;this Agreement has been terminated in
                                            accordance with the provisions of Section&nbsp;13. Notwithstanding the foregoing, the Corporation
                                            may not deliver a Placement Notice to an Agent if the Corporation has delivered a Placement
                                            Notice which remains in effect to another Agent, unless the Corporation has terminated the
                                            prior Placement Notice in accordance with the notice requirements set forth in Section&nbsp;4.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><U>Placement Fee</U>. The amount of compensation
                                            to be paid by the Corporation to an Agent with respect to each Placement for which such Agent
                                            acted as sales Agent under this Agreement shall be equal to up to 3.0% of the gross proceeds
                                            from such Placement (the &ldquo;<B>Placement Fee</B>&rdquo;), which amount shall be paid
                                            in the same currency as the gross proceeds from the sale of the Placement Shares to which
                                            it pertains.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><U>No Obligation</U>. It is expressly
                                            acknowledged and agreed that neither the Corporation nor any Agent will have any obligation
                                            whatsoever with respect to a Placement or any Placement Shares unless and until the Corporation
                                            delivers a Placement Notice to the applicable Agent, which Placement Notice has not been
                                            declined, suspended or otherwise terminated in accordance with the terms of this Agreement,
                                            and then only upon the terms specified therein and herein. It is also expressly acknowledged
                                            that the Agents will be under no obligation to purchase Placement Shares on a principal basis
                                            and any purchase by the Agents as principal will be subject to the prior approval of the
                                            TSX. In the event of a conflict between the terms of this Agreement and the terms of a Placement
                                            Notice, the terms of the Placement Notice will prevail.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><U>Limitations on Placements</U>. Under
                                            no circumstances shall the Corporation deliver a Placement Notice (i)&nbsp;to the Canadian
                                            Agent to effect sales in the Canadian Offering if, after giving effect to the issuance of
                                            the Placement Shares requested to be issued under such Placement Notice, the aggregate sales
                                            price of the Placement Shares sold in the Canadian Offering pursuant to this Agreement would
                                            exceed US$50,000,000 (or the equivalent in Canadian currency), or (ii)&nbsp;to either Agent
                                            if, after giving effect to the issuance of the Placement Shares requested to be issued under
                                            such Placement Notice, the aggregate sales price of the Placement Shares sold in the Offerings
                                            pursuant to this Agreement would exceed the Maximum Amount. Notwithstanding anything to the
                                            contrary contained herein, the parties hereto acknowledge and agree that compliance with
                                            the limitations set forth in this Section&nbsp;2(d)&nbsp;on the dollar amount of Placement
                                            Shares that may be issued and sold under this Agreement from time to time shall be the sole
                                            responsibility of the Corporation, and that the Agents shall have no obligation in connection
                                            with such compliance. The Corporation acknowledges and agrees that each Agent has informed
                                            the Corporation that the Agents may, to the extent permitted under the Securities Act, the
                                            Exchange Act (including, without limitation, Regulation M promulgated thereunder), Canadian
                                            Securities Laws, the rules&nbsp;of the TSX and Nasdaq and this Agreement, purchase and sell
                                            Shares for its own account while this Agreement is in effect, and shall be under no obligation
                                            to purchase Placement Shares on a principal basis pursuant to this Agreement, except as otherwise
                                            agreed by an Agent and the Corporation, subject to the prior approval of the TSX.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>3.</B></TD><TD><B><U>Sale of Placement Shares by the Agents</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Subject to the terms and conditions of
                                            this Agreement, upon the Corporation&rsquo;s issuance of a Placement Notice, and unless the
                                            sale of the Placement Shares described therein has been declined, suspended, or otherwise
                                            terminated in accordance with the terms of this Agreement, the applicable Agent will use
                                            its commercially reasonable efforts consistent with its normal trading and sales practices
                                            to sell, on behalf of the Corporation and as agent, such Placement Shares up to the amount
                                            specified during the time period specified, and otherwise in accordance with the terms of
                                            such Placement Notice, subject to applicable federal, provincial, territorial and state laws,
                                            rules&nbsp;and regulations, and the rules&nbsp;of the TSX and Nasdaq. The applicable Agent
                                            will provide written confirmation (by email correspondence to an individual set forth on
                                            Schedule 1) to the Corporation no later than the opening of the Trading Day immediately following
                                            the Trading Day on which such Agent has made sales of Placement Shares hereunder setting
                                            forth (i)&nbsp;the number of Placement Shares sold on such day (showing the number of Placement
                                            Shares sold on the TSX, on any other &ldquo;marketplace&rdquo; (as such term is defined in
                                            NI 21-101) in Canada (a &ldquo;<B>Canadian Marketplace</B>&rdquo;), on Nasdaq, on any other
                                            &ldquo;marketplace&rdquo; in the United States (a &ldquo;<B>United States Marketplace</B>&rdquo;)
                                            and pursuant to any other sales method used by the Agents, including to or through a market
                                            maker), (ii)&nbsp;the price of the Placement Shares sold (showing the price of the Placement
                                            Shares sold on the TSX, a Canadian Marketplace, Nasdaq, a United States Marketplace and pursuant
                                            to any other sales method used by the Agents, including to or through a market maker), (iii)&nbsp;the
                                            aggregate gross proceeds of the Placement, (iv)&nbsp;the Placement Fee payable by the Corporation
                                            to the Agents with respect to such sales of Placement Shares (including the currency payable
                                            in respect thereof), and (v)&nbsp;the Net Proceeds payable to the Corporation. Subject to
                                            the terms and conditions of the Placement Notice, the Agents may sell Placement Shares by
                                            any method permitted by law that constitutes an &ldquo;at-the-market distribution&rdquo;
                                            under NI 44-102 including, without limitation, sales made directly on Nasdaq and the TSX,
                                            on any Canadian Marketplace or United States Marketplace, in block transactions, or by any
                                            other method permitted by law. The U.S. Agent covenants and agrees with the Corporation that
                                            (i)&nbsp;it shall not, directly or indirectly, advertise or solicit offers to purchase or
                                            sell Placement Shares in Canada, and (ii)&nbsp;it shall not sell Placement Shares on the
                                            TSX or on any Canadian Marketplace. For the avoidance of doubt, the U.S. Agent is not acting
                                            as an underwriter of the Placement Shares in the Canadian Qualifying Jurisdictions and no
                                            action on the part of the U.S. Agent in its capacity as an Agent of the offering of the Placement
                                            Shares in the United States is intended to create any impression or support any conclusion
                                            that it is acting as an underwriter of the Placement Shares in the Canadian Qualifying Jurisdictions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Each of the Agents hereby covenants and
                                            agrees that, during the time an Agent is the recipient of a Placement Notice pursuant to
                                            Section&nbsp;2 hereof that has not been declined, suspended or terminated in accordance with
                                            the terms hereof, such Agent will prudently and actively monitor the market&rsquo;s reaction
                                            to trades made on any &ldquo;marketplace&rdquo; pursuant to this Agreement in order to evaluate
                                            the likely market impact of future trades, and that, if such Agent has concerns as to whether
                                            a particular sale contemplated by a Placement Notice may have a significant effect on the
                                            market price of the Shares, the applicable Agent will immediately recommend to the Corporation
                                            against effecting the trade at that time or on the terms proposed. Notwithstanding the foregoing,
                                            the Corporation acknowledges and agrees that the Agents cannot provide complete assurances
                                            that any sale will not have a significant effect on the market price of the Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">The Agents covenant that the Agents will
                                            not (nor will any affiliate thereof or person or company acting jointly or in concert therewith),
                                            in connection with the distribution of Placement Shares in an &ldquo;at-the-market distribution&rdquo;
                                            (as defined in NI 44-102), enter into any transaction that is intended to stabilize or maintain
                                            the market price of the Placement Shares or the Shares, including selling an aggregate number
                                            or principal amount of Placement Shares that would result in creating an over-allocation
                                            position in the Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">Notwithstanding anything to the contrary
                                            set forth in this Agreement or a Placement Notice, the Corporation acknowledges and agrees
                                            that (i)&nbsp;there can be no assurance that the Agents will be successful in selling any
                                            Placement Shares or as to the price at which any Placement Shares are sold, if at all, and
                                            (ii)&nbsp;the Agents will incur no liability or obligation to the Corporation or any other
                                            person or entity if they do not sell Placement Shares for any reason other than a failure
                                            by the Agents to use their commercially reasonable efforts consistent with their normal trading
                                            and sales practices to sell, on behalf of the Corporation and as agent, such Placement Shares
                                            as provided under this Section&nbsp;3.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>4.</B></TD><TD><B><U>Suspension of Sales</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">The Corporation or the applicable Agent
                                            may, upon notice to the other party in writing, by telephone (confirmed immediately by e-mail)
                                            or by e-mail notice (or other method mutually agreed to in writing by the parties), suspend
                                            any sale of Placement Shares for which it has delivered or received, as applicable, a Placement
                                            Notice; provided, however, that such suspension shall not affect or impair any party&rsquo;s
                                            obligations with respect to any Placement Shares sold hereunder prior to the receipt of such
                                            notice of suspension. The Corporation and the Agents agree that no such notice shall be effective
                                            against any other party unless it is made to one of the individuals named on Schedule 1 hereto,
                                            as such Schedule 1 may be amended from time to time by notice given in accordance with Section&nbsp;14.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Notwithstanding any other provision of
                                            this Agreement, during any period in which the Corporation is in possession of material non-public
                                            information with respect to the Corporation and its Subsidiaries or the Shares, the Corporation
                                            and the Agents (provided they have been given prior written notice of such by the Corporation,
                                            which notice the Agents agree to treat confidentially) agree that no sale of Placement Shares
                                            will take place. The Corporation and the Agents agree that no such notice shall be effective
                                            against any applicable Agents unless it is made in writing to the individuals named on Schedule
                                            1 hereto, as such Schedule 1 may be amended from time to time by notice given in accordance
                                            with Section&nbsp;14. Material non-public information includes, without limitation, any material
                                            fact or material change that has not been disclosed, and any information that constitutes
                                            &ldquo;privileged information&rdquo; within the meaning of the <I>Securities Act </I>(Qu&eacute;bec).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>5.</B></TD><TD><B><U>Settlement</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><U>Settlement of Placement Shares</U>.
                                            Unless otherwise specified in the applicable Placement Notice, settlement for sales of Placement
                                            Shares will occur on the first (1st) Trading Day on the applicable stock exchange following
                                            the date on which the Placement Shares were sold or, if the Placement Shares are not sold
                                            on a stock exchange, on the first (1st) Trading Day (or, in either case, such earlier day
                                            as is agreed by the parties to be industry practice for regular-way trading) following the
                                            date on which such sales are made (each, a &ldquo;<B>Settlement Date</B>&rdquo;). The amount
                                            of proceeds to be delivered to the Corporation on a Settlement Date against the receipt of
                                            the Placement Shares sold will be equal to the aggregate sales price at which such Placement
                                            Shares were sold, after deduction for the Placement Fee for such sales payable by the Corporation
                                            to the applicable Agent pursuant to Section&nbsp;2 hereof and expenses pursuant to Section&nbsp;8(h)&nbsp;hereof
                                            (the &ldquo;<B>Net Proceeds</B>&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Delivery
                                            of Shares</U>. On each Settlement Date, the Corporation will, or will cause its transfer
                                            agent to, electronically transfer the Placement Shares being sold by crediting the applicable
                                            Agent&rsquo;s account or its designee&rsquo;s account (provided that the applicable Agent
                                            shall have given the Corporation written notice of such designee at least one Trading Day
                                            prior to the Settlement Date) at CDS Clearing and Depository Services Inc. through its CDSX
                                            system for Placement Shares sold in Canada and at The Depository Trust Company through its
                                            Deposit Withdrawal at Custodian System for Placement Shares sold in the United States or
                                            by such other means of delivery as may be mutually agreed upon by the Corporation and the
                                            applicable Agent and, upon receipt of such Placement Shares, which in all cases shall be
                                            freely tradeable, transferable, registered shares in good deliverable form, the applicable
                                            Agent will, on each Settlement Date, or such other date as agreed between the Agents and
                                            the Corporation in writing, deliver the related Net Proceeds in same day funds to an account
                                            designated by the Corporation prior to the Settlement Date. </FONT>The Agents covenant and
                                            agree to copy or otherwise include the Corporation on all correspondence between the Agents
                                            and the Corporation&rsquo;s transfer agent, in connection with or relating to the settlement
                                            (electronic or otherwise) of any sale of Placement Shares hereunder and further, shall be
                                            responsible for taking all actions required to be taken by it within the applicable time
                                            periods to ensure that all sales of Placement Shares hereunder are settled without default
                                            in accordance with existing industry practice for regular-way trading. If the Corporation
                                            defaults in its obligation to deliver Placement Shares on a Settlement Date, the Corporation
                                            agrees that in addition to and in no way limiting the rights and obligations set forth in
                                            Section&nbsp;11 hereof, it will (i)&nbsp;hold the Agents harmless against any loss, claim,
                                            damage, or expense (including reasonable legal fees and expenses), as incurred, arising out
                                            of or in connection with such default by the Corporation and (ii)&nbsp;pay to the Agents
                                            any Placement Fee, discount, or other compensation to which it would otherwise have been
                                            entitled absent such default; provided, however, that without limiting Section&nbsp;11 hereof,
                                            with respect to (ii)&nbsp;above, the Corporation shall not be obligated to pay the Agents
                                            any Placement Fee, discount or other compensation on any Placement Shares that it is not
                                            possible to settle due to: (A)&nbsp;a suspension or material limitation in trading in securities
                                            generally on the TSX or Nasdaq; (B)&nbsp;a material disruption in securities settlement or
                                            clearance services in the United States or Canada; or (C)&nbsp;failure by an Agent to comply
                                            with its obligations under the terms of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>6.</B></TD><TD><B><U>Registration Statement and Prospectuses</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">The Corporation has prepared and filed
                                            with the Canadian Qualifying Authorities in the Canadian Qualifying Jurisdictions the Canadian
                                            Preliminary Base Prospectus and has prepared and filed with the Canadian Qualifying Authorities
                                            in the Canadian Qualifying Jurisdictions the Canadian Base Prospectus in respect of an aggregate
                                            of up to US$500,000,000 in Shares, Exchangeable Shares, debt securities, subscription receipts,
                                            units and warrants of the Corporation (collectively, the &ldquo;<B>Shelf Securities</B>&rdquo;)
                                            in each case in accordance with Canadian Securities Laws. The Ontario Securities Commission
                                            (the &ldquo;<B>Reviewing Authority</B>&rdquo;) is the principal regulator of the Corporation
                                            under the passport system procedures provided for under Multilateral Instrument 11-102 &mdash;
                                            <I>Passport System </I>and National Policy 11-202 &mdash; <I>Process for Prospectus Reviews
                                            in Multiple Jurisdictions</I> in respect of the Shelf Securities and the Canadian Offering.
                                            The Reviewing Authority has issued a receipt evidencing that a receipt has been issued on
                                            behalf of itself and the other Canadian Qualifying Authorities for the Canadian Base Prospectus
                                            (the &ldquo;<B>Receipt</B>&rdquo;). The term &ldquo;<B>Canadian Base Prospectus</B>&rdquo;
                                            means the (final) short form base shelf prospectus of the Corporation (in the English language)
                                            dated June&nbsp;5, 2024 filed with the Canadian Qualifying Authorities, at the time the Reviewing
                                            Authority issued the Receipt with respect thereto in accordance with Canadian Securities
                                            Laws, including NI 44-101 and NI 44-102, and includes all documents incorporated therein
                                            by reference and the documents otherwise deemed to be a part thereof or included therein
                                            pursuant to Canadian Securities Laws, including but not limited to, all Designated News Releases.
                                            As used herein, a &ldquo;<B>Designated News Release</B>&rdquo; means a news release disseminated
                                            by the Corporation in respect of previously undisclosed information that, in the Corporation&rsquo;s
                                            determination, constitutes a &ldquo;material fact&rdquo; (as such term is defined in Canadian
                                            Securities Laws) and identified by the Corporation as a &ldquo;designated news release&rdquo;
                                            in writing on the face page&nbsp;of the version of such news release that is filed by the
                                            Corporation on SEDAR+ in compliance with Section&nbsp;5.5 of the Companion Policy to NI 44-102.
                                            As used herein, &ldquo;<B>Canadian Prospectus Supplement</B>&rdquo; means the most recent
                                            prospectus supplement (in the English language) to the Canadian Base Prospectus relating
                                            to the Placement Shares, to be filed by the Corporation with the Canadian Qualifying Authorities
                                            in accordance with Canadian Securities Laws. The Canadian Prospectus Supplement shall provide
                                            that any and all Designated News Releases shall be deemed to be incorporated by reference
                                            in the Canadian Base Prospectus. As of the date of this Agreement, there is a sufficient
                                            remaining amount of unsold Shelf Securities under the Canadian Base Prospectus to cover the
                                            offering and sale of Placement Shares up to the maximum US$50,000,000 to be qualified for
                                            distribution under the Canadian Offering.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">The Corporation has prepared and filed
                                            a registration statement on Form&nbsp;S-3ASR, dated June&nbsp;5, 2024 (File No.&nbsp;333-279949)
                                            (the &ldquo;<B>Initial Registration Statement</B>&rdquo;), which was amended on May&nbsp;29,
                                            2025 on SEC form type &ldquo;POSASR&rdquo; (as amended, the &ldquo;<B>Amended Registration
                                            Statement</B>&rdquo;), and further amended by the Corporation on May&nbsp;30, 2025 by way
                                            of a post-effective amendment to the Amended Registration Statement on SEC form type &ldquo;POS
                                            AM&rdquo; to convert the Amended Registration Statement to a non-WKSI registration statement
                                            on Form&nbsp;S-3 (as so further amended, the &ldquo;<B>POS AM</B>&rdquo;), in each case,
                                            including a related U.S. Base Prospectus (as defined below), covering the registration of
                                            the Shelf Securities under the Securities Act and the rules&nbsp;and regulations of the SEC
                                            thereunder (the &ldquo;<B>Rules&nbsp;and Regulations</B>&rdquo;), together with a U.S. Prospectus
                                            Supplement thereto, covering the sale of Placement Shares up to the Maximum Amount, and such
                                            further amendments to such Registration Statement as may be permitted or required for the
                                            registration of such Shelf Securities. For purposes of this Agreement, references to the
                                            &ldquo;<B>U.S. Base Prospectus</B>&rdquo; shall mean the U.S. base prospectus that is included
                                            in the POS AM. As of the date and time of the filing of the U.S. Prospectus Supplement, there
                                            is a sufficient remaining amount of unsold Shelf Securities under the Registration Statement
                                            to cover the Maximum Amount (less any amounts previously sold in the Offerings).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Any reference herein to the Registration
                                            Statement, the Base Prospectuses, the Prospectus Supplements or the Prospectuses or any amendment
                                            or supplement thereto shall be deemed to refer to and include the documents incorporated
                                            by reference therein, and any reference herein to the terms &ldquo;amend,&rdquo; &ldquo;amendment&rdquo;
                                            or &ldquo;supplement&rdquo; with respect to the Registration Statement, the Base Prospectuses,
                                            the Prospectus Supplements or the Prospectuses shall be deemed to refer to and include the
                                            filing or furnishing of any document with or to the SEC or the Canadian Qualifying Authorities,
                                            as applicable, on or after the effective date of the Registration Statement or the date of
                                            the Base Prospectuses, the Prospectus Supplements or the Prospectuses, as the case may be,
                                            and deemed to be incorporated by reference therein. For purposes of this Agreement, all references
                                            to the Canadian Base Prospectus, the Canadian Prospectus Supplement and the Canadian Prospectus
                                            or any amendment or supplement thereto shall be deemed to include any copy filed with any
                                            Canadian Qualifying Jurisdiction on SEDAR+ and all references to the Registration Statement,
                                            the U.S. Base Prospectus, the U.S. Prospectus Supplement and the U.S. Prospectus or any amendment
                                            or supplement thereto shall be deemed to include any copy filed with the SEC on EDGAR.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">All references in this Agreement to financial
                                            statements and schedules and other information which is &ldquo;contained,&rdquo; &ldquo;included&rdquo;
                                            or &ldquo;stated&rdquo; in the Registration Statement, the U.S. Base Prospectus, the U.S.
                                            Prospectus Supplement and the U.S. Prospectus (or other references of like import) shall
                                            be deemed to mean and include all such financial statements and schedules and other information
                                            which is incorporated by reference in or otherwise deemed by the Rules&nbsp;and Regulations
                                            to be a part of or included in the Registration Statement, the U.S. Base Prospectus, the
                                            U.S. Prospectus Supplement or the U.S. Prospectus, as the case may be; and all references
                                            in this Agreement to amendments or supplements to the Registration Statement, the U.S. Base
                                            Prospectus, the U.S. Prospectus Supplement or the U.S. Prospectus shall be deemed to mean
                                            and include the filing of any document under the Exchange Act, and which is deemed to be
                                            incorporated therein by reference or otherwise deemed by the Rules&nbsp;and Regulations to
                                            be a part of or included in the Registration Statement, the U.S. Base Prospectus, the U.S.
                                            Prospectus Supplement or the U.S. Prospectus, as the case may be. All references in this
                                            Agreement to financial statements and other information which is &ldquo;described,&rdquo;
                                            &ldquo;contained,&rdquo; &ldquo;included&rdquo; or &ldquo;stated&rdquo; in the Canadian Base
                                            Prospectus, the Canadian Prospectus Supplement or the Canadian Prospectus (or other references
                                            of like import) shall be deemed to mean and include all such financial statements and other
                                            information which is incorporated by reference in or otherwise deemed by Canadian Securities
                                            Laws to be a part of or included in the Canadian Base Prospectus, the Canadian Prospectus
                                            Supplement or the Canadian Prospectus, as the case may be.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>7.</B></TD><TD><B><U>Representations and Warranties of the Corporation</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Corporation represents
and warrants to, and agrees with, the Agents that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><U>Prospectuses and Registration Statement</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">The Corporation is qualified in accordance
                                            with the provisions of NI 44-101 and NI 44-102 to file a short form base shelf prospectus
                                            in each of the Canadian Qualifying Jurisdictions and the entering into of this Agreement
                                            will not cause the Receipt to cease to be effective. Any amendment or supplement to the Registration
                                            Statement or the Prospectuses required by this Agreement will be so prepared and filed by
                                            the Corporation and, as applicable, the Corporation will use commercially reasonable efforts
                                            to cause it to become effective as soon as reasonably practicable. No stop order suspending
                                            the effectiveness of the Registration Statement has been issued under the Securities Act,
                                            and no proceeding for that purpose has been instituted or, to the knowledge of the Corporation,
                                            threatened by the SEC, and any request on the part of the SEC for additional or supplemental
                                            information has been complied with. No order preventing or suspending the use of the Base
                                            Prospectuses, the Prospectus Supplements, the Prospectuses or any Issuer Free Writing Prospectus
                                            has been issued by the SEC or any Canadian Qualifying Authority. The Canadian Prospectus,
                                            at the time of filing thereof with the Canadian Qualifying Authorities, complied in all material
                                            respects and, as amended or supplemented, if applicable, will comply in all material respects
                                            with Canadian Securities Laws. The Canadian Prospectus, as amended or supplemented, as of
                                            its date, did not and, as of each Applicable Time and Settlement Date, if any, will not contain
                                            a misrepresentation, as defined under Canadian Securities Laws. The Canadian Prospectus,
                                            as amended or supplemented, as of its date, did and, as of each Applicable Time and Settlement
                                            Date, if any, will contain full, true and plain disclosure of all material facts relating
                                            to the Placement Shares and to the Corporation. The representations and warranties set forth
                                            in the two immediately preceding sentences do not apply to statements in or omissions from
                                            the Canadian Prospectus, or any amendments or supplements thereto, made in reliance upon
                                            and in conformity with information furnished to the Corporation in writing by or on behalf
                                            of the Agents expressly for use therein, it being understood and agreed that the only information
                                            furnished by any Agent consists of the information described as such in Section&nbsp;11(a)&nbsp;hereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">At the time of filing the Initial Registration
                                            Statement, the Corporation met the requirements to file a registration statement on Form&nbsp;S-3ASR;
                                            at the time of filing the Amended Registration Statement, the Corporation met the requirements
                                            to file an amendment to the Initial Registration Statement on SEC form type &ldquo;POSASR&rdquo;;
                                            and at the time of filing the POS AM, the Corporation met the requirements to file an amendment
                                            to the Amended Registration Statement on SEC form type &ldquo;POS AM&rdquo; to convert the
                                            Amended Registration Statement to a non-WKSI registration statement on Form&nbsp;S-3. As
                                            of the date hereof, the Corporation remains permitted to use the POS AM for the offering
                                            and sale of the Placement Shares up to the Maximum Amount and other Shelf Securities in reliance
                                            on General Instruction I.B.1 of Form&nbsp;S-3. The initial Effective Date of the Registration
                                            Statement was not earlier than the date three years before the Execution Time. The Registration
                                            Statement, including any amendments thereto, remains effective, and no stop order suspending
                                            the effectiveness of the Registration Statement has been issued under the Securities Act
                                            and no proceedings for that purpose have been instituted or are pending or, to the knowledge
                                            of the Corporation, are contemplated or threatened by the SEC, and any request on the part
                                            of the SEC for additional or supplemental information has been complied with.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">The Corporation shall file with the SEC
                                            a U.S. Prospectus Supplement relating to the sale of Placement Shares up to the Maximum Amount
                                            in accordance with Rule&nbsp;424(b)&nbsp;promptly after the execution of this Agreement (but
                                            in any event in the time period prescribed by Rule&nbsp;424(b)). As filed, the U.S. Prospectus
                                            shall contain all information required by the Securities Act, and, except to the extent the
                                            Agents shall agree in writing to a modification, shall be in all substantive respects in
                                            the form furnished to the Agents prior to the execution of this Agreement or prior to any
                                            such time this representation is repeated or deemed to be made. The Registration Statement,
                                            at the Execution Time, and during any period in which a prospectus relating to any Placement
                                            Shares is required to be delivered by the Agents (including in circumstances where such requirement
                                            may be satisfied pursuant to Rule&nbsp;172 under the Securities Act or similar rule) (the
                                            &ldquo;<B>Prospectus Delivery Period</B>&rdquo;), meets, or will meet, the requirements for
                                            a continuous or delayed offering set forth in Rule&nbsp;415(a)(1)(x)&nbsp;under the Securities
                                            Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">The Corporation has delivered to each of
                                            the Agents one complete copy of each of the Canadian Base Prospectus and the Registration
                                            Statement and a copy of each consent of experts filed as a part thereof, and conformed copies
                                            of the Canadian Base Prospectus, the Registration Statement (without exhibits) and the Prospectuses,
                                            as amended or supplemented, at such places as the Agents have reasonably requested (provided
                                            that the Corporation shall not be required to deliver any such document if such document
                                            is accessible from SEDAR+ or EDGAR).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><U>No Misstatement or Omission</U>. The
                                            Registration Statement, at the Execution Time, on each Effective Date, at each deemed effective
                                            date with respect to the Agents pursuant to Rule&nbsp;430B(f)(2)&nbsp;under the Securities
                                            Act, at each Applicable Time and Settlement Date, if any, and the U.S. Prospectus, on the
                                            date of filing thereof with the SEC and at each Applicable Time and Settlement Date, conformed,
                                            or will conform in all material respects, with the applicable requirements of the Rules&nbsp;and
                                            Regulations, and the Registration Statement, when it became effective and at each deemed
                                            effective date with respect to the Agents pursuant to Rule&nbsp;430B(f)(2)&nbsp;under the
                                            Securities Act, did not or will not contain any untrue statement of a material fact or omit
                                            to state a material fact required to be stated therein or necessary to make the statements
                                            therein not misleading; and the U.S. Prospectus, on the date of filing thereof with the SEC,
                                            and the U.S. Prospectus and the applicable Issuer Free Writing Prospectus, if any, issued
                                            at or prior to such Applicable Time, taken together (collectively, and with respect to any
                                            Placement Shares, together with the applicable sale price of such Placement Shares, the &ldquo;<B>Disclosure
                                            Package</B>&rdquo;) and at each Applicable Time and Settlement Date, if any, did not or will
                                            not include any untrue statement of a material fact or omit to state a material fact necessary
                                            in order to make the statements therein, in the light of the circumstances under which they
                                            were made, not misleading; except that the foregoing shall not apply to statements or omissions
                                            in any such document based upon and in conformity with information furnished in writing to
                                            the Corporation by or on behalf of any Agent specifically for inclusion therein, it being
                                            understood and agreed that the only information furnished by the Agents consist of the information
                                            described as such in Section&nbsp;11(a)&nbsp;hereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><U>Incorporation and Good Standing of
                                            Corporation</U>. The Corporation has been duly incorporated and is validly existing and is
                                            in good standing under the laws of its jurisdiction of incorporation and has all requisite
                                            corporate power and authority to carry on its business as now carried on and presently proposed
                                            to be conducted as is or will be described in the Registration Statement, the Prospectuses
                                            and the Disclosure Package and to carry out the transactions contemplated by this Agreement,
                                            and is duly qualified to transact business and is in good standing in each jurisdiction in
                                            which such qualification is required.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><U>Title</U>. The material subsidiaries
                                            of the Corporation as of August&nbsp;29, 2025 are set out in Exhibit&nbsp;D and are directly
                                            or indirectly owned by the Corporation in the percentages set out therein (each, a &ldquo;<B>Material
                                            Subsidiary</B>&rdquo;, and collectively, the &ldquo;<B>Material Subsidiaries</B>&rdquo;).
                                            Other than the Material Subsidiaries, neither the Corporation nor any Material Subsidiary
                                            has, directly or indirectly, any interest (whether equity, debt or otherwise) in any entity
                                            other than: (i)&nbsp;immaterial subsidiaries of the Corporation as of August&nbsp;29, 2025
                                            which are set out in Exhibit&nbsp;E and which are directly or indirectly owned by the Corporation
                                            in the percentages set out therein (the &ldquo;<B>Immaterial Subsidiaries</B>&rdquo;); and
                                            (ii)&nbsp;the Investment Entities. Each of the Subsidiaries and, to the knowledge of the
                                            Corporation, the Investment Entities, is a corporation, company or limited partnership organized
                                            and existing under the laws of the jurisdiction of its incorporation or formation, is current
                                            and up-to-date with all material filings required to be made under the laws of its jurisdiction
                                            of incorporation or formation and has the requisite power and capacity to own, lease and
                                            operate its properties and assets and to conduct its business as now carried on by it, and
                                            is duly qualified to transact business and is in good standing in each jurisdiction in which
                                            such qualification is required, whether by reason of the ownership, leasing or licensing
                                            of property or the conduct of business, except where the failure to be so would not have
                                            a Material Adverse Effect. The term &ldquo;<B>Material Adverse Effect</B>&rdquo; means an
                                            effect, change, event or occurrence that, individually or in the aggregate, has or would
                                            reasonably be expected to have a material adverse effect on: (A)&nbsp;the business, general
                                            affairs, management, condition (financial or otherwise), results of operations, shareholders&rsquo;
                                            equity, properties or prospects of the Corporation and its Subsidiaries, taken as a whole,
                                            or (B)&nbsp;the ability of the Corporation to consummate the transactions contemplated herein.
                                            No Subsidiary is currently prohibited, directly or indirectly, from paying any dividends
                                            to the Corporation, from making any other distribution on such Subsidiary&rsquo;s share capital,
                                            from repaying to the Corporation any loans or advances to such Subsidiary from the Corporation
                                            or from transferring any of such Subsidiary&rsquo;s property or assets to the Corporation
                                            or any other Subsidiary, as the case may be. All of the issued and outstanding shares or
                                            other equity interests in the capital of each Subsidiary and, to the extent such equity interests
                                            are owned by the Corporation or a Subsidiary, of each Investment Entity, have been duly authorized
                                            and validly issued, are fully paid and non-assessable and are directly or indirectly beneficially
                                            owned by the Corporation, free and clear of any encumbrance or title defect of whatever kind
                                            or nature, regardless of form, whether or not registered or registrable or arising by law
                                            (statutory or otherwise), including any mortgage, lien, charge, pledge or security interest,
                                            whether fixed or floating, or any assignment, lease, option, right of pre-emption, privilege,
                                            encumbrance, easement, servitude, right of way, restrictive covenant, right of use or any
                                            other right or claim of any kind or nature whatever which affects ownership or possession
                                            of, or title to, any interest in, or the right to use or occupy such property or assets (each,
                                            a &ldquo;<B>Lien</B>&rdquo;, and together, the &ldquo;<B>Liens</B>&rdquo;) except such as
                                            are described in the Registration Statement, the Prospectuses and the Disclosure Package
                                            or such as do not (individually or in the aggregate) materially affect the value of such
                                            shares or other equity interests, and none of the outstanding shares or other equity interests
                                            of any Subsidiary was issued in violation of pre-emptive or similar rights of any security
                                            holder of such subsidiary. There exist no options, warrants, purchase rights, or other contracts
                                            or commitments that could require the Corporation to sell, transfer or otherwise dispose
                                            of any shares or equity interest of any Material Subsidiary or Investment Entity. No act
                                            or proceeding has been taken by or against the Material Subsidiaries or, to the knowledge
                                            of the Corporation, the Investment Entities, in connection with their liquidation, winding-up
                                            or bankruptcy.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify"><U>Licences</U>. Each of the Corporation,
                                            the Subsidiaries and, to the knowledge of the Corporation, the Investment Entities has all
                                            requisite power, capacity and authority, and all necessary consents, approvals, authorizations,
                                            orders, registrations, qualifications, licences, filings and permits of, with and from all
                                            judicial, regulatory and other legal or governmental agencies and bodies and all third parties,
                                            Canadian, U.S. or foreign, including without limitation, those administered by Health Canada
                                            and any successor thereof (&ldquo;<B>Health Canada</B>&rdquo;) or any other governments,
                                            regulatory authorities, governmental departments, agencies, commissions, bureaus, officials,
                                            ministers, Crown corporations, courts, bodies, boards, tribunals, commercial registers or
                                            dispute settlement panels or other law, rule&nbsp;or regulation-making organizations or entities
                                            (&ldquo;<B>Governmental Authorities</B>&rdquo;) in Canada or any other country performing
                                            functions similar to those performed by Health Canada (collectively, the &ldquo;<B>Consents</B>&rdquo;),
                                            to own, lease and operate its properties and conduct its business as it is now being conducted
                                            or, except as disclosed in the Registration Statement, the Prospectuses and the Disclosure
                                            Package, proposed to be conducted, in each case as disclosed in the Registration Statement,
                                            the Prospectuses and the Disclosure Package, and each such Consent is valid, existing, in
                                            good standing and in full force and effect, except in each case as would not have, individually
                                            or in the aggregate, any Material Adverse Effect. Neither the Corporation nor any Subsidiary
                                            nor, to the knowledge of the Corporation, any Investment Entity, has received notice of any
                                            investigation or proceedings which, if decided adversely to the Corporation, any such Subsidiary
                                            or Investment Entity, as the case may be, could reasonably be expected to result in a Material
                                            Adverse Effect. The Corporation, each Subsidiary, and, to the knowledge of the Corporation,
                                            each Investment Entity, have been and are in compliance with the terms and conditions of
                                            all such Consents, except where the failure to so comply would not, individually or in the
                                            aggregate, have any Material Adverse Effect.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify"><U>Compliance with Applicable Laws</U>.
                                            Each of the Corporation and the Subsidiaries has conducted and is conducting its business
                                            and activities in compliance in all material respects with all applicable laws, rules&nbsp;and
                                            regulations of each jurisdiction in which it carries on such business and activities. To
                                            the knowledge of the Corporation, each of the Investment Entities has conducted and is conducting
                                            its business and activities in compliance in all material respects with all applicable laws,
                                            rules&nbsp;and regulations of each jurisdiction in which it carries on such business and
                                            activities except as disclosed in the Registration Statement, the Prospectuses and the Disclosure
                                            Package. Neither the Corporation nor any Subsidiary, nor to the knowledge of the Corporation,
                                            any Investment Entity, has received any notice of any alleged violation of any laws, rules&nbsp;or
                                            regulations.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify"><U>No Defaults</U>. None of the Corporation
                                            or the Subsidiaries is in default of any term, covenant or condition under or in respect
                                            of any judgment, order, agreement or instrument to which it is a party or to which it or
                                            any of the properties or assets thereof are or may be subject, and no event has occurred
                                            and is continuing, and no circumstance exists which constitutes a default by it in respect
                                            of any commitment, agreement, document or other instrument to which the Corporation or any
                                            Subsidiary is a party or by which it is otherwise bound entitling any other party thereto
                                            to accelerate the maturity of any amount owing thereunder, except with respect to all of
                                            the foregoing such as would not, individually or in the aggregate, if the subject of an unfavourable
                                            decision, order, ruling or finding, have a Material Adverse Effect.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify"><U>Enforceability of Agreement</U>. The
                                            Corporation has duly authorized, executed and delivered this Agreement and this Agreement
                                            constitutes a legal, valid and binding obligation of the Corporation enforceable against
                                            it in accordance with its terms, subject to the exceptions as to enforceability as are contained
                                            in the opinion of Cassels Brock&nbsp;&amp; Blackwell LLP referred to in Section&nbsp;8(o)&nbsp;hereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify"><U>No Consents Required</U>. Except as
                                            shall have been made or obtained on or before each Applicable Time and Settlement Date, if
                                            any, each of which is, or shall be, in full force and effect (on a conditional basis, in
                                            the case of the consent of the TSX), no consent, approval, authorization, registration or
                                            qualification of any court, governmental agency or body, regulatory authority or contractual
                                            party is required for the execution, delivery and performance of this Agreement, the distribution
                                            of the Placement Shares or the consummation of the transactions contemplated herein.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(j)</TD><TD STYLE="text-align: justify"><U>Due Authorization</U>. The Corporation
                                            has the necessary corporate power and authority to execute and deliver the Registration Statement
                                            and the Canadian Prospectus and, if applicable, will have the necessary corporate power and
                                            authority to execute and deliver any amendment to the Registration Statement or the Canadian
                                            Prospectus prior to the filing thereof, and all necessary corporate action has been taken
                                            by the Corporation to authorize the execution and delivery by it of the Registration Statement,
                                            the Canadian Prospectus and the filing thereof, as the case may be, in each of the Canadian
                                            Qualifying Jurisdictions under Canadian Securities Laws or with the SEC under the Securities
                                            Act, as applicable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(k)</TD><TD STYLE="text-align: justify"><U>No Material Change</U>. Subsequent
                                            to the respective dates as of which information is given in the Registration Statement, the
                                            Prospectuses and the Disclosure Package, except as disclosed in the Registration Statement,
                                            the Prospectuses and the Disclosure Package, (i)&nbsp;the Corporation has not declared or
                                            paid any dividends, or made any other distribution of any kind, on or in respect of its share
                                            capital, (ii)&nbsp;there has not been any material change in the share capital or long-term
                                            or short-term debt of the Corporation or any Subsidiary, (iii)&nbsp;neither the Corporation
                                            nor any Subsidiary has sustained any loss or interference with its business or properties
                                            from fire, explosion, flood, hurricane, accident or other calamity, whether or not covered
                                            by insurance, or from any labor dispute or any legal or governmental proceeding except where
                                            the loss or interference would not, result in a Material Adverse Effect, and (iv)&nbsp;there
                                            has not been any Material Adverse Effect or any development involving a prospective Material
                                            Adverse Effect, whether or not arising from transactions in the ordinary course of business,
                                            in or affecting the business, general affairs, management, condition (financial or otherwise),
                                            results of operations, shareholders&rsquo; equity, properties or prospects of the Corporation
                                            and the Subsidiaries, taken as a whole. Since the date of the latest balance sheet included,
                                            or incorporated by reference, in the Registration Statement, the Prospectuses and the Disclosure
                                            Package, neither the Corporation nor any Subsidiary has incurred or undertaken any liabilities
                                            or obligations, whether direct or indirect, liquidated or contingent, matured or unmatured,
                                            or entered into any transactions, including any acquisition or disposition of any business
                                            or asset, which are material to the Corporation and the Subsidiaries, taken as a whole, except
                                            for liabilities, obligations and transactions which are disclosed in the Registration Statement,
                                            the Prospectuses and the Disclosure Package.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(l)</TD><TD STYLE="text-align: justify"><U>Financial Information</U>. The consolidated
                                            financial statements of the Corporation and its consolidated subsidiaries, and any Rule&nbsp;3-09
                                            Financial Statements (as defined below), that are included or incorporated by reference in
                                            the Registration Statement, the Prospectuses and the Disclosure Package (the &ldquo;<B>Corporation
                                            Financial Information</B>&rdquo;), together with the related schedules and notes, (i)&nbsp;present
                                            fairly, in all material respects, the financial position of the Corporation and its consolidated
                                            subsidiaries (or equity investees(s), as applicable), as at the date specified in such Corporation
                                            Financial Information; (ii)&nbsp;have been prepared in accordance with accounting principles
                                            generally accepted in the United States of America (&ldquo;<B>U.S. GAAP</B>&rdquo;) applied
                                            on a consistent basis throughout the periods involved, (iii)&nbsp;comply with the requirements
                                            of Canadian Securities Laws and U.S. Securities Laws, subject to any duly obtained waiver
                                            therefrom, and (iv)&nbsp;do not contain any misrepresentation (within the meaning of Canadian
                                            Securities Laws). No other financial statements or supporting schedules are required to be
                                            included, or incorporated by reference in the Registration Statement, the Prospectuses and
                                            the Disclosure Package by Canadian Securities Laws, the Securities Act or the Exchange Act.
                                            The other financial and statistical information included or incorporated by reference in
                                            the Registration Statement, the Prospectuses and the Disclosure Package, including the selected
                                            consolidated financial data set forth under the caption &ldquo;Consolidated Capitalization&rdquo;
                                            in the Canadian Prospectus present fairly the information included or incorporated by reference
                                            therein and have been prepared on a basis consistent with that of the financial statements
                                            that are included or incorporated by reference in the Registration Statement, and the Prospectuses,
                                            and with the books and records of the Corporation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(m)</TD><TD STYLE="text-align: justify"><U>Non-GAAP Measures</U>. All disclosures
                                            contained in the Registration Statement, the Disclosure Package and the Prospectuses regarding
                                            &ldquo;non-GAAP financial measures&rdquo; (as such term is defined by the rules&nbsp;and
                                            regulations of the SEC and under Canadian Securities Laws) comply in all material respects
                                            with Regulation G under the Exchange Act, paragraph (e)&nbsp;of Item 10 of Regulation S-K
                                            under the Securities Act, and Canadian Securities Laws, in each case to the extent applicable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(n)</TD><TD STYLE="text-align: justify"><U>No Undisclosed Liabilities</U>. Neither
                                            the Corporation nor the Subsidiaries have any liabilities, obligations, indebtedness or commitments,
                                            whether accrued, absolute, contingent or otherwise, which are not disclosed or referred to
                                            in the Corporation Financial Information and in the Registration Statement, the Prospectuses
                                            and the Disclosure Package.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(o)</TD><TD STYLE="text-align: justify"><U>Material Interests</U>. Except as disclosed
                                            in the Registration Statement, the Prospectuses and the Disclosure Package, none of the directors,
                                            officers or employees of the Corporation, the Subsidiaries or, to the knowledge of the Corporation,
                                            the Investment Entities or any other person who owns, directly or indirectly, more than 10%
                                            of any class of securities of the Corporation or securities of any person exchangeable for
                                            more than 10% of any class of securities of the Corporation, or any associate or affiliate
                                            of any of the foregoing, had or has any material interest, direct or indirect, in any transaction
                                            or any proposed transaction (including, without limitation, any loan made to or by any such
                                            person) with the Corporation which, as the case may be, materially affects, is material to
                                            or will materially affect the Corporation or any Subsidiary.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(p)</TD><TD STYLE="text-align: justify"><U>Operational Restrictions</U>. Neither
                                            the Corporation nor any Subsidiary is a party to, bound by or affected by any commitment,
                                            agreement or document containing any covenant which expressly and materially limits the freedom
                                            of the Corporation or a Subsidiary to compete in any line of business, transfer or move any
                                            of its respective assets or operations or could reasonably be expected to have a Material
                                            Adverse Effect. The operations of Canopy USA are limited by the Second Amended and Restated
                                            Protection Agreement by and among the Corporation and Canopy USA.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(q)</TD><TD STYLE="text-align: justify"><U>Legal Proceedings</U>. Except as disclosed
                                            in the Registration Statement, the Prospectuses and the Disclosure Package, there is no judicial,
                                            regulatory, arbitral or other legal or governmental proceeding, investigation or other litigation
                                            or arbitration, Canadian, United States or foreign, including any proceeding before Health
                                            Canada or any other Governmental Authority in Canada or any other country performing functions
                                            similar to those performed by Health Canada, in progress or pending to which the Corporation,
                                            any Subsidiary or, to the knowledge of the Corporation, any Investment Entity, are a party
                                            or of which any of their respective property, operations or assets is the subject which,
                                            individually or in the aggregate, if determined adversely to the Corporation, any Subsidiary,
                                            or any Investment Entity, as the case may be, would reasonably be expected to have a Material
                                            Adverse Effect, nor are there any matters under discussion outside of the ordinary course
                                            of business with any Governmental Authority relating to taxes, governmental charges, orders
                                            or assessments asserted by any such authority except as disclosed in the Registration Statement,
                                            the Prospectuses and the Disclosure Package, and to the knowledge of the Corporation there
                                            are no facts or circumstances that would reasonably be expected to form the basis for any
                                            such litigation, governmental or other proceeding or investigation, taxes, governmental charges,
                                            orders or assessments except as disclosed in the Registration Statement, the Prospectuses
                                            and the Disclosure Package; to the Corporation&rsquo;s knowledge, no such proceeding, investigation,
                                            litigation or arbitration is threatened or contemplated except as disclosed in the Registration
                                            Statement, the Prospectuses and the Disclosure Package; and the defense of all such proceedings,
                                            investigations, litigation and arbitrations against or involving the Corporation, any Subsidiary
                                            or, to the knowledge of the Corporation, any Investment Entity would not reasonably be expected
                                            to have a Material Adverse Effect. Except as disclosed in the Registration Statement, the
                                            Prospectuses, and the Disclosure Package, none of the Corporation, any Subsidiary or, to
                                            the knowledge of the Corporation, any Investment Entity, or any director or officer thereof,
                                            is or has been the subject of any judicial, regulatory, arbitral or other legal or governmental
                                            proceeding, investigation or other litigation or arbitration involving a claim of violation
                                            of or liability under federal, provincial, territorial or state securities laws or a claim
                                            of breach of fiduciary duty.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(r)</TD><TD STYLE="text-align: justify"><U>Labor Relations</U>. Each of the Corporation
                                            and its Subsidiaries is in compliance, in all material respects, with the provisions of all
                                            applicable federal, provincial, territorial, state, local and other laws and regulations
                                            respecting employment and employment practices, terms and conditions of employment and wages
                                            and hours. No labor disturbance by the employees of the Corporation or any Subsidiary exists
                                            or, to the knowledge of the Corporation, is imminent and the Corporation is not aware of
                                            any existing or imminent labor disturbances by the employees of any of its or any Subsidiary&rsquo;s
                                            principal suppliers, manufacturers, customers or contractors, which, in either case (individually
                                            or in the aggregate), would have a Material Adverse Effect. No union has been accredited
                                            or otherwise designated to represent any employees of the Corporation or any Subsidiary and,
                                            to the knowledge of the Corporation, no accreditation request or other representation question
                                            is pending with respect to the employees of the Corporation or any Subsidiary, and no collective
                                            agreement or collective bargaining agreement or modification thereof has expired or is in
                                            effect in any of the Corporation&rsquo;s or any Subsidiary&rsquo;s facilities and none is
                                            currently being negotiated by the Corporation or any Subsidiary.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(s)</TD><TD STYLE="text-align: justify"><U>Third-Party Relationships</U>. Except
                                            for such matters as would not, individually or in the aggregate, have a Material Adverse
                                            Effect, no existing supplier, distributor, service provider, manufacturer or contractor of
                                            the Corporation or any Subsidiary has indicated that it intends to terminate its relationship
                                            with the Corporation or such Subsidiary or that it will alter or be unable to meet the Corporation&rsquo;s
                                            or such Subsidiary&rsquo;s supply, distribution, service, manufacturing or contracting requirements.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(t)</TD><TD STYLE="text-align: justify"><U>Pre-Emptive Rights</U>. Except as disclosed
                                            in the Registration Statement, the Prospectuses and the Disclosure Package, the distribution
                                            of the Placement Shares is not subject to the pre-emptive rights of any shareholder of the
                                            Corporation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(u)</TD><TD STYLE="text-align: justify"><U>Translation Relief</U>. The Corporation
                                            has received the French Translation Exemption in respect of the Canadian Base Prospectus
                                            and the Canadian Prospectus Supplement, and such relief remains in full force and effect
                                            without amendment.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify"><U>No Violation</U>. The execution and
                                            delivery of this Agreement, the compliance by the Corporation with the provisions of this
                                            Agreement or the consummation of the transactions contemplated herein or contemplated by,
                                            or described in, the Registration Statement, the Prospectuses and the Disclosure Package,
                                            including, without limitation, the distribution of the Placement Shares by the Corporation
                                            for the consideration and upon the terms and conditions as set out herein, do not or will
                                            not:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">result in any breach of, or constitute a
                                            default under, and do not and will not create a state of facts which, after notice or lapse
                                            of time or both, would result in a breach of or constitute a default under, (a)&nbsp;any
                                            term or provision of the articles, by-laws or resolutions of the Corporation, (b)&nbsp;any
                                            indenture, mortgage, note, contract, agreement (written or oral), instrument, lease or other
                                            document to which the Corporation or any Subsidiary is a party or to which any of them or
                                            any of the properties or assets currently owned by them are subject, except as such would
                                            not have a Material Adverse Effect, or (c)&nbsp;any judgment, decree, order, statute, rule&nbsp;or
                                            regulation of any court, governmental authority, arbitrator, stock exchange or securities
                                            regulatory authority applicable to the Corporation or any Subsidiary or any of the properties
                                            or assets currently owned by them; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">except as disclosed in the Registration
                                            Statement, the Prospectuses and the Disclosure Package, create a right for any other party
                                            to terminate, accelerate or in any way alter any other rights existing under any indenture,
                                            mortgage, note, contract, agreement (written or oral), instrument, lease or other document
                                            to which the Corporation or any Subsidiary is a party or by which any of them or any of the
                                            properties or assets currently owned is bound, except such as would not have a Material Adverse
                                            Effect.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-size: 10pt">Neither
the Corporation nor any Subsidiary nor, to the Corporation&rsquo;s knowledge, any Investment Entity (i)&nbsp;is in violation of its certificate
or articles of incorporation, by-laws, certificate of formation, limited liability company agreement, partnership agreement or other
organizational documents, (ii)&nbsp;is in default under, and no event has occurred which, with notice or lapse of time or both, would
constitute a default under or result in the creation or imposition of any Lien upon any property or assets of the Corporation or any
Subsidiary pursuant to, any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which it is a party
or by which it is bound or to which any of its property or assets is subject, or (iii)&nbsp;is in violation of any statute, law, rule,
regulation, ordinance, directive, judgment, decree or order of any judicial, regulatory or other legal or governmental agency or body,
Canadian, U.S. or foreign, except </FONT>as disclosed in the Registration Statement, the Prospectuses and the Disclosure Package and
except (in the case of clauses (ii)&nbsp;and (iii)&nbsp;above) in any such case for violations or defaults that would not (individually
or in the aggregate) have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(w)</TD><TD STYLE="text-align: justify"><U>Compliance with Anti-Corruption Laws</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">None of the Corporation, any Subsidiary,
                                            any director or officer thereof acting on behalf of the Corporation or any Subsidiary or,
                                            to the knowledge of the Corporation, any agent, employee, affiliate or other person acting
                                            on behalf of the Corporation or any Subsidiary, or, to the knowledge of the Corporation,
                                            any Investment Entity, any director or officer thereof or any agent, employee, affiliate
                                            or other person acting on behalf of any Investment Entity, is aware of or has taken any action,
                                            directly or indirectly, that would result in a violation by such persons of the Foreign Corrupt
                                            Practices Act of 1977, as amended, and the rules&nbsp;and regulations thereunder (the &ldquo;<B>FCPA</B>&rdquo;),
                                            the <I>Corruption of Foreign Public Officials Act</I> (Canada) (the &ldquo;<B>CFPOA</B>&rdquo;),
                                            the <I>Criminal Code</I> (Canada) or any other applicable anti-corruption laws, rules, or
                                            regulation of Canada or any other jurisdiction in which the Corporation, any Subsidiary or
                                            any Investment Entity conducts business, including, without limitation, making use of the
                                            mails or any means or instrumentality of interstate commerce corruptly in furtherance of
                                            an offer, payment, promise to pay or authorization of the payment of any money, or other
                                            property, gift, promise to give, or authorization of the giving of anything of value to any
                                            &ldquo;foreign official&rdquo; or &ldquo;foreign public official&rdquo; (as such terms are
                                            defined in the FCPA and CFPOA, as applicable) or any foreign political party or official
                                            thereof or any candidate for foreign political office, in contravention of the FCPA or the
                                            CFPOA, or to any Canadian public official in contravention of the <I>Criminal Code</I> and
                                            the Corporation,= and the Subsidiaries have conducted their businesses in compliance with
                                            the FCPA, CFPOA, and the <I>Criminal Code</I> (Canada) and have instituted and maintain policies
                                            and procedures designed to ensure, and which are reasonably expected to continue to ensure,
                                            continued compliance therewith.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">None of the Corporation, any Subsidiary,
                                            any director or officer thereof acting on behalf of the Corporation or any Subsidiary or,
                                            to the knowledge of the Corporation, any agent, employee, affiliate or other person acting
                                            on behalf of the Corporation or any Subsidiary, nor, to the knowledge of the Corporation,
                                            any Investment Entity any director or officer thereof or any agent, employee, affiliate or
                                            other person acting on behalf of any Investment Entity, has at any time during the last five
                                            years (i)&nbsp;made any unlawful contribution to any candidate for non-United States office,
                                            or failed to disclose fully any such contribution in violation of law, or (ii)&nbsp;made
                                            any payment to any federal or state governmental officer or official, or other person charged
                                            with similar public or quasi-public duties, other than payments required or permitted by
                                            the laws of the United States or any jurisdiction thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(x)</TD><TD STYLE="text-align: justify"><U>Compliance with Anti-Money Laundering
                                            Laws</U>. The operations of the Corporation, each Subsidiary and, to the knowledge of the
                                            Corporation, any Investment Entity, are and have been conducted at all times in compliance
                                            with applicable financial record-keeping and reporting requirements of the Currency and Foreign
                                            Transactions Reporting Act of 1970, as amended, the <I>Proceeds of Crime (Money Laundering)</I>
                                            and <I>Terrorist Financing Act</I> (Canada), with the <I>Criminal Code</I> (Canada), and
                                            with the money laundering statutes of all other applicable jurisdictions, the rules&nbsp;and
                                            regulations thereunder and any related or similar rules, regulations or guidelines issued,
                                            administered or enforced by any governmental agency (collectively, the &ldquo;<B>Money Laundering
                                            Laws</B>&rdquo;) and no action, suit or proceeding by or before any court or governmental
                                            agency, authority or body or any arbitrator involving the Corporation, any Subsidiary or,
                                            to the knowledge of the Corporation, any Investment Entity, with respect to the Money Laundering
                                            Laws is pending or, to the knowledge of the Corporation, threatened.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(y)</TD><TD STYLE="text-align: justify"><U>Compliance with Sanctions Laws</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">Neither the Corporation nor any Subsidiary
                                            nor any director or officer thereof nor, to the Corporation&rsquo;s knowledge, any employee,
                                            agent, affiliate, representative or other person acting on behalf of the Corporation or any
                                            Subsidiary, is an individual or entity (&ldquo;<B>Specified Person</B>&rdquo;) that is, or
                                            is 50% or more owned or controlled by a Specified Person that is: (i)&nbsp;the subject or
                                            target of any sanctions administered or enforced by the U.S. Department of Treasury&rsquo;s
                                            Office of Foreign Assets Control, the United Nations Security Council, the European Union,
                                            His Majesty&rsquo;s Treasury, Global Affairs Canada, Public Safety Canada or other relevant
                                            sanctions authority (collectively, &ldquo;<B>Sanctions</B>&rdquo;), nor (ii)&nbsp;located,
                                            organized or resident in a country or territory that is the subject or target of comprehensive
                                            economic Sanctions including, without limitation, Cuba, Burma (Myanmar),&nbsp;Iran, North
                                            Korea, Sudan, Syria, the Crimea Region and the non-government controlled areas of Zaporizhzhia
                                            and Kherson Regions of Ukraine, the so-called Donetsk People&rsquo;s Republic and the so-called
                                            Luhansk People&rsquo;s Republic (each, a &ldquo;<B>Sanctioned Territory</B>&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">The Corporation will not, directly or indirectly,
                                            use the proceeds of the Offerings, or lend, contribute or otherwise make available such proceeds
                                            to any subsidiary, joint venture partner or other person: (i)&nbsp;to fund or facilitate
                                            any unauthorized activities or business of or with any person that, at the time of such funding
                                            or facilitation, is the subject of Sanctions, or in any Sanctioned Territory; or (ii)&nbsp;in
                                            any other manner that will result in a violation of Sanctions by any person (including any
                                            person participating in the Offerings, whether as underwriter, advisor, investor or otherwise).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">For the past five years, the Corporation,
                                            its Subsidiaries and, to the knowledge of the Corporation, the Investment Entities, have
                                            not knowingly engaged in, are not now knowingly engaged in, and will not engage in, any direct
                                            or indirect dealings or transactions in violation of applicable Sanctions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(z)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Corporation
                                            Activities</U>. N</FONT>either the Corporation nor any of its Subsidiaries nor any director,
                                            officer, employee or any agent or other person acting on behalf of the Corporation or any
                                            Subsidiary has cultivated, produced, processed, imported or distributed any cannabis or cannabinoid
                                            product or has otherwise engaged in any direct or indirect dealings or transactions, in each
                                            case, involving the purchase or sale of cannabis or cannabinoid product by the Corporation
                                            or any of its Subsidiaries in or to any jurisdiction (including the United States of America,
                                            its territories and possessions, any state of the United States and the District of Columbia)
                                            where such activity is illegal. The Corporation and its Subsidiaries have instituted and
                                            maintained policies and procedures reasonably designed to ensure that the Corporation and
                                            its Subsidiaries do not carry on any activities in, or distribute any products to, any jurisdiction
                                            where such activities or products are not in compliance with applicable laws.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(aa)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt"><U>Criminal
                                            Laws</U>. </FONT>Neither the Corporation nor any of its Subsidiaries has violated, and does
                                            not reasonably expect it will violate, U.S. federal or state criminal laws, including, without
                                            limitation, the Federal Cannabis Laws, the Racketeering Influenced and Corrupt Practices
                                            Act, the Travel Act or any anti-money laundering statute. No action, suit or proceeding by
                                            or before any U.S. court or governmental agency, authority or body or any arbitrator involving
                                            the Corporation or any of its Subsidiaries with respect to U.S. federal or state criminal
                                            laws is pending or, to the Corporation&rsquo;s knowledge, threatened.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(bb)</TD><TD STYLE="text-align: justify"><U>U.S. Cannabis Compliance</U>. As of
                                            the date hereof, the Corporation&rsquo;s interest in the Investment Entities is structured
                                            (the &ldquo;<B>Canopy USA Structure</B>&rdquo;) such that the Corporation holds non-voting,
                                            non-participating securities in the Investment Entities on the terms and conditions as described
                                            in the Registration Statement, the Prospectuses and the Disclosure Package, and in connection
                                            therewith, the Corporation does not, directly or indirectly, exercise control or direction
                                            over any of the Investment Entities or their respective subsidiaries, and under the terms
                                            of the Canopy USA Structure, the Investment Entities are prohibited from paying any dividends
                                            or making any other distribution on share capital to the Corporation and its Subsidiaries.
                                            None of the Nasdaq, TSX, SEC, OSC or any other Governmental Authority, as of the date hereof,
                                            has raised any objections with respect to the Canopy USA Structure that have not been adequately
                                            remedied. As of the date hereof, the Corporation has completed the deconsolidation of the
                                            Investment Entities under U.S. GAAP in accordance with the terms of the Canopy USA Structure;
                                            and the Corporation and its Subsidiaries, and, to the knowledge of the Corporation, the Investment
                                            Entities, have conducted their operations in compliance with the terms and conditions of
                                            the Canopy USA Structure. The Corporation and its Subsidiaries are not considered a U.S.
                                            Marijuana Issuer (as defined in the Canadian Securities Administrators Staff Notice 51-352
                                            &ndash; <I>Issuers with U.S. Marijuana-Related Activities</I> (the &ldquo;<B>Staff Notice</B>&rdquo;))
                                            nor does the Corporation have material ancillary involvement in the U.S. cannabis industry
                                            in accordance with the Staff Notice.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(cc)</TD><TD STYLE="text-align: justify"><U>Financial and Disclosure Controls</U>.
                                            The Corporation and each of its Subsidiaries maintain a system of internal accounting and
                                            other controls sufficient to provide reasonable assurance that (i)&nbsp;transactions are
                                            executed in accordance with management&rsquo;s general or specific authorizations, (ii)&nbsp;transactions
                                            are recorded as necessary to permit preparation of financial statements in conformity with
                                            U.S. GAAP and to maintain asset accountability, (iii)&nbsp;access to assets is permitted
                                            only in accordance with management&rsquo;s general or specific authorization, and (iv)&nbsp;the
                                            recorded accountability for assets is compared with the existing assets at reasonable intervals
                                            and appropriate action is taken with respect to any differences. Except as disclosed in the
                                            Registration Statement, the Prospectuses or the Disclosure Package, the Corporation&rsquo;s
                                            &ldquo;internal control over financial reporting&rdquo; (as such term is defined in Rule&nbsp;13a-15(f)&nbsp;under
                                            the Exchange Act and Canadian Securities Laws) are effective and the Corporation and its
                                            Subsidiaries are not aware of any material weakness in their internal control over financial
                                            reporting. Since the date of the latest audited consolidated financial statements included
                                            or incorporated by reference in the Registration Statement, the Prospectuses and the Disclosure
                                            Package there has been no change in the Corporation&rsquo;s internal control over financial
                                            reporting that would have a Material Adverse Effect. Except as disclosed in the Registration
                                            Statement, the Prospectuses and the Disclosure Package, the Corporation and its Subsidiaries
                                            maintain &ldquo;disclosure controls and procedures&rdquo; (as such term is defined in Rule&nbsp;13a-15(e)&nbsp;under
                                            the Exchange Act and Canadian Securities Laws) that have been designed to ensure that material
                                            information relating to the Corporation and its Subsidiaries is made known to the Corporation&rsquo;s
                                            principal executive officer and principal financial officer. Except as disclosed in the Registration
                                            Statement, the Prospectuses or the Disclosure Package, such disclosure controls and procedures
                                            of the Corporation and the Subsidiaries were effective as at the date of the Corporation&rsquo;s
                                            most recent balance sheet.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(dd)</TD><TD STYLE="text-align: justify"><U>Tax Returns</U>. Except as has been
                                            disclosed in each of the Registration Statement, the Prospectuses and the Disclosure Package:
                                            (i)&nbsp;each of the Corporation and the Subsidiaries has, on a timely basis, accurately
                                            prepared and filed all U.S., Canadian and foreign tax returns that are required to be filed
                                            by it and has paid or made provision for the payment of all applicable taxes, assessments,
                                            governmental or other similar charges with respect to the periods covered by such tax returns,
                                            except to the extent that the failure to do any of the foregoing would not be expected to
                                            have a Material Adverse Effect; (ii)&nbsp;each of the Corporation and the Subsidiaries has
                                            paid all sales and use taxes and all taxes which the Corporation or any Subsidiary is obligated
                                            to withhold from amounts owing to employees, creditors and third parties, except in any such
                                            case as would not have a Material Adverse Effect; (iii)&nbsp;the Corporation is not aware
                                            of any tax deficiencies or interest or penalties accrued or accruing or alleged to be accrued
                                            or accruing, thereon with respect to itself or any Subsidiary which have not otherwise been
                                            provided for by the Corporation, except to the extent that any such deficiency, interest
                                            or penalty would not be expected to have a Material Adverse Effect; (iv)&nbsp;there are no
                                            transfer taxes or other similar fees or charges under Canadian or U.S. federal law or the
                                            laws of any state, province, territory or any political subdivision thereof, required to
                                            be paid in connection with the execution and delivery of this Agreement or the issuance by
                                            the Corporation or sale by the Corporation of the Placement Shares; and (v)&nbsp;no stamp
                                            duty, registration or documentary taxes, duties or similar charges are payable under Canadian
                                            or U.S. federal laws or the laws of any state, province, territory or any political subdivision
                                            thereof in connection with the creation, issuance, sale and delivery to the Agents of the
                                            Placement Shares or the authorization, execution, delivery and performance of this Agreement
                                            or the resale of Placement Shares by an Agent to U.S. residents. The accruals and reserves
                                            on the books and records of the Corporation and the Subsidiaries in respect of tax liabilities
                                            for any taxable period not finally determined are adequate to meet any assessments and related
                                            liabilities for any such period and, since the date of the most recent audited consolidated
                                            financial statements of the Corporation, the Corporation and the Subsidiaries have not incurred
                                            any liability for taxes other than in the ordinary course of their business, except to the
                                            extent that any such liability would not be expected to have a Material Adverse Effect. There
                                            is no tax lien, whether imposed by any U.S., Canadian or other taxing authority, outstanding
                                            against the assets, properties or business of the Corporation or any Subsidiary, except to
                                            the extent that any such tax lien would not be expected to have a Material Adverse Effect.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ee)</TD><TD STYLE="text-align: justify"><U>Accurate Disclosures</U>. The statements
                                            set forth in the Canadian Base Prospectus under the captions &ldquo;<I>Description of Securities</I>&rdquo;,
                                            &ldquo;<I>The Corporation</I>&rdquo; and &ldquo;<I>Risk Factors</I>&rdquo;; in the U.S. Base
                                            Prospectus under the captions &ldquo;<I>Description of Capital Shares</I>&rdquo;, &ldquo;<I>The
                                            Company</I>&rdquo;, &ldquo;<I>Risk Factors</I>&rdquo; and &ldquo;<I>Enforceability of Civil
                                            Liabilities</I>&rdquo;; in the Corporation&rsquo;s most recently filed Annual Report on Form&nbsp;10-K
                                            under the caption &ldquo;<I>Item 1. Business</I>&rdquo; (as updated by the Corporation&rsquo;s
                                            most recently filed Quarterly Report on Form&nbsp;10-Q, if applicable); in the U.S. Prospectus
                                            Supplement under the captions &ldquo;<I>Certain Canadian Income Tax Considerations</I>&rdquo;
                                            and &ldquo;<I>Certain United States Federal Income Tax Considerations</I>&rdquo;; in the
                                            Canadian Prospectus Supplement under the captions &ldquo;<I>Certain Canadian Federal Income
                                            Tax Considerations</I>&rdquo; and &ldquo;<I>Certain United States Federal Income Tax Considerations</I>&rdquo;;
                                            and in the Registration Statement under <I>&ldquo;Part&nbsp;II &ndash; Item 15. Indemnification
                                            of Directors and Officers</I>&rdquo;, insofar as such statements summarize legal matters,
                                            agreements, documents or proceedings discussed therein, are, in all material respects, accurate,
                                            complete and fair summaries of such legal matters, agreements, documents or proceedings.
                                            There is no franchise, contract or other document of a character required to be described
                                            in the Registration Statement, the Prospectuses or the Disclosure Package, or to be filed
                                            as an exhibit thereto, which is not described or filed as required; insofar as such descriptions
                                            summarize legal matters, agreements, documents or proceedings discussed therein, such descriptions
                                            are accurate and fair summaries of such legal matters, agreements, documents or proceedings.
                                            This Agreement conforms in all material respects to the description thereof in the Prospectuses.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ff)</TD><TD STYLE="text-align: justify"><U>Significant Acquisitions or Dispositions</U>.
                                            Except as disclosed in the Registration Statement, the Prospectuses and the Disclosure Package,
                                            no acquisition or disposition has been completed by the Corporation during its three most
                                            recent fiscal years or since the beginning of the Corporation&rsquo;s current fiscal year
                                            that would be a significant acquisition or disposition for the purposes of Canadian Securities
                                            Laws, the Securities Act or the Rules&nbsp;and Regulations or that would require the financial
                                            statement and/or pro forma disclosure in respect of the acquired business in the Registration
                                            Statement, the Prospectuses and the Disclosure Package, and no proposed acquisition by the
                                            Corporation has progressed to a state where a reasonable person would believe that the likelihood
                                            of the Corporation completing the acquisition is high or would be considered &ldquo;probable&rdquo;
                                            (within the meaning of Regulation S-X under the Securities Act) and that: (i)&nbsp;if completed
                                            by the Corporation at the date of the Prospectuses, would be a significant acquisition for
                                            the purposes of Canadian Securities Laws, the Securities Act or the Rules&nbsp;and Regulations
                                            or (ii)&nbsp;would require the financial statement disclosure in respect of the acquired
                                            business in the Registration Statement, the Prospectuses and the Disclosure Package.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(gg)</TD><TD STYLE="text-align: justify"><U>Capitalization</U>. The Corporation
                                            is authorized to issue an unlimited number of Shares and an unlimited number of Exchangeable
                                            Shares. All of the issued and outstanding Shares and Exchangeable Shares are fully paid and
                                            non-assessable and have been duly and validly authorized and issued, in material compliance
                                            with all applicable Canadian, United States and other securities laws and not in violation
                                            of or subject to any pre-emptive or similar right that entitles any person to acquire from
                                            the Corporation any Shares, Exchangeable Shares or other security of the Corporation or any
                                            security convertible into, or exercisable or exchangeable for, Shares, Exchangeable Shares
                                            or any other such security (any &ldquo;<B>Relevant Security</B>&rdquo;), except for such
                                            rights as (i)&nbsp;may have been fully satisfied or waived prior to the date hereof, or (ii)&nbsp;are
                                            disclosed in the Registration Statement, the Prospectuses and the Disclosure Package. The
                                            form of the certificates for the Shares and the Exchangeable Shares have been approved by
                                            the board of directors of the Corporation and adopted by the Corporation and comply with
                                            all applicable legal and stock exchange requirements and do not conflict with the Corporation&rsquo;s
                                            constating documents. Except as disclosed in the Registration Statement, the Prospectuses
                                            and the Disclosure Package, no holder of any Relevant Security has any rights to require
                                            registration or qualification under the Securities Act or Canadian Securities Laws of any
                                            Relevant Security in connection with the offer and sale of the Shares contemplated hereby.
                                            No person has the right to act as an underwriter or as a financial advisor to the Corporation
                                            in connection with the offer and sale of the Placement Shares hereunder, as a result of the
                                            sale of the Placement Shares as contemplated hereby or otherwise. Except as disclosed in
                                            the Registration Statement, the Prospectuses and the Disclosure Package, there are no shareholders&rsquo;
                                            agreements, voting agreements, investors&rsquo; rights agreements or other agreements in
                                            force or effect which in any manner affects or will affect the voting or control of any of
                                            the securities of the Corporation or its Subsidiaries, the nomination of directors to the
                                            board of the Corporation or the operations or affairs of the Corporation or its Subsidiaries.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(hh)</TD><TD STYLE="text-align: justify"><U>Description of Shares</U>. The Shares
                                            conform and will conform to all statements relating thereto contained in the Registration
                                            Statement, the Prospectuses and the Disclosure Package and such description conforms to the
                                            rights set forth in the instruments defining the same.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify"><U>The Placement Shares</U>. The Corporation
                                            has full power and authority (corporate or otherwise) to issue the Placement Shares up to
                                            the Maximum Amount and to perform its obligations hereunder. When issued in accordance with
                                            this Agreement, and upon receipt of payment for the Placement Shares, the Placement Shares
                                            will have been duly and validly created and issued as fully paid and non-assessable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(jj)</TD><TD STYLE="text-align: justify"><U>No Undisclosed Relationships</U>.
                                            Neither the Corporation nor any Subsidiary (i)&nbsp;has any material lending or other relationship
                                            with any bank or lending affiliate of any of the Agents, (ii)&nbsp;intends to use any of
                                            the proceeds from the sale of the Placement Shares hereunder to repay any outstanding debt
                                            owed to any affiliate of any of the Agents, (iii)&nbsp;except as disclosed in the Canadian
                                            Prospectus Supplement, has any other relationship with any of the Agents that would require
                                            disclosure in the Canadian Prospectus pursuant to NI 33-105, or (iv)&nbsp;has been involved
                                            in any related party transactions or off-balance sheet transactions or any other non-arm&rsquo;s
                                            length transactions involving the Corporation or its Subsidiaries that are required to be
                                            disclosed under NI 33-105 or the rules&nbsp;and regulations of FINRA, that have not been
                                            described in the Registration Statement, the Prospectuses or the Disclosure Package or to
                                            be filed as exhibits thereto which have not been so filed as required.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(kk)</TD><TD STYLE="text-align: justify"><U>Public Filings</U>. There are no reports
                                            or information that in accordance with the requirements of Canadian Securities Laws must
                                            be made publicly available in connection with the Offerings that have not been made publicly
                                            available as required; there are no documents required to be filed as of the date hereof
                                            with the Canadian Qualifying Authorities in connection with the Offerings that have not been
                                            filed as required; and the Corporation has not filed any confidential material change reports
                                            or similar confidential report with any securities regulatory authority that is still maintained
                                            on a confidential basis. There are no contracts or other documents that are required by the
                                            Securities Act to be described in the U.S. Prospectus or filed as exhibits to the Registration
                                            Statement, or that are required by the Exchange Act to be filed as exhibits to a document
                                            incorporated by reference into the U.S. Prospectus, that have not been so described in the
                                            U.S. Prospectus or filed as exhibits to the Registration Statement or such incorporated document.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ll)</TD><TD STYLE="text-align: justify"><U>No Brokerage or Finder&rsquo;s Fees</U>.
                                            Other than the Agents, there is no person acting or, to the knowledge of the Corporation,
                                            purporting to act at the request of the Corporation, who is entitled to any brokerage, finder&rsquo;s
                                            fees or other like payment in connection with the transactions contemplated herein or, to
                                            the Corporation&rsquo;s knowledge, any arrangements, agreements, understandings, payments
                                            or issuance with respect to the Corporation or any of its officers, directors, shareholders,
                                            partners, employees, Subsidiaries or affiliates that may affect the Agents&rsquo; compensation
                                            as determined by FINRA.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(mm)</TD><TD STYLE="text-align: justify"><U>No Rulings Against Directors or Officers</U>.
                                            Except as disclosed in the Registration Statement, the Prospectuses and the Disclosure Package,
                                            to the knowledge of the Corporation, none of the directors or officers of the Corporation
                                            are now, or have been in the ten (10)&nbsp;years prior to the date hereof, subject to an
                                            order or ruling of any securities regulatory authority or stock exchange prohibiting such
                                            individual from acting as a director or officer of a public company or of a company listed
                                            on a particular stock exchange.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(nn)</TD><TD STYLE="text-align: justify"><U>Transactions at Arm&rsquo;s Length</U>.
                                            Neither the Corporation nor any of the Subsidiaries owes any amount to, nor has the Corporation
                                            or any of the Subsidiaries made any present loans to, or borrowed any amount from or is otherwise
                                            indebted to, any officer, director, employee or securityholder of any of them or any person
                                            not dealing at &ldquo;arm&rsquo;s-length&rdquo; (within the meaning of such term for purposes
                                            of the <I>Income Tax Act</I> (Canada)) with any of them, except for usual employee reimbursements
                                            and compensation paid in the ordinary and normal course of the business of the Corporation
                                            or any of the Subsidiaries. Except as disclosed in the Registration Statement, the Prospectuses
                                            and the Disclosure Package, and usual employee or consulting arrangements made in the ordinary
                                            and normal course of business, neither the Corporation nor any of the Subsidiaries is a party
                                            to any contract, agreement or understanding with any officer, director, employee or securityholder
                                            of any of them or any other person not dealing at arm&rsquo;s-length with the Corporation
                                            and the Subsidiaries.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(oo)</TD><TD STYLE="text-align: justify"><U>Compliance with Sarbanes-Oxley Act</U>.
                                            The Corporation and its Subsidiaries are in compliance in all material respects with the
                                            applicable provisions of Sarbanes-Oxley.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(pp)</TD><TD STYLE="text-align: justify"><U>No Orders</U>. No securities commission
                                            or any similar regulatory authority in any jurisdiction has issued any order which is currently
                                            outstanding preventing or suspending trading in any securities of the Corporation and no
                                            such proceeding is, to the knowledge of the Corporation, pending, contemplated or threatened,
                                            and the Corporation is not in material default of any requirement of Canadian Securities
                                            Laws, the Securities Act or the Exchange Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(qq)</TD><TD STYLE="text-align: justify"><U>Listing on TSX and Nasdaq</U>. The
                                            issued and outstanding Shares are listed and posted for trading on the TSX and Nasdaq, and
                                            the Corporation reasonably believes that it is in compliance with the current listing requirements
                                            of the TSX and Nasdaq; and the Placement Shares will be listed and posted for trading on
                                            the TSX and Nasdaq as of each Applicable Time. Except as disclosed in the Registration Statement,
                                            the Prospectuses and the Disclosure Package, the Corporation has not, in the 12 months preceding
                                            the date the first Placement Notice is given hereunder, received notice from the TSX or Nasdaq
                                            to the effect that the Corporation is not in compliance with the listing or maintenance requirements
                                            of each such stock exchange. Except as disclosed in the Registration Statement, the Prospectuses
                                            and the Disclosure Package, the Corporation has no reason to believe that it will not in
                                            the foreseeable future continue to be in compliance with all such listing and maintenance
                                            requirements.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(rr)</TD><TD STYLE="text-align: justify"><U>Canadian Reporting Issuer; SEC Registration</U>.
                                            The Corporation is a &ldquo;reporting issuer&rdquo; or the equivalent thereof in each of
                                            the Canadian Qualifying Jurisdictions where such concept exists, is not on the list of defaulting
                                            reporting issuers maintained by the Canadian Qualifying Authorities in each such Canadian
                                            Qualifying Jurisdiction that maintains such a list and its securities are not the subject
                                            of a general cease trade order by any of the Canadian Qualifying Authorities. The Corporation
                                            is subject to the reporting requirements of Section&nbsp;13 of the Exchange Act and files
                                            periodic reports with the SEC; the Shares are registered with the SEC under Section&nbsp;12(b)&nbsp;of
                                            the Exchange Act, and the Registration Statement is not the subject of a stop order by the
                                            SEC.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ss)</TD><TD STYLE="text-align: justify"><U>Transfer Agents and Registrar</U>.
                                            Odyssey Trust Company at its principal offices in Calgary, Alberta, is the duly appointed
                                            registrar and transfer agent of the Corporation in Canada and the United States with respect
                                            to the Shares and the Exchangeable Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(tt)</TD><TD STYLE="text-align: justify"><U>Investment Company Act</U>. The Corporation
                                            is not and, solely after giving effect to the Offerings and the application of the Net Proceeds
                                            as described in the Registration Statement, the Prospectuses and the Disclosure Package,
                                            will not be an &ldquo;investment company&rdquo; as defined in the United States Investment
                                            Company Act of 1940, as amended, and the rules&nbsp;and regulations of the SEC promulgated
                                            thereunder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(uu)</TD><TD STYLE="text-align: justify"><U>Independent Accountants</U>. PKF O&rsquo;Connor
                                            Davies, LLP, the current independent registered public accounting firm for the Corporation,
                                            is independent with respect to the Corporation within the meaning of the Chartered Professional
                                            Accountants of Ontario CPA Code of Professional Conduct and is an independent registered
                                            public accounting firm with respect to the Corporation within the meaning of the Securities
                                            Act and the Public Company Accounting Oversight Board (United States), and is registered
                                            with the Canadian Public Accountability Board. KPMG LLP, the former independent registered
                                            public accounting firm for the Corporation, was at all applicable times independent with
                                            respect to the Corporation within the meaning of the Chartered Professional Accountants of
                                            Ontario CPA Code of Professional Conduct and was at all applicable times an independent registered
                                            public accounting firm with respect to the Corporation within the meaning of the Securities
                                            Act and the Public Company Accounting Oversight Board (United States). There has not been
                                            any reportable event (within the meaning of NI 51-102) between the Corporation and its auditors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(vv)</TD><TD STYLE="text-align: justify"><U>No Stabilization</U>. The Corporation
                                            has not taken, directly or indirectly, any action designed to or that would constitute or
                                            that might reasonably be expected to cause or result in, under Canadian Securities Laws,
                                            the Exchange Act or otherwise, stabilization or manipulation of the price of the Shares to
                                            facilitate the sale or resale of the Placement Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ww)</TD><TD STYLE="text-align: justify"><U>Purchases by the Agents</U>. The Corporation
                                            acknowledges and agrees that the Agents have informed the Corporation that the Agents may,
                                            but are not required to, to the extent permitted under the Securities Act, the Exchange Act,
                                            Canadian Securities Laws, the rules&nbsp;of the TSX and Nasdaq and this Agreement, purchase
                                            and sell Shares for the Agents&rsquo; own accounts and for the accounts of their clients
                                            at the same time as sales of Placement Shares occur pursuant to this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(xx)</TD><TD STYLE="text-align: justify"><U>Conformity of Issuer Free Writing
                                            Prospectus</U>. Each Issuer Free Writing Prospectus conformed or will conform in all respects
                                            with the requirements of the Securities Act on the date of first use, and the Corporation
                                            has complied or will comply with any filing requirements applicable to such Issuer Free Writing
                                            Prospectus pursuant to the Securities Act. Each Issuer Free Writing Prospectus, as of its
                                            issue date and at all subsequent times through the completion of the public offer and sale
                                            of the Placement Shares, did not, does not and will not include any information that conflicted,
                                            conflicts or will conflict with the information contained in the Registration Statement or
                                            the Prospectuses, including any document incorporated by reference therein that has not been
                                            superseded or modified. The Corporation has not made any offer relating to the Shares that
                                            would constitute an Issuer Free Writing Prospectus without the prior written consent of the
                                            Agents. The Corporation has retained in accordance with the Securities Act all Issuer Free
                                            Writing Prospectuses that were not required to be filed pursuant to the Securities Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(yy)</TD><TD STYLE="text-align: justify"><U>Compliance with Regulatory Laws</U>.
                                            Except where the failure to comply would not, individually or in the aggregate, reasonably
                                            be expected to have a Material Adverse Effect, each of the Corporation, the Subsidiaries
                                            and their respective directors, officers and employees acting on behalf of the Corporation
                                            or any Subsidiary: (A)&nbsp;is and at all times has been in compliance with all applicable
                                            federal, provincial, state, municipal, local, or foreign statutes, rules, regulations, ordinances,
                                            orders, decrees and guidances including, without limitation, the <I>Food and Drugs Act</I>
                                            R.S.C. 1985, c. F-27, the Cannabis Act, and the <I>Controlled Drugs and Substances Act</I>
                                            S.C. 1996, c. 19; (B)&nbsp;has not received any correspondence, inspection report, notice
                                            of adverse finding, warning letter or other notice from any Governmental Authority alleging
                                            or asserting material non-compliance with any applicable laws or any licences, certificates,
                                            approvals, consents, clearances, registrations, qualifications, authorizations, permits and
                                            supplements or amendments thereto required by any such applicable laws (collectively, &ldquo;<B>Authorizations</B>&rdquo;);
                                            (C)&nbsp;possesses all Authorizations required for the conduct of its business, and such
                                            Authorizations are valid and in full force and effect, and the Corporation, the Subsidiaries
                                            and all directors, officers and employees of each acting on behalf of the Corporation or
                                            any Subsidiary are not in violation of any term of any such Authorization; (D)&nbsp;has not
                                            received notice of any pending or threatened claim, suit, proceeding, charge, hearing, enforcement,
                                            audit, investigation, inspection, arbitration or other action from any Governmental Authority
                                            or third party alleging that any operation or activity of the Corporation, the Subsidiaries
                                            or any of their directors, officers and/or employees acting on behalf of the Corporation
                                            or any Subsidiary is in violation of any applicable laws or Authorizations and, except as
                                            disclosed in the Registration Statement and the Prospectuses, has no knowledge or reason
                                            to believe that any such Governmental Authority or third party is considering or would have
                                            reasonable grounds to consider any such claim, suit, proceeding, charge, hearing, enforcement,
                                            audit, investigation, arbitration or other action; (E)&nbsp;has not received notice that
                                            any Governmental Authority has taken, is taking, or intends to take action to limit, suspend,
                                            modify or revoke any material Authorizations and, except as disclosed in the Registration
                                            Statement, the Prospectuses and the Disclosure Package, has no knowledge or reason to believe
                                            that any such Governmental Authority is considering taking or would have reasonable grounds
                                            to take such action; (F)&nbsp;has, or has had on its behalf, filed, declared, obtained, maintained
                                            or submitted all reports, documents, forms, notices, applications, renewals, records, claims,
                                            submissions and supplements or amendments as required by any applicable laws or Authorizations
                                            and to keep its Authorizations that are described or referred to in the Registration Statement,
                                            the Prospectuses and the Disclosure Package in good standing and that all such reports, documents,
                                            forms, notices, applications, renewals, records, claims, submissions and supplements or amendments
                                            were materially complete and correct on the date filed (or were corrected or supplemented
                                            by a subsequent submission); and (G)&nbsp;has not, either voluntarily or involuntarily, initiated,
                                            conducted or issued or caused to be initiated, conducted or issued, any recall, market withdrawal
                                            or replacement, safety alert, post-sale warning or other notice or action relating to the
                                            alleged safety or efficacy of any product or any alleged product defect or violation and,
                                            to the knowledge of the Corporation, there is no basis for any such notice or action.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(zz)</TD><TD STYLE="text-align: justify"><U>Insurance</U>. Each of the Corporation
                                            and the Subsidiaries maintain insurance in such amounts and covering such risks as the entity
                                            reasonably considers adequate for the conduct of its business and the value of its properties
                                            and as is customary for companies engaged in similar businesses in similar industries, including,
                                            but not limited to, in the case of the Corporation and the Subsidiaries, directors and officers
                                            insurance coverage in such amounts as are prudent and customary in the businesses in which
                                            the Corporation and the Subsidiaries are engaged, all of which insurance is in full force
                                            and effect. There are no material claims by the Corporation or any Subsidiary under any such
                                            policy or instrument as to which any insurance company is denying liability or defending
                                            under a reservation of rights clause. The Corporation has no reason to believe that it will
                                            be unable to renew its existing insurance as and when such coverage expires or will be able
                                            to obtain replacement insurance adequate for the conduct of the business and the value of
                                            its properties at a cost that would not have a Material Adverse Effect.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(aaa)</TD><TD STYLE="text-align: justify"><U>Owned Premises</U>. All real property
                                            owned by the Corporation or the Subsidiaries is 100% legally and beneficially owned by the
                                            Corporation or a Subsidiary, and the Corporation or the applicable Subsidiary holds valid,
                                            subsisting and enforceable title documents and such title documents permit the Corporation
                                            and such Subsidiary to carry on the business thereon as currently conducted.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(bbb)</TD><TD STYLE="text-align: justify"><U>Leased Premises</U>. The Corporation
                                            and its Subsidiaries have the exclusive right to occupy and use all real property that is
                                            leased by the Corporation or a Subsidiary and each of the corresponding leases is valid,
                                            subsisting and enforceable and in good standing and in full force and effect with such exceptions
                                            as are not material to, and do not materially interfere with, the use made and proposed to
                                            be made of such property and buildings by the Corporation and the Subsidiaries. The performance
                                            of obligations pursuant to and in compliance with the terms of this Agreement, and the completion
                                            of the transactions described herein by the Corporation, will not afford any of the parties
                                            to such leases or any other person the right to terminate such lease or result in any additional
                                            or more onerous obligations under such leases. Except for such matters as would not, individually
                                            or in the aggregate, have a Material Adverse Effect, neither the Corporation nor any Subsidiary
                                            is in default or breach of any real property lease, and neither the Corporation nor any Subsidiary
                                            has received any notice or other communication from the owner or manager of any real property
                                            leased by the Corporation or any Subsidiary that the Corporation or such Subsidiary is not
                                            in compliance with any real property lease, and to the knowledge of the Corporation, no such
                                            notice or other communication is pending or has been threatened.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ccc)</TD><TD STYLE="text-align: justify"><U>PFIC</U>. The Corporation was not
                                            classified as a &ldquo;passive foreign investment company&rdquo; (a &ldquo;<B>PFIC</B>&rdquo;)
                                            for United States federal income tax purposes within the meaning of Section&nbsp;1297 of
                                            the United States Internal Revenue Code of 1986, as amended (the &ldquo;<B>Code</B>&rdquo;),
                                            for its most recently-completed taxable year.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ddd)</TD><TD STYLE="text-align: justify"><U>Intellectual Property</U>. (i)&nbsp;Each
                                            of the Corporation and its Subsidiaries owns all rights in or has obtained valid and enforceable
                                            licences or other rights to use, the systems, recipes, know how (including trade secrets
                                            and other proprietary or confidential information), trade-marks (both registered and unregistered),
                                            trade names, patents, patent applications, inventions, copyrights and any other intellectual
                                            property (collectively, &ldquo;<B>Intellectual Property</B>&rdquo;) described in the Registration
                                            Statement, the Prospectuses and the Disclosure Package as being owned or licensed by the
                                            Corporation or which are used or necessary for the conduct of the Corporation&rsquo;s business
                                            as currently carried on and presently proposed to be carried on, free and clear of any Lien,
                                            except such as are described in the Registration Statement, the Prospectuses and the Disclosure
                                            Package or such as do not (individually or in the aggregate) materially affect the value
                                            of such Intellectual Property or materially interfere with the use made or proposed to be
                                            made of such Intellectual Property by the Corporation and the Subsidiaries, or other adverse
                                            claim or interest of any kind or nature affecting the assets of the Corporation; (ii)&nbsp;to
                                            the knowledge of the Corporation, except where any infringement would not, individually or
                                            in the aggregate, have any Material Adverse Effect, there is no infringement, violation or
                                            misappropriation by third parties of any Intellectual Property owned, licensed or commercialized
                                            by the Corporation; (iii)&nbsp;there is no action, suit, proceeding, claim, or allegation
                                            pending or, to the knowledge of the Corporation, threatened by others challenging the Corporation&rsquo;s
                                            rights in or to any Intellectual Property or the validity or scope of any Intellectual Property
                                            owned, licensed or commercialized by the Corporation or its Subsidiaries, or alleging that
                                            the Corporation or its Subsidiaries have infringed, violated or misappropriated Intellectual
                                            Property rights of a third party, and the Corporation is unaware of any other fact which
                                            could form a reasonable basis for any such action, suit, proceeding, claim or allegation,
                                            in each case, except as would not, individually or in the aggregate, have any Material Adverse
                                            Effect; and (iv)&nbsp;to the Corporation&rsquo;s knowledge, all trade secrets and other confidential
                                            proprietary information forming part of or in relation to the Intellectual Property being
                                            owned or licensed by the Corporation or any Subsidiary is and remains confidential to the
                                            Corporation or such Subsidiary, as the case may be.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(eee)</TD><TD STYLE="text-align: justify"><U>IT Systems</U>. The Corporation&rsquo;s
                                            and its Subsidiaries&rsquo; information technology assets and equipment, computers, systems,
                                            networks, hardware, software, websites, applications, and databases (collectively, &ldquo;<B>IT
                                            Systems</B>&rdquo;) are adequate for, and operate and perform in all material respects as
                                            required in connection with, the operation of the business of the Corporation and the Subsidiaries
                                            as currently conducted, to the knowledge of the Corporation, are free and clear of all material
                                            bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants and the Corporation
                                            and its Subsidiaries have valid, enforceable and sufficient rights to use all such IT systems.
                                            The Corporation and its Subsidiaries maintain commercially reasonable controls, policies,
                                            procedures, and safeguards to maintain and protect their material confidential information
                                            and the integrity, continuous operation, redundancy and security of all IT Systems and all
                                            personal, personally identifiable, sensitive, confidential or regulated data (&ldquo;<B>Personal
                                            Data</B>&rdquo;) processed and stored thereon, and there have been no breaches, incidents,
                                            violations, outages, compromises or unauthorized uses of or accesses to same, except for
                                            those that have been remedied without material cost or liability or the duty to notify any
                                            other person or Governmental Authority, nor any incidents under internal review or investigations
                                            relating to the same. The Corporation and its Subsidiaries are presently in compliance with
                                            all applicable laws or statutes and all applicable judgments, orders, rules&nbsp;and regulations
                                            of any court or arbitrator or governmental or regulatory authority, applicable industry standards,
                                            internal policies and contractual obligations relating to the privacy and security of IT
                                            Systems and Personal Data and to the protection of such IT Systems and Personal Data from
                                            unauthorized use, access, misappropriation or modification (&ldquo;<B>Privacy Requirements</B>&rdquo;),
                                            except for any such noncompliance that would not have a Material Adverse Effect. There is
                                            no action, suit, proceeding, claim, or allegation pending or, to the knowledge of the Corporation,
                                            threatened by any third party with respect to any actual or alleged breach of Personal Data,
                                            unauthorized processing, or other misuse of any Personal Data or with respect to any violation
                                            of any applicable Privacy Requirement, and the Corporation is unaware of any other fact which
                                            could form a reasonable basis for any such action, suit, proceeding, claim or allegation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(fff)</TD><TD STYLE="text-align: justify"><U>Properties and Leases</U>. Except
                                            as disclosed in the Registration Statement, the Prospectuses and the Disclosure Package,
                                            (i)&nbsp;each of the Corporation and the Subsidiaries owns or leases all such properties
                                            as are necessary to the conduct of its business as presently operated as described in the
                                            Registration Statement, the Prospectuses and the Disclosure Package; (ii)&nbsp;each of the
                                            Corporation and the Subsidiaries has good and marketable title in fee simple to all real
                                            property owned by them and good and marketable title to all personal property owned by them,
                                            in each case free and clear of any and all Liens except such as are described in the Registration
                                            Statement, the Prospectuses and the Disclosure Package or such as do not (individually or
                                            in the aggregate) materially affect the value of such property or materially interfere with
                                            the use made or proposed to be made of such property by the Corporation and the Subsidiaries;
                                            and (iii)&nbsp;neither the Corporation nor any Subsidiary has received any notice or other
                                            communication of any claim adverse to its ownership of any real or personal property or of
                                            any claim against the continued possession of any real property, whether owned or held under
                                            lease or sublease by the Corporation or any Subsidiary, except as would not have a Material
                                            Adverse Effect. Except for the sale of inventory in the ordinary course of business and as
                                            disclosed in the Registration Statement, the Prospectuses and the Disclosure Package, no
                                            person has any contract or any right or privilege capable of becoming a right to purchase
                                            any property from the Corporation or any Subsidiary.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ggg)</TD><TD STYLE="text-align: justify"><U>Facilities</U>. The Corporation&rsquo;s,
                                            the Subsidiaries&rsquo; and, to the knowledge of the Corporation, the Investment Entities&rsquo;
                                            facilities and product research and development activities are and have been in compliance
                                            in all respects with applicable good practices, processes, standards and procedures as required
                                            by Health Canada and any other Governmental Authority, except as would not, individually
                                            or in the aggregate, have a Material Adverse Effect.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(hhh)</TD><TD STYLE="text-align: justify"><U>Environmental Laws</U>. There has
                                            been no storage, generation, transportation, handling, use, treatment, disposal, discharge,
                                            emission, contamination, release or other activity involving any kind of hazardous, toxic
                                            or other wastes, pollutants, contaminants, petroleum products or other hazardous or toxic
                                            substances, chemicals or materials (&ldquo;<B>Hazardous Substances</B>&rdquo;) by, due to,
                                            on behalf of, or caused by the Corporation or any Subsidiary (or, to the knowledge of the
                                            Corporation, any other entity for whose acts or omissions the Corporation is or may be liable)
                                            upon any property now or previously owned, operated, used or leased by the Corporation or
                                            any Subsidiary, or upon any other property, which would be a violation of or give rise to
                                            any liability under any applicable law, rule, regulation, order, judgment, decree or permit,
                                            common law provision or other legally binding standard relating to pollution or protection
                                            of human health and the environment (&ldquo;<B>Environmental Law</B>&rdquo;), except for
                                            violations and liabilities which, individually or in the aggregate, would not have a Material
                                            Adverse Effect. There has been no disposal, discharge, emission contamination or other release
                                            of any kind at, onto or from any such property or into the environment surrounding any such
                                            property of any Hazardous Substances with respect to which the Corporation or any Subsidiary,
                                            except as would not, individually or in the aggregate, have a Material Adverse Effect. There
                                            is no pending or, to the knowledge of the Corporation, threatened administrative, regulatory
                                            or judicial action, claim or notice of noncompliance or violation, investigation or proceedings
                                            relating to any Environmental Law against the Corporation or any Subsidiary, except as would
                                            not, individually or in the aggregate, have a Material Adverse Effect. No property of the
                                            Corporation or any Subsidiary is subject to any Lien under any Environmental Law. Except
                                            as disclosed in the Registration Statement, the Prospectuses and the Disclosure Package,
                                            neither the Corporation nor any Subsidiary is subject to any order, decree, agreement or
                                            other individualized legal requirement related to any Environmental Law, which, in any case
                                            (individually or in the aggregate), would have a Material Adverse Effect. The Corporation
                                            and its Subsidiaries have all permits, authorizations and approvals required under all applicable
                                            Environmental Laws and are each in compliance with their requirements.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify"><U>Changes in Law</U>. To the knowledge
                                            of the Corporation, there is no pending or contemplated change to any law, regulation or
                                            position of a Governmental Authority that would have a Material Adverse Effect.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(jjj)</TD><TD STYLE="text-align: justify"><U>Corporate Records</U>. The minute
                                            books and corporate records of the Corporation and its Material Subsidiaries are true, complete,
                                            and correct in all material respects.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(kkk)</TD><TD STYLE="text-align: justify"><U>Foreign Private Issuer Status</U>.
                                            The Corporation is not, and upon completion of the transactions contemplated herein, and
                                            assuming the anticipated use of the Net Proceeds thereof as described in the Registration
                                            Statement, the Prospectuses and the Disclosure Package, will not be, a &ldquo;foreign private
                                            issuer&rdquo; within the meaning of Rule&nbsp;3b-4 under the Exchange Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(lll)</TD><TD STYLE="text-align: justify"><U>Forward-Looking Information and Third-Party
                                            Data</U>. The Corporation has a reasonable basis for disclosing all forward-looking information
                                            (as defined in NI 51-102) or forward-looking information (within the meaning of Section&nbsp;27A
                                            of the Securities Act and Section&nbsp;21E of the Exchange Act) contained in the Registration
                                            Statement, the Prospectuses and the Disclosure Package. The statistical, industry-related
                                            and market-related data included in the Registration Statement, the Prospectuses and the
                                            Disclosure Package are based on or derived from sources which the Corporation reasonably
                                            and in good faith believes are reliable and accurate, and such data agree with the sources
                                            from which they are derived. The Corporation has obtained the consent to the use of such
                                            data or information from such sources to the extent required.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(mmm)</TD><TD STYLE="text-align: justify"><U>Incentive Plans</U>. Each stock option
                                            granted under the Corporation&rsquo;s stock option plan or other security based compensation
                                            plan of the Corporation (each, a &ldquo;<B>Stock Plan</B>&rdquo;) was granted with an exercise
                                            price no less than the fair market value per Share on the grant date of such option, determined
                                            in accordance with the rules&nbsp;of the TSX, and no such grant involved any &ldquo;back-dating,&rdquo;
                                            &ldquo;forward-dating&rdquo; or similar practice with respect to the effective date of such
                                            grant; each such option (i)&nbsp;was granted in compliance with applicable law and with the
                                            applicable Stock Plan(s), (ii)&nbsp;was duly approved by the board of directors (or a duly
                                            authorized committee thereof) of the Corporation and (iii)&nbsp;has been or will be properly
                                            accounted for in the Corporation&rsquo;s financial statements and has been or will be disclosed,
                                            to the extent required, in the Corporation&rsquo;s filings or submissions with the SEC and
                                            the Canadian Qualifying Authorities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(nnn)</TD><TD STYLE="text-align: justify"><U>Security Clearance</U>. Except as
                                            disclosed in the Registration Statement, the Prospectuses and the Disclosure Package or for
                                            security clearances which have been applied for and are in process with Health Canada, each
                                            director, executive officer, and other personnel of the Corporation or the Subsidiaries that
                                            is required to hold a security clearance under the Cannabis Act and related regulations holds
                                            such security clearance and to the knowledge of the Corporation, there are no circumstances
                                            that would affect or prevent them from obtaining, or which would lead to the suspension,
                                            revocation or cancellation of, such security clearances.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ooo)</TD><TD STYLE="text-align: justify"><U>XBRL</U>. The interactive data in
                                            eXtensible Business Reporting Language included or incorporated by reference in the Registration
                                            Statement fairly presents the information called for in all material respects and has been
                                            prepared in accordance with the SEC&rsquo;s rules&nbsp;and guidelines applicable thereto.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ppp)</TD><TD STYLE="text-align: justify"><U>No Reliance</U>. The Corporation
                                            has not relied upon the Agents or legal counsel for the Agents for any legal, tax or accounting
                                            advice in connection with the offering and sale of the Placement Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(qqq)</TD><TD STYLE="text-align: justify"><U>Continuous Offering Agreements</U>.
                                            Except for this Agreement, the Corporation is not party to any other equity distribution
                                            or sales agency agreement or other similar arrangement with any other agent or any other
                                            representative in respect of any &ldquo;at the market offering&rdquo; or other continuous
                                            equity offering transaction.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(rrr)</TD><TD STYLE="text-align: justify"><U>Corporation Certificates</U>. Any
                                            certificate signed by a director or an officer of the Corporation and delivered to an Agent
                                            or to counsel for such Agent pursuant to or in connection with this Agreement shall be deemed
                                            to be a representation and warranty by the Corporation to such Agent as to the matters set
                                            forth therein.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(sss)</TD><TD STYLE="text-align: justify"><U>Canadian Shelf Procedures</U>. The
                                            Corporation will, following the execution of this Agreement, promptly issue and file a news
                                            release that (i)&nbsp;states that the Corporation has entered into this Agreement and has
                                            filed or will file the Prospectus Supplements, and (ii)&nbsp;specifies where and how a purchaser
                                            of Placement Shares hereunder may obtain a copy of this Agreement and the Prospectuses.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Corporation acknowledges that each
Agent and, for purposes of opinions that may be delivered by them, counsel to the Corporation and to the Agents, will rely upon the accuracy
and truthfulness of the foregoing representations and hereby consents to such reliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>8.</B></TD><TD><B><U>Covenants of the Corporation</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Corporation covenants
and agrees with the Agents that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><U>Prospectus and Registration Statement
                                            Amendments</U>. After the date of this Agreement and until the latest of the date on which
                                            the sale of the Maximum Amount of Placement Shares through the Agents on the terms and subject
                                            to the conditions set forth herein has been completed, the end of the Prospectus Delivery
                                            Period or the termination of this Agreement in accordance with the terms and conditions contained
                                            herein, (i)&nbsp;the Corporation will notify the Agents promptly of the time when any amendment
                                            or replacement to the Canadian Base Prospectus or the Registration Statement has been filed,
                                            as applicable, with any Canadian Qualifying Authority or the SEC and has become effective
                                            or where a receipt has been issued therefor, as applicable, or any subsequent supplement
                                            or replacement to the U.S. Prospectus or the Canadian Prospectus has been filed (each, an
                                            &ldquo;<B>Amendment Date</B>&rdquo;) and of any request by the SEC or any Canadian Qualifying
                                            Authority for any amendment, supplement or replacement to the Registration Statement or the
                                            Prospectuses or for additional information; (ii)&nbsp;the Corporation will file promptly
                                            all other material required to be filed by it with the SEC pursuant to Rule&nbsp;433(d)&nbsp;of
                                            the Securities Act and with the Canadian Qualifying Authorities in connection with the Offerings;
                                            (iii)&nbsp;the Corporation will submit to the Agents a copy of any amendment, supplement
                                            or replacement to the Registration Statement or the Prospectuses (other than a copy of any
                                            documents incorporated by reference into the Registration Statement or the Prospectuses)
                                            within a reasonable period of time before the filing thereof and will afford the Agents and
                                            the Agents&rsquo; counsel a reasonable opportunity to comment on any such proposed filing
                                            and to perform any due diligence investigations as may reasonably be required prior to such
                                            proposed filing; and (iv)&nbsp;the Corporation will furnish to the Agents at the time of
                                            filing thereof a copy of any document that upon filing is deemed to be incorporated by reference
                                            in the Registration Statement or the Prospectuses (provided that the Corporation shall not
                                            be required to deliver documents or information incorporated by reference into the Registration
                                            Statement or the Prospectuses if such documents are accessible from SEDAR+ or EDGAR) and
                                            the Corporation will cause (A)&nbsp;each amendment or supplement to the U.S. Prospectus to
                                            be filed with the SEC within the time period prescribed by the Securities Act and the Rules&nbsp;and
                                            Regulations or, in the case of any document to be incorporated therein by reference, to be
                                            filed with the SEC as required pursuant to the Exchange Act, within the time period prescribed
                                            and (B)&nbsp;each amendment, supplement or replacement to the Canadian Prospectus to be filed
                                            with the Canadian Qualifying Authorities as required pursuant to the Canadian Shelf Procedures
                                            or, in the case of any document to be incorporated therein by reference, to be filed with
                                            the Canadian Qualifying Authorities as required pursuant to Canadian Securities Laws, within
                                            the time period prescribed.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><U>Notice of Cease Trade or Stop Orders</U>.
                                            After the date of this Agreement and until the latest of the date on which the sale of the
                                            Maximum Amount of Placement Shares through the Agents on the terms and subject to the conditions
                                            set forth herein has been completed, the end of the Prospectus Delivery Period or the termination
                                            of this Agreement in accordance with the terms and conditions contained herein, the Corporation
                                            will advise the Agents, promptly after it receives notice thereof, of the issuance by the
                                            SEC or the Canadian Qualifying Authorities of any stop order, cease trade order or of any
                                            order preventing or suspending the use of the Prospectuses or other prospectus in respect
                                            of the Shares, of any notice of objection of the SEC to the use of the form of the Registration
                                            Statement or any post-effective amendment thereto, of the suspension of the qualification
                                            of the Shares for offering or sale in the United States or the Canadian Qualifying Jurisdictions,
                                            of the initiation or threatening of any proceeding for any such purpose, or of any request
                                            by the SEC or the Canadian Qualifying Authorities for the amending or supplementing of the
                                            Registration Statement or the Prospectuses or for additional information relating to the
                                            Shares. If there is a Placement Notice that has been issued by the Corporation that has not
                                            been suspended or terminated in accordance with Section&nbsp;4 or Section&nbsp;13 of this
                                            Agreement, the Corporation will use its commercially reasonable efforts to prevent the issuance
                                            of any stop order, cease trade order or any order preventing or suspending the use of the
                                            Prospectuses or other prospectus in respect of the Shares, a notice of objection of the SEC
                                            to the form of the Registration Statement or any post-effective amendment thereto, the suspension
                                            of any qualification for offering or sale in the United States or the Canadian Qualifying
                                            Jurisdictions, and, in the event of the issuance of any such stop order, cease trade order
                                            or any such order preventing or suspending the use of any prospectus relating to the Shares
                                            or suspending any such qualification, the Corporation will use its commercially reasonable
                                            efforts to obtain the lifting or withdrawal of such order as soon as possible. If there is
                                            no such outstanding Placement Notice, then, if, in the Corporation&rsquo;s determination
                                            and at the Corporation&rsquo;s sole discretion, it is necessary to prevent the issuance of
                                            any stop order or cease trade order or have a stop order or cease trade order lifted, the
                                            Corporation will use its commercially reasonable efforts to prevent the issuance of any stop
                                            order, cease trade order or any order preventing or suspending the use of the Prospectuses
                                            or other prospectus in respect of the Shares, a notice of objection of the SEC to the form
                                            of the Registration Statement or any post-effective amendment thereto, the suspension of
                                            any qualification for offering or sale in the United States or the Canadian Qualifying Jurisdictions,
                                            and, in the event of the issuance of any such stop order, cease trade order or any such order
                                            preventing or suspending the use of any prospectus relating to the Shares or suspending any
                                            such qualification, the Corporation will use its commercially reasonable efforts to obtain
                                            the lifting or withdrawal of such order as soon as possible.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><U>Delivery of Prospectus; Subsequent
                                            Changes</U>. After the date of this Agreement and until the latest of the date on which the
                                            sale of the Maximum Amount of Placement Shares through the Agents on the terms and subject
                                            to the conditions set forth herein has been completed or the termination of this Agreement
                                            in accordance with the terms and conditions contained herein, within the time during which
                                            a prospectus relating to the Shares is required to be delivered by the Agents under the Securities
                                            Act (including in circumstances where such requirement may be satisfied pursuant to Rule&nbsp;172
                                            or Rule&nbsp;173(a)&nbsp;under the Securities Act) or Canadian Securities Laws, the Corporation
                                            will comply in all material respects with such applicable requirements imposed upon it by
                                            the Securities Act and by Canadian Securities Laws, as appropriate and as from time to time
                                            in force, and will file or furnish on or before their respective due dates all reports required
                                            to be filed or furnished by it with the SEC pursuant to Sections&nbsp;13(a), 13(c), or 15(d)&nbsp;of
                                            the Exchange Act, if applicable, or any other provision of or under the Exchange Act or with
                                            the Canadian Qualifying Authorities pursuant to Canadian Securities Laws, as appropriate.
                                            If during such period any event occurs as a result of which the Prospectuses as then amended
                                            or supplemented would include an untrue statement of material fact or omit to state a material
                                            fact necessary to make the statements therein, in light of the circumstances then existing,
                                            not misleading, or if during such period it is necessary to amend or supplement the Registration
                                            Statement or the Prospectuses to comply with the Securities Act, the Rules&nbsp;and Regulations
                                            or Canadian Securities Laws, the Corporation will immediately notify the Agents to suspend
                                            the offering of Placement Shares during such period and, if, in the Corporation&rsquo;s determination
                                            and at the Corporation&rsquo;s sole discretion, it is necessary to file an amendment or supplement
                                            to the Registration Statement or the Prospectuses to comply with the Securities Act, the
                                            Rules&nbsp;and Regulations or Canadian Securities Laws, the Corporation will promptly prepare
                                            and, after complying with Section&nbsp;8(a)(iii)&nbsp;hereof, file with the Canadian Qualifying
                                            Authorities and the SEC such amendment or supplement as may be necessary to correct such
                                            statement or omission or to make the Registration Statement or the Prospectuses comply with
                                            such requirements, and the Corporation will furnish to the Agents such number of copies of
                                            such amendment or supplement as the Agents may reasonably request. The Corporation shall
                                            in good faith discuss with the Agents any change in a fact or circumstance (actual, proposed
                                            or prospective) which is of such a nature that there is reasonable doubt whether notice need
                                            be given to the Agents pursuant to this Section&nbsp;8(c).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><U>Delivery of Registration Statement
                                            and Prospectuses</U>. After the date of this Agreement and until the latest of the date on
                                            which the sale of the Maximum Amount of Placement Shares through the Agents on the terms
                                            and subject to the conditions set forth herein has been completed, the end of the Prospectus
                                            Delivery Period or the termination of this Agreement in accordance with the terms and conditions
                                            contained herein, the Corporation will furnish to the Agents and their counsel (at the expense
                                            of the Corporation) copies of the Registration Statement, the Prospectuses (including all
                                            documents incorporated by reference therein) and all amendments and supplements to the Registration
                                            Statement or the Prospectuses that are filed with the SEC or Canadian Qualifying Authorities
                                            during the period in which a prospectus relating to the Shares is required to be delivered
                                            under the Securities Act (including all documents filed with the SEC during such period that
                                            are deemed to be incorporated by reference therein) or the Canadian Qualifying Authorities
                                            (including all documents filed with the Canadian Qualifying Authorities during such period
                                            that are deemed to be incorporated by reference therein), in each case as soon as reasonably
                                            practicable and in such quantities as the Agents may from time to time reasonably request;
                                            provided, however, the Corporation shall not be required to furnish any documents to the
                                            Agents that are available on SEDAR+ or EDGAR.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify"><U>Corporation Information</U>. After
                                            the date of this Agreement and until the latest of the date on which the sale of the Maximum
                                            Amount of Placement Shares through the Agents on the terms and subject to the conditions
                                            set forth herein has been completed, the end of the Prospectus Delivery Period or the termination
                                            of this Agreement in accordance with the terms and conditions contained herein, the Corporation
                                            will furnish to the Agents such information in its possession as is reasonably requested
                                            by the Agents as necessary or appropriate to fulfil their obligations as agent pursuant to
                                            this Agreement, the Securities Act and Canadian Securities Laws.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify"><U>Earnings Statement</U>. The Corporation
                                            will make generally available to its shareholders as soon as practicable, but in any event,
                                            not later than 15 months after the end of the Corporation&rsquo;s current fiscal quarter,
                                            an earnings statement covering a 12-month period that satisfies the provisions of Section&nbsp;11(a)&nbsp;of
                                            the Securities Act and Rule&nbsp;158 under the Securities Act.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify"><U>Material Non-public Information</U>.
                                            Subject to such further limitations on offers and sales of Placement Shares or delivery of
                                            instructions to offer and sell Placement Shares as are set forth herein and as may be mutually
                                            agreed upon by the Corporation and the Agents, the Corporation shall not request the sale
                                            of any Placement Shares that would be sold, and no Agent shall be obligated to sell, (i)&nbsp;any
                                            time during the period commencing on the tenth Business Day prior to the time the Corporation
                                            shall issue a press release and/or file a Current Report on Form&nbsp;8-K containing, or
                                            shall otherwise publicly announce, its earnings, revenues or other results of operations
                                            (each, an &ldquo;<B>Earnings Announcement</B>&rdquo;) through and including the time that
                                            is 24 hours after the time that the Corporation files a Quarterly Report on Form&nbsp;10-Q
                                            or an Annual Report on Form&nbsp;10-K that includes consolidated financial statements as
                                            of and for the same period or periods, as the case may be, covered by such Earnings Announcement,
                                            or (ii)&nbsp;during any other period in which the Corporation is in possession of material
                                            non-public information regarding the Corporation and the Subsidiaries, taken as a whole,
                                            or the Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify"><U>Expenses</U>. The Corporation, whether
                                            or not the transactions contemplated hereunder are consummated or this Agreement is terminated
                                            in accordance with Section&nbsp;13, will pay all expenses relating to the following matters:
                                            (i)&nbsp;the preparation and filing of the Registration Statement and each amendment or supplement
                                            thereto, each of the Prospectuses and each amendment and supplement thereto and each Issuer
                                            Free Writing Prospectus, (ii)&nbsp;the preparation, issuance and delivery of the Placement
                                            Shares, (iii)&nbsp;all fees and disbursements of the Corporation&rsquo;s counsel, accountants
                                            and other advisors, (iv)&nbsp;reimbursement for the reasonable and documented fees, disbursements
                                            and expenses of counsel to the Agents in connection with this Agreement, the Registration
                                            Statement and the Prospectuses and the reasonable and documented fees, disbursements and
                                            expenses of counsel to the Agents for their ongoing services in connection with the transactions
                                            contemplated hereunder, up to a maximum of US$200,000 plus applicable taxes, (v)&nbsp;the
                                            qualification of the Placement Shares under securities law, including filing fees in connection
                                            therewith, (vi)&nbsp;the printing and delivery to the Agents of copies of the Prospectuses
                                            and any amendments or supplements thereto, and of this Agreement, (vii)&nbsp;the fees and
                                            expenses incurred in connection with the listing or qualification of the Placement Shares
                                            for trading on the TSX and Nasdaq, and (viii)&nbsp;the filing fees and expenses related to
                                            the SEC, the Canadian Qualifying Authorities and FINRA. All fees and expenses are to be paid
                                            in the currency in which such fees and expenses were incurred.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify"><U>Use of Proceeds</U>. The Corporation
                                            will use the Net Proceeds as described in the Prospectuses. The Corporation will not use
                                            the Net Proceeds in any manner that may violate Federal Cannabis Laws.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(j)</TD><TD STYLE="text-align: justify"><U>Change of Circumstances</U>. During
                                            the term of this Agreement, the Corporation will, at any time during a fiscal quarter in
                                            which the Corporation has or intends to deliver a Placement Notice to the Agents to sell
                                            Placement Shares, advise the Agents promptly after it has received notice or obtained knowledge
                                            thereof, of any information or fact that would alter or affect in any material respect any
                                            applicable opinion, certificate, letter or other document provided or to be provided to the
                                            Agents pursuant to this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(k)</TD><TD STYLE="text-align: justify"><U>Due Diligence Cooperation</U>. After
                                            the date of this Agreement and until the completion of the latest of the sales of all of
                                            the Placement Shares contemplated hereunder or the termination of this Agreement in accordance
                                            with the terms and conditions contained herein, the Corporation will cooperate with any due
                                            diligence review conducted by the Agents or their agents during periods in which the Offerings
                                            are being utilized, including, without limitation, providing information and making available
                                            documents and senior corporate officers, as the Agents or their counsel may reasonably request;
                                            provided, however, that the Corporation shall be required to make available senior corporate
                                            officers only (i)&nbsp;by telephone or at the Corporation&rsquo;s principal offices and (ii)&nbsp;during
                                            the Corporation&rsquo;s ordinary business hours.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(l)</TD><TD STYLE="text-align: justify"><U>Affirmation of Representations, Warranties,
                                            Covenants and Other Agreements</U>. Upon commencement of the offering of the Placement Shares
                                            under this Agreement (and upon the recommencement of the offering of the Placement Shares
                                            under this Agreement following any suspension of sales under Section&nbsp;4), and at each
                                            Applicable Time, each Settlement Date and each Amendment Date, as applicable, the Corporation
                                            shall be deemed to have affirmed each representation and warranty contained in this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(m)</TD><TD STYLE="text-align: justify"><U>Required Filings Relating to Placement
                                            of Placement Shares</U>. In each quarterly report (including on Form&nbsp;10-Q), management&rsquo;s
                                            discussion and analysis, annual information form or annual financial statements/annual report
                                            on Form&nbsp;10-K filed by the Corporation in respect of any period in which sales of Placement
                                            Shares were made by the Agents under this Agreement, the Corporation shall set forth with
                                            regard to such period (i)&nbsp;the number and average price of Placement Shares sold through
                                            the Agents under this Agreement, (ii)&nbsp;the aggregate gross and Net Proceeds received
                                            by the Corporation and (iii)&nbsp;the aggregate compensation paid or payable by the Corporation
                                            to the Agents with respect to sales of Placement Shares pursuant to this Agreement during
                                            such annual or quarterly period, as applicable. For so long as the Shares are listed on the
                                            TSX, the Corporation will provide the TSX with all information it requires with respect to
                                            the Offerings within the timelines prescribed by the TSX.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(n)</TD><TD STYLE="text-align: justify"><U>Representation Dates; Certificate</U>.
                                            As of the date of this Agreement and each time, during the term of this Agreement, that the
                                            Corporation (i)&nbsp;files the Prospectuses or a U.S. Prospectus relating to the Placement
                                            Shares or amends or supplements the Registration Statement or the Prospectuses relating to
                                            the Placement Shares by means of a post-effective amendment or supplement but not by means
                                            of incorporation of document(s)&nbsp;into the Registration Statement or the Prospectuses
                                            relating to the Placement Shares by reference; (ii)&nbsp;files or amends an annual report
                                            on Form&nbsp;10-K; (iii)&nbsp;files, furnishes or amends interim financial statements on
                                            Form&nbsp;8-K or Form&nbsp;10-Q; or (iv)&nbsp;at any other time reasonably requested by the
                                            Agents (each date of filing of one or more of the documents referred to in clauses (i)&nbsp;through
                                            (iii)&nbsp;and any time of request pursuant to (iv)&nbsp;above shall be a &ldquo;<B>Representation
                                            Date</B>&rdquo;), the Corporation shall furnish the Agents with a certificate, in the form
                                            attached hereto as Exhibit&nbsp;A within three (3)&nbsp;Trading Days of any Representation
                                            Date. The requirement to provide a certificate under this Section&nbsp;8(n)&nbsp;shall be
                                            waived for any Representation Date occurring at a time at which no Placement Notice is pending,
                                            which waiver shall continue until the earlier to occur of the date the Corporation delivers
                                            a Placement Notice hereunder (which for such calendar quarter shall be considered a Representation
                                            Date) and the next occurring Representation Date; provided, however, that such waiver shall
                                            not apply for any Representation Date on which the Corporation files its annual report on
                                            Form&nbsp;10-K. Notwithstanding the foregoing, if the Corporation subsequently decides to
                                            sell Placement Shares following a Representation Date when the Corporation relied on such
                                            waiver and did not provide the Agents with a certificate under this Section&nbsp;8(n), then
                                            before the Corporation delivers the Placement Notice or the Agents sell any Placement Shares,
                                            the Corporation shall provide the Agents with a certificate, in the form attached hereto
                                            as Exhibit&nbsp;A, dated the date of the Placement Notice.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(o)</TD><TD STYLE="text-align: justify"><U>Legal Opinions</U>. Upon execution
                                            of this Agreement and (x)&nbsp;within three (3)&nbsp;Trading Days of each Representation
                                            Date with respect to which the Corporation is obligated to deliver a certificate in the form
                                            attached hereto as Exhibit&nbsp;A for which no waiver is applicable and (y)&nbsp;concurrently
                                            with the delivery of a certificate pursuant to the last sentence of Section&nbsp;8(n), the
                                            Corporation will furnish or cause to be furnished to the Agents and to counsel to the Agents,
                                            (i)&nbsp;the written opinion of Cassels Brock&nbsp;&amp; Blackwell LLP (Toronto, Ontario),
                                            and other local counsel as required, such opinions to be substantially similar to the form
                                            attached hereto as Exhibit&nbsp;B, and (ii)&nbsp;the written opinion and negative assurance
                                            letter of Paul Hastings&nbsp;LLP (New York, New York), in form and substance reasonably satisfactory
                                            to the Agents, each dated the date that the opinion or letter, as applicable, is required
                                            to be delivered, or, in lieu of such opinions or letter, as applicable, counsel last furnishing
                                            such opinion or letter, as applicable to the Agents may furnish the Agents with a letter
                                            to the effect that the Agents may rely on such last opinion or letter, as applicable, to
                                            the same extent as though it was dated the date of such letter authorizing reliance (except
                                            that statements in such last opinion or letter, as applicable, shall be deemed to relate
                                            to the Registration Statement and the Prospectuses as amended and supplemented to the time
                                            of delivery of such letter authorizing reliance).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(p)</TD><TD STYLE="text-align: justify"><U>Auditor Comfort Letters</U>. Upon execution
                                            of this Agreement and (x)&nbsp;within three (3)&nbsp;Trading Days of each Representation
                                            Date with respect to which the Corporation is obligated to deliver a certificate in the form
                                            attached hereto as Exhibit&nbsp;A for which no waiver is applicable and (y)&nbsp;concurrently
                                            with the delivery of a certificate pursuant to the last sentence of Section&nbsp;8(n), the
                                            Corporation shall cause (i)&nbsp;each of PKF O&rsquo;Connor Davies, LLP and KPMG LLP, the
                                            Corporation&rsquo;s current and former auditors, respectively; it being understood that no
                                            Auditor Comfort Letter (as defined below) of KPMG LLP shall be required if and when the applicable
                                            audit report(s)&nbsp;of KPMG LLP are no longer included or deemed to be incorporated by reference
                                            in the Registration Statement, the Prospectuses and the Disclosure Package by Canadian Securities
                                            Laws, the Securities Act or the Exchange Act; and (ii)&nbsp;each auditor of the Rule&nbsp;3-09
                                            Financial Statements (if any), if the audit report(s)&nbsp;of such auditor(s)&nbsp;are included
                                            or deemed incorporated by reference in the Registration Statement, the Prospectuses and the
                                            Disclosure Package, to furnish to the Agents a letter (each, an &ldquo;<B>Auditor Comfort
                                            Letter</B>&rdquo;) addressed to the Agents dated the date such Auditor Comfort Letter is
                                            delivered, in form and substance satisfactory to the Agents, acting reasonably, (A)&nbsp;relating
                                            to the verification of certain of the financial information and statistical and accounting
                                            data relating to the Corporation and its Subsidiaries (or any equity investee, to the extent
                                            Rule&nbsp;3-09 Financial Statements are required for such equity investee), as applicable,
                                            contained in the Registration Statement and the Prospectuses or the documents incorporated
                                            by reference therein, which Auditor Comfort Letters shall be based on a review having a cut-off
                                            date not more than two Business Days prior to the date of such letter, (B)&nbsp;stating that
                                            such auditors were at the time of their report independent public accountants within the
                                            meaning of the Securities Act, the Rules&nbsp;and Regulations, and Canadian Securities Laws
                                            and the rules&nbsp;and regulations thereunder, and that in their opinion the portion of the
                                            audited financial statements of the Corporation and its Subsidiaries (or the equity investee(s),
                                            as applicable) incorporated by reference in the Registration Statement and the Prospectuses
                                            and audited by such auditors comply as to form in all material respects with the applicable
                                            accounting requirements of the Securities Act and Canadian Securities Laws and the related
                                            regulations adopted by the SEC and the Canadian Qualifying Authorities (the first such letter
                                            in each case, the &ldquo;<B>Initial Auditor Comfort Letter</B>&rdquo;) and (C)&nbsp;if applicable,
                                            updating the Initial Auditor Comfort Letter with any information which would have been included
                                            in the Initial Auditor Comfort Letter had it been given on such date and modified as necessary
                                            to relate to the Registration Statement and the Prospectuses, as amended and supplemented
                                            to the date of such letter.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(q)</TD><TD STYLE="text-align: justify"><U>Chief Financial Officer Certificate</U>.
                                            Upon execution of this Agreement and (i)&nbsp;within three (3)&nbsp;Trading Days of each
                                            Representation Date with respect to which the Corporation is obligated to deliver a certificate
                                            in the form attached hereto as Exhibit&nbsp;A for which no waiver is applicable, and (ii)&nbsp;concurrently
                                            with the delivery of a certificate pursuant to the last sentence of Section&nbsp;8(n), the
                                            Corporation will furnish the Agents a certificate of the Chief Financial Officer of the Corporation
                                            in the form attached hereto as Exhibit&nbsp;C with respect to certain financial information
                                            in the Registration Statement and the Prospectuses, as amended and supplemented to the date
                                            of such certificate (the &ldquo;<B>CFO Certificate</B>&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(r)</TD><TD STYLE="text-align: justify"><U>Market Activities</U>. During the term
                                            of this Agreement, the Corporation will not, directly or indirectly, (i)&nbsp;take any action
                                            designed to or that would constitute, under Canadian Securities Laws or the Exchange Act
                                            or otherwise, stabilization or manipulation of the price of any security of the Corporation
                                            to facilitate the sale or resale of the Placement Shares or (ii)&nbsp;bid for, or purchase
                                            the Placement Shares, or pay anyone any compensation for soliciting purchases of the Placement
                                            Shares other than the Agents.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(s)</TD><TD STYLE="text-align: justify"><U>Investment Company Act</U>. During
                                            the term of this Agreement, the Corporation will conduct its affairs in such a manner so
                                            as to reasonably ensure that, prior to the termination of this Agreement, it will not be
                                            or become an &ldquo;investment company&rdquo; as defined in the United States Investment
                                            Company Act of 1940, as amended, and the rules&nbsp;and regulations thereunder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(t)</TD><TD STYLE="text-align: justify"><U>No Offer to Sell</U>. Other than a
                                            free writing prospectus (as defined in Rule&nbsp;405) approved in advance by the Corporation
                                            and the Agents in each of their capacities as principal or agent hereunder, neither the Agents
                                            nor the Corporation (including its agents and representatives, other than the Agents in each
                                            of their capacities as such) will make, use, prepare, authorize, approve or refer to any
                                            written communication (as defined in Rule&nbsp;405 under the Securities Act), required to
                                            be filed by it with the SEC, that constitutes an offer to sell or solicitation of an offer
                                            to buy Placement Shares hereunder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(u)</TD><TD STYLE="text-align: justify"><U>Consent to the Agents&rsquo; Trading</U>.
                                            To the extent permitted under the Securities Act, the Exchange Act, Canadian Securities Laws,
                                            the rules&nbsp;of the TSX and Nasdaq and under this Agreement, the Corporation consents to
                                            the Agents trading in the Shares of the Corporation: (i)&nbsp;for the account of their other
                                            clients at the same time as sales of Placement Shares occur pursuant to this Agreement; and
                                            (ii)&nbsp;for the Agents&rsquo; own accounts, provided that no such purchase or sale shall
                                            take place by an Agent while such Agent has received a Placement Notice that remains in effect,
                                            unless the Corporation has expressly authorized or consented in writing to any such trades
                                            by such Agent except that such Agent may engage in trading that is permitted by &sect;619
                                            of the Dodd-Frank Wall Street Reform and Consumer Protection Act (the Volcker Rule).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify"><U>Actively-Traded Security</U>. After
                                            the date of this Agreement and until the date on which the sale of the Maximum Amount of
                                            Placement Shares through the Agents on the terms and subject to the conditions set forth
                                            herein has been completed or the termination of this Agreement in accordance with the terms
                                            and conditions contained herein, the Corporation shall notify the Agents immediately by an
                                            email addressed to each of the respective individuals from each of the Agents set forth on
                                            Schedule 1 hereto if the Shares cease to qualify as an &ldquo;actively-traded security&rdquo;
                                            exempted from the requirements of Rule&nbsp;101 of Regulation M under the Exchange Act by
                                            subsection&nbsp;(c)(1)&nbsp;of such rule&nbsp;and the sales shall be suspended until that
                                            or other exemptive provisions have been satisfied in the judgment of each party.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(w)</TD><TD STYLE="text-align: justify"><U>Corporation Activities</U>. After the
                                            date of this Agreement and until the latest of the completion of all of the sales of the
                                            Placement Shares contemplated hereunder, the end of the Prospectus Delivery Period or the
                                            termination of this Agreement in accordance with the terms and conditions contained herein:
                                            (i)&nbsp;neither the Corporation nor any of its Subsidiaries nor any director, officer, employee,
                                            agent or other person acting on behalf of the Corporation or any Subsidiary will cultivate,
                                            produce, process, import, sell or distribute any cannabis or cannabinoid product or otherwise
                                            engage in any direct or indirect dealings or transactions, in each case, involving the purchase
                                            or sale of cannabis or cannabinoid product by the Corporation or any of its Subsidiaries
                                            in or to the United States of America, its territories and possessions, any state of the
                                            United States or the District of Columbia or any other jurisdiction unless such activity
                                            is in compliance with all federal, state and provincial or territorial laws applicable to
                                            such activity; and (ii)&nbsp;the Corporation will conduct its business and affairs in compliance
                                            with the terms and conditions of the Canopy USA Structure and in such a manner so as to reasonably
                                            ensure that the Corporation and the Subsidiaries will remain in compliance with Federal Cannabis
                                            Laws. The Corporation will notify the Agents promptly if the Corporation, any Subsidiary
                                            or any director, officer, employee, agent or other person acting on behalf of the Corporation
                                            or any Subsidiary has received notice of any investigation or proceedings related to the
                                            matters set forth in this Section&nbsp;8(w).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(x)</TD><TD STYLE="text-align: justify"><U>Investment Entities&rsquo; Activities</U>.
                                            After the date of this Agreement and until the latest of the date on which the sale of the
                                            Maximum Amount of Placement Shares through the Agents on the terms and subject to the conditions
                                            set forth herein has been completed, the end of the Prospectus Delivery Period or the termination
                                            of this Agreement in accordance with the terms and conditions contained herein, the Corporation
                                            will take all necessary actions to maintain compliance with the applicable TSX and Nasdaq
                                            policies, rules&nbsp;and regulations in effect at the applicable time with respect to the
                                            cannabis sector and the Investment Entities, including, without limitation, conducting the
                                            business and affairs of the Corporation and its Subsidiaries in accordance with the terms
                                            and conditions of the Canopy USA Structure. The Corporation will notify the Agents promptly
                                            if it has received notice of any investigation or proceedings related to the matters set
                                            forth in this Section&nbsp;8(x). Notwithstanding anything to the contrary set forth in this
                                            Section&nbsp;8(x), the Corporation shall have no obligation to the Agents under the terms
                                            of this Agreement to sell, transfer or dispose of the Corporation&rsquo;s non-participating,
                                            non-voting interests in the Investment Entities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(y)</TD><TD STYLE="text-align: justify"><U>Notice of Other Sales</U>. During the
                                            pendency of any Placement Notice given hereunder, the Corporation shall provide the Agents
                                            notice as promptly as reasonably possible before it offers to sell, contracts to sell, sells,
                                            grants any option to sell or otherwise disposes of any Shares (other than Placement Shares
                                            offered pursuant to the provisions of this Agreement) or securities convertible or exercisable
                                            into or exchangeable for Shares; provided, that such notice shall not be required in connection
                                            with the (i)&nbsp;issuance, grant or sale of Shares, options or other rights to purchase
                                            or otherwise acquire Shares, or Shares issuable upon the exercise of options or other equity
                                            awards, in each case granted pursuant to any stock option, stock bonus or other stock or
                                            compensatory plan or arrangement, whether now in effect or hereafter implemented, (ii)&nbsp;issuance
                                            of securities in connection with an acquisition, merger or sale or purchase of assets which
                                            either (a)&nbsp;is disclosed in filings by the Corporation available on SEDAR+ or EDGAR or
                                            otherwise in writing to the Agents; or (b)&nbsp;involves an immaterial amount of Shares being
                                            issued, (iii)&nbsp;issuance or sale of Shares upon conversion of securities or the exercise
                                            of warrants, options or other rights then in effect or outstanding which either (a)&nbsp;is
                                            disclosed in filings by the Corporation available on SEDAR+ or EDGAR or otherwise in writing
                                            to the Agents; or (b)&nbsp;involves an immaterial amount of Shares being issued, or (iv)&nbsp;issuance
                                            or sale of Shares pursuant to any dividend reinvestment and stock purchase plan that the
                                            Corporation has in effect or may adopt from time to time, provided that the implementation
                                            of such new plan is disclosed to the Agents in advance. If the Corporation notifies the Agents
                                            under this Section&nbsp;8(y)&nbsp;of a proposed sale of Shares or Share equivalents, the
                                            Agents may suspend any offers and sales of Shares under this Agreement for a period of time
                                            deemed appropriate by the Agents.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(z)</TD><TD STYLE="text-align: justify"><U>Insurance</U>. During the term of this
                                            Agreement, each of the Corporation and its Subsidiaries shall maintain, or cause to be maintained,
                                            insurance in such amounts and covering such risks as such entity reasonably considers adequate
                                            for the conduct of its business and the value of its properties and as is customary for companies
                                            engaged in similar businesses in similar industries.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(aa)</TD><TD STYLE="text-align: justify"><U>Compliance with Laws</U>. During the
                                            term of this Agreement, the Corporation and each of the Subsidiaries shall maintain, or cause
                                            to be maintained, all material permits, licences and other authorizations required by federal,
                                            provincial, territorial, state and local law in order to conduct their businesses as described
                                            in the Registration Statement and the Prospectuses, and the Corporation and each of the Subsidiaries
                                            shall conduct their businesses, or cause their businesses to be conducted, in compliance
                                            with such permits, licences and authorizations and with applicable laws, except where the
                                            failure to maintain or be in compliance with such permits, licences and authorizations could
                                            not reasonably be expected to result in a Material Adverse Effect.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(bb)</TD><TD STYLE="text-align: justify"><U>Securities Act and Exchange Act</U>.
                                            During the term of this Agreement, the Corporation will use its commercially reasonable efforts
                                            to comply with all requirements imposed upon it by Canadian Securities Laws, the Securities
                                            Act, the Exchange Act, the Rules&nbsp;and Regulations, the TSX and Nasdaq as from time to
                                            time in force, so far as necessary to permit the continuance of sales of, or dealings in,
                                            the Placement Shares as contemplated by the provisions hereof and the Prospectuses.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>9.</B></TD><TD><B><U>Additional Representations and Covenants of the Corporation</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><U>Issuer Free Writing Prospectuses</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">The Corporation represents that it has not
                                            made, and covenants that, unless it obtains the prior written consent of the Agents, it will
                                            not make any offer relating to the Placement Shares that would constitute an Issuer Free
                                            Writing Prospectus required to be filed by it with the SEC or retained by the Corporation
                                            under Rule&nbsp;433; except as set forth in a Placement Notice, no use of any Issuer Free
                                            Writing Prospectus has been consented to by the Agents. The Corporation agrees that it will
                                            comply with the requirements of Rules&nbsp;164 and 433 under the Securities Act applicable
                                            to any Issuer Free Writing Prospectus, including not making use of any Issuer Free Writing
                                            Prospectuses unless eligible to do so, and including the timely filing with the SEC or retention
                                            where required and legending.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">The Corporation agrees that no Issuer Free
                                            Writing Prospectus, if any, will include any information that conflicts with the information
                                            contained in the Registration Statement, including any document incorporated by reference
                                            therein that has not been superseded or modified, or the Prospectuses. In addition, no Issuer
                                            Free Writing Prospectus, if any, together with the Prospectuses, will include an untrue statement
                                            of a material fact or omit to state a material fact necessary to make the statements therein,
                                            in the light of the circumstances under which they were made, not misleading; provided, however,
                                            the foregoing shall not apply to any statements or omissions in any Issuer Free Writing Prospectus
                                            made in reliance on information furnished in writing to the Corporation by the Agents expressly
                                            stating that such information is intended for use therein, it being understood and agreed
                                            that the only information furnished by any Agent consists of the information described as
                                            such in Section&nbsp;11(a)&nbsp;hereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">The Corporation agrees that if at any
                                            time following issuance of an Issuer Free Writing Prospectus any event occurred or occurs
                                            as a result of which such Issuer Free Writing Prospectus would conflict with the information
                                            in the Registration Statement, including any document incorporated by reference therein that
                                            has not been superseded or modified, or the Prospectuses or would include an untrue statement
                                            of a material fact or omit to state a material fact necessary to make the statements therein,
                                            in the light of the circumstances under which they were made, not misleading, the Corporation
                                            will give prompt notice thereof to the Agents and, if requested by the Agents, will prepare
                                            and furnish without charge to the Agents an Issuer Free Writing Prospectus or other document
                                            which will correct such conflict, statement or omission; provided, however, the foregoing
                                            shall not apply to any statements or omissions in any Issuer Free Writing Prospectus made
                                            in reliance on information furnished in writing to the Corporation by the Agents expressly
                                            stating that such information is intended for use therein, it being understood and agreed
                                            that the only information furnished by any Agent consists of the information described as
                                            such in Section&nbsp;11(a)&nbsp;hereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><U>Non-Issuer Free Writing Prospectus</U>.
                                            The Corporation consents to the use by the Agents, at any time that the Corporation is eligible
                                            to do so, of a free writing prospectus that (a)&nbsp;is not an Issuer Free Writing Prospectus,
                                            and (b)&nbsp;contains only information describing the terms of the Shares or the Offerings,
                                            or information permitted under Rule&nbsp;134 under the Securities Act; provided that the
                                            Agents covenant with the Corporation not to take any action that would result in the Corporation
                                            being required to file with the SEC under Rule&nbsp;433(d)&nbsp;a free writing prospectus
                                            prepared by or on behalf of the Agents that otherwise would not be required to be filed by
                                            the Corporation thereunder, but for the action of the Agents.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><U>Distribution of Offering Materials</U>.
                                            The Corporation and the Agents have not distributed and will not distribute, during the term
                                            of this Agreement, any &ldquo;marketing materials&rdquo; (as defined in National Instrument
                                            41-101 &ndash; <I>General Prospectus Requirements</I>) in connection with the offering and
                                            sale of the Placement Shares other than the Registration Statement, the Prospectuses, the
                                            Disclosure Package or any Issuer Free Writing Prospectus reviewed and consented to by the
                                            Agents and included in a Placement Notice (as described in clause&nbsp;(a)(i)&nbsp;above),
                                            provided that the Agents covenant with the Corporation not to take any action that would
                                            result in the Corporation being required to file with the Canadian Qualifying Authorities
                                            any &ldquo;marketing materials&rdquo; that otherwise would not be required to be filed by
                                            the Corporation, but for the action of the Agents.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>10.</B></TD><TD><B><U>Conditions to the Agents&rsquo; Obligations</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The obligations of the Agents
hereunder with respect to a Placement will be subject to the continuing accuracy and completeness of the representations and warranties
made by the Corporation herein, to the due performance by the Corporation of its obligations hereunder, to the completion by the Agents
of a due diligence review satisfactory to the Agents in their reasonable judgment, and to the continuing satisfaction (or waiver by the
Agents in their sole discretion) of the following additional conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><U>Canadian Prospectus Supplement</U>.
                                            The Canadian Prospectus Supplement shall have been filed with the Canadian Qualifying Authorities
                                            under the Canadian Shelf Procedures and in accordance with this Agreement, all requests for
                                            additional information on the part of the Canadian Qualifying Authorities shall have been
                                            complied with to the reasonable satisfaction of the Agents and the Agents&rsquo; counsel.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><U>U.S. Prospectus; Registration Statement
                                            Effective</U>. The U.S. Prospectus, and any supplement thereto, required by Rule&nbsp;424
                                            to be filed with the SEC shall have been filed in the manner and within the time period required
                                            by Rule&nbsp;424(b)&nbsp;with respect to any sale of Placement Shares; any material required
                                            to be filed by the Corporation pursuant to Rule&nbsp;433(d)&nbsp;under the Securities Act
                                            shall have been filed with the SEC within the applicable time periods prescribed for such
                                            filings by Rule&nbsp;433. The Registration Statement shall remain effective and shall be
                                            available for the sale of (i)&nbsp;all Placement Shares issued pursuant to all prior Placements
                                            and not yet sold by the Agents and (ii)&nbsp;all Placement Shares contemplated to be issued
                                            by the Placement Notice relating to such Placement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><U>No Material Notices; Other Events</U>.
                                            None of the following events shall have occurred and be continuing: (i)&nbsp;receipt by the
                                            Corporation of any request for additional information from the SEC, the Canadian Qualifying
                                            Authorities or any other federal or state or foreign or other governmental, administrative
                                            or self-regulatory authority during the period of effectiveness of the Registration Statement
                                            and the Prospectuses, the response to which would require any amendments or supplements to
                                            the Registration Statement or the Prospectuses; (ii)&nbsp;the issuance by the SEC, the Canadian
                                            Qualifying Authorities or any other federal or state or foreign or other Governmental Authority
                                            of any stop order suspending the effectiveness of the Registration Statement or the Prospectuses
                                            or the initiation of any proceedings for that purpose; (iii)&nbsp;receipt by the Corporation
                                            of any notification with respect to the suspension of the qualification or exemption from
                                            qualification of any of the Placement Shares for sale in any jurisdiction or the initiation
                                            or threatening of any proceeding for such purpose; (iv)&nbsp;the occurrence of any event
                                            that makes any statement made in the Registration Statement or the Prospectuses or any document
                                            incorporated or deemed to be incorporated therein by reference untrue in any material respect
                                            or that requires the making of any changes in the Registration Statement, Prospectuses or
                                            documents so that, in the case of the Registration Statement, it will not contain any untrue
                                            statement of a material fact or omit to state any material fact required to be stated therein
                                            or necessary to make the statements therein not misleading, and in the case of each Prospectus,
                                            it will not contain any untrue statement of a material fact or omit to state any material
                                            fact required to be stated therein or necessary to make the statements therein, in the light
                                            of the circumstances under which they were made, not misleading; (v)&nbsp;the Corporation&rsquo;s
                                            reasonable determination that a post-effective amendment to the Registration Statement or
                                            the filing of a new or amended Prospectus would be appropriate; (vi)&nbsp;any outbreak or
                                            escalation of hostilities or other national or international calamity or crisis, including
                                            acts of terrorism, or material adverse change or disruption in economic conditions in, or
                                            in the financial markets of, the United States or Canada (it being understood that any such
                                            change or disruption shall be relative to such conditions and markets as in effect on the
                                            date hereof), if the effect of such outbreak, escalation, calamity, crisis, act or material
                                            adverse change in the economic conditions in, or in the financial markets of, the United
                                            States or Canada could be reasonably expected to make it, in the sole judgement of the Agents,
                                            impracticable or inadvisable to proceed with the offering of the Placement Shares on the
                                            terms and in the manner contemplated in the Prospectuses or to enforce contracts for the
                                            sale of securities; or (vii)&nbsp;the declaration of a banking moratorium by any Governmental
                                            Authority or the taking of any action by any Governmental Authority after the date hereof
                                            in respect of its monetary or fiscal affairs that could be reasonably expected to make it,
                                            in the sole judgement of the Agents, impracticable or inadvisable to proceed with the offering
                                            of the Placement Shares on the terms and in the manner contemplated in the Prospectuses.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><U>Material Changes</U>. Except as contemplated
                                            and appropriately disclosed in the Prospectuses, or disclosed in the Corporation&rsquo;s
                                            reports filed with the SEC and Canadian Qualifying Authorities, in each case at the time
                                            the applicable Placement Notice is delivered, there shall not have been any material change,
                                            on a consolidated basis, in the authorized share capital of the Corporation, or any development
                                            that causes or could reasonably be expected to cause a Material Adverse Effect (financial
                                            or otherwise), the effect of which, in the sole judgment of the Agents (without relieving
                                            the Corporation of any obligation or liability it may otherwise have), acting reasonably,
                                            is so material as to make it impracticable or inadvisable to proceed with the offering of
                                            the Placement Shares on the terms and in the manner contemplated in the Prospectuses.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify"><U>Certificate</U>. The Agents shall have
                                            received the certificate required to be delivered pursuant to Section&nbsp;8(n)&nbsp;on or
                                            before the date on which delivery of such certificate is required pursuant to Section&nbsp;8(n).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify"><U>Legal Opinions</U>. The Agents shall
                                            have received the opinions of counsel to be delivered pursuant to Section&nbsp;8(o)&nbsp;on
                                            or before the date on which such delivery of such opinions are required pursuant to Section&nbsp;8(o).
                                            In addition, on such dates that the opinions required by Section&nbsp;8(o)&nbsp;are delivered,
                                            the Agents shall have also received (i)&nbsp;the opinion and negative assurance letter of
                                            Torys LLP, U.S. counsel to the Agents, with respect to the issuance and sale of the Placement
                                            Shares in the United States, the Registration Statement, the Disclosure Package, the U.S.
                                            Prospectus and other related matters as the Agents may reasonably require, and (ii)&nbsp;the
                                            opinion of Torys LLP, Canadian counsel for the Agents, with respect to the issuance and sale
                                            of the Placement Shares in Ontario, the Canadian Prospectus and other related matters as
                                            the Agents may reasonably require, it being understood that counsel for the Agents may rely
                                            on the opinions of counsel for the Corporation and that counsel for the Agents and counsel
                                            for the Corporation may rely upon the opinions of local counsel as to all matters not governed
                                            by the laws of the respective jurisdictions in which they are qualified to practice, and
                                            may rely, to the extent appropriate in the circumstances, as to matters of fact on certificates
                                            of the Corporation, auditors and public officials, and that the opinions of counsel may be
                                            subject to usual qualifications as to equitable remedies, creditors&rsquo; rights laws and
                                            public policy considerations.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify"><U>Comfort Letters</U>. The Agents shall
                                            have received the Auditor Comfort Letter(s)&nbsp;required to be delivered pursuant to Section&nbsp;8(p)&nbsp;on
                                            or before the date on which the delivery of such letter is required pursuant to Section&nbsp;8(p).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify"><U>Approval for Listing; No Suspension</U>.
                                            The Placement Shares shall have either been (i)&nbsp;approved for listing, subject to notice
                                            of issuance, on Nasdaq and the TSX, or (ii)&nbsp;(1)&nbsp;the Corporation shall have filed
                                            an application for listing of the Placement Shares on the TSX at or prior to the issuance
                                            of the Placement Notice and (2)&nbsp;the Corporation shall have notified Nasdaq of the offering
                                            of the Placement Shares up to the Maximum Amount and Nasdaq shall have raised no objections
                                            at or prior to the issuance of the Placement Notice. Trading in the Shares shall not have
                                            been suspended or delisted from either the TSX or Nasdaq.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify"><U>CFO Certificate</U>. The Agents shall
                                            have received the CFO Certificate required to be delivered pursuant to Section&nbsp;8(q)&nbsp;on
                                            or before the date on which such delivery of such certificate is required pursuant to Section&nbsp;8(q).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(j)</TD><TD STYLE="text-align: justify"><U>Other Materials</U>. On each date on
                                            which the Corporation is required to deliver a certificate pursuant to Section&nbsp;8(n),
                                            the Corporation shall have furnished to the Agents such appropriate further information,
                                            certificates and documents as the Agents may reasonably request.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(k)</TD><TD STYLE="text-align: justify"><U>FINRA</U>. If a filing with FINRA is
                                            required, FINRA shall not have objected to the fairness or reasonableness of the terms or
                                            arrangements for the Agents&rsquo; compensation under this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>11.</B></TD><TD><B><U>Indemnification and Contribution</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">The Corporation agrees to indemnify and
                                            hold harmless each Agent, and each of their respective officers, employees, and agents, and
                                            each person, if any, who controls any Agent within the meaning of either Section&nbsp;15
                                            of the Securities Act or Section&nbsp;20 of the Exchange Act (the &ldquo;<B>Agent Indemnified
                                            Parties</B>&rdquo;), and each affiliate of any Agent within the meaning of Rule&nbsp;405
                                            under the Securities Act from and against any and all losses (other than loss of profits),
                                            claims, damages and liabilities (including, without limitation, any documented legal or other
                                            expenses reasonably incurred in connection with defending, settling and/or satisfying a judgement
                                            in any such action or claim) caused by or based upon:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">any untrue statement or alleged untrue statement
                                            of a material fact contained in the Registration Statement or any amendment thereto, any
                                            Issuer Free Writing Prospectus, the U.S. Prospectus or any amendment thereto, the Canadian
                                            Prospectus or any amendment thereto, or caused by any omission or alleged omission to state
                                            therein a material fact required to be stated therein or necessary to make the statements
                                            therein not misleading in the light of the circumstances under which they were made, or any
                                            misrepresentation within the meaning of Canadian Securities Laws contained therein, except
                                            insofar as such losses, claims, damages or liabilities are caused by any such untrue statement
                                            or omission or alleged untrue statement or omission made in reliance upon and in conformity
                                            with written information relating to any Agent furnished to the Corporation in writing by
                                            such Agent expressly for use therein (it being understood and agreed that information in
                                            the tenth and eleventh paragraphs under the heading &ldquo;Plan of Distribution&rdquo; in
                                            the U.S. Prospectus Supplement and the corresponding paragraphs in the Canadian Prospectus
                                            Supplement and the names of the Agents set forth on the cover constitutes the only information
                                            furnished in writing by or on behalf of the Agents for inclusion in the Prospectuses or any
                                            Issuer Free Writing Prospectus); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">any
                                            order made or any inquiry, investigation (whether formal or informal) or proceeding commenced
                                            or threatened by any securities, regulatory or other competent authority based upon the circumstances
                                            described in subsection (i)&nbsp;above (for greater certainty, </FONT>excluding any order,
                                            inquiry, investigation or proceeding based solely on the activities of the Agent), which
                                            operates to prevent or restrict the trading in or the distribution of the Placement Shares
                                            or any of them in any of the provinces and territories of Canada or in the United States,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><FONT STYLE="font-size: 10pt">except
that if and to the extent that a court of competent jurisdiction in a final judgment that has become non-appealable determines that the
loss, claim, damage or liability resulted from the gross negligence, fraud or wilful misconduct of the </FONT>Agent Indemnified Party
claiming indemnity, such Agent Indemnified Party will promptly reimburse the Corporation any funds advanced to the Agent Indemnified
Party in respect of such loss, claim, damage or liability and the indemnity provided for in this Section&nbsp;11(a)&nbsp;shall cease
to apply to such Agent Indemnified Party in respect of such loss, claim, damage or liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Each Agent agrees to indemnify and hold
                                            harmless the Corporation, its directors, its officers who sign the Registration Statement
                                            and each person, if any, who controls the Corporation within the meaning of either Section&nbsp;15
                                            of the Securities Act or Section&nbsp;20 of the Exchange Act (the &ldquo;<B>Corporation Indemnified
                                            Parties</B>&rdquo;) from and against any and all losses (other than loss of profits), claims,
                                            damages and liabilities (including, without limitation, any legal or other expenses reasonably
                                            incurred in connection with defending, settling and/or satisfying a judgment in any such
                                            action or claim) caused by or based upon any untrue statement or alleged untrue statement
                                            of a material fact contained or incorporated by reference in the Registration Statement or
                                            any amendment thereto, any Issuer Free Writing Prospectus, the U.S. Prospectus or any amendment
                                            thereto, the Canadian Prospectus or any amendment thereto, or caused by any omission or alleged
                                            omission to state therein a material fact required to be stated therein or necessary to make
                                            the statements therein not misleading in the light of the circumstances under which they
                                            were made, or any misrepresentation within the meaning of Canadian Securities Laws contained
                                            therein, but only with reference to the information relating to any Agent furnished to the
                                            Corporation in writing by such Agent expressly for use therein (it being understood and agreed
                                            that the only information furnished by any Agent consists of the information described as
                                            such in Section&nbsp;11(a)&nbsp;hereof).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 49; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">In case any proceeding (including any
                                            governmental investigation) shall be instituted involving an Agent Indemnified Party in respect
                                            of which indemnity may be sought pursuant to Section&nbsp;11(a)&nbsp;or a Corporation Indemnified
                                            Party in respect of which indemnity may be sought pursuant to Section&nbsp;11(b), such person
                                            (the &ldquo;<B>Indemnified Party</B>&rdquo;) shall promptly notify the person against whom
                                            such indemnity may be sought (the &ldquo;<B>Indemnifying Party</B>&rdquo;) in writing and
                                            the Indemnifying Party, upon request of the Indemnified Party, shall retain counsel reasonably
                                            satisfactory to the Indemnified Party to represent the Indemnified Party and any others the
                                            Indemnifying Party may designate in such proceeding and shall pay the reasonable and documented
                                            fees and disbursements of such counsel related to such proceeding. In any such proceeding,
                                            any Indemnified Party shall have the right to retain its own counsel, but the fees and expenses
                                            of such counsel shall be at the expense of such Indemnified Party unless (1)&nbsp;the Indemnifying
                                            Party and the Indemnified Party shall have mutually agreed to the retention of such counsel
                                            or (2)&nbsp;the named parties to any such proceeding (including any impleaded parties) include
                                            both the Indemnifying Party and the Indemnified Party and representation of both parties
                                            by the same counsel would be inappropriate due to actual or potential differing interests
                                            between them. It is understood that the Indemnifying Party shall not, in respect of the legal
                                            expenses of any Indemnified Party in connection with any proceeding or related proceedings
                                            in the same jurisdiction, be liable for (i)&nbsp;the fees and expenses of more than one separate
                                            firm (in addition to any local counsel) for any Agent Indemnified Party and (ii)&nbsp;the
                                            fees and expenses of more than one separate firm (in addition to any local counsel) for the
                                            Corporation Indemnified Parties. In the case of any such separate firm for the Canadian Agent
                                            and such officers, employees and agents, and such control persons and affiliates of any Agent,
                                            such firm shall be designated in writing by the Canadian Agent. In the case of any such separate
                                            firm for the U.S. Agent and such officers, employees and agents, and such control persons
                                            and affiliates of any Agent, such firm shall be designated in writing by the U.S. Agent.
                                            In the case of any such separate firm for the Corporation Indemnified Parties, such firm
                                            shall be designated in writing by the Corporation. The Indemnifying Party shall not be liable
                                            for any settlement of any proceeding effected without its written consent, but if settled
                                            with such consent or if there be a final judgment for the plaintiff, the Indemnifying Party
                                            agrees to indemnify the Indemnified Party from and against any loss or liability by reason
                                            of such settlement or judgment. Notwithstanding the foregoing sentence, if at any time an
                                            Indemnified Party shall have requested the Indemnifying Party to reimburse the Indemnified
                                            Party for reasonable and documented fees and expenses of counsel as contemplated by the second
                                            and third sentences of this paragraph, the Indemnifying Party agrees that it shall be liable
                                            for any settlement of any proceeding effected without its written consent if (i)&nbsp;such
                                            settlement is entered into more than 60 days after receipt by the Indemnifying Party of the
                                            aforesaid request and (ii)&nbsp;the Indemnifying Party shall not have reimbursed the Indemnified
                                            Party in accordance with such request prior to the date of such settlement. The Indemnifying
                                            Party shall not, without the prior written consent of the Indemnified Party, effect any settlement
                                            of any pending or threatened proceeding in respect of which any Indemnified Party is or could
                                            have been a party and indemnity could have been sought hereunder by such Indemnified Party,
                                            unless such settlement includes an unconditional release of such Indemnified Party from all
                                            liability on claims that are the subject matter of such proceeding and does not include a
                                            statement as to or an admission of fault, culpability or a failure to act by or on behalf
                                            of any Indemnified Party.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 50; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">To the extent the indemnification provided
                                            for in Section&nbsp;11(a)&nbsp;or Section&nbsp;11(b)&nbsp;is unavailable to an Indemnified
                                            Party or insufficient in respect of any losses, claims, damages or liabilities referred to
                                            therein, then the Corporation or the Agents, as applicable, in lieu of indemnifying such
                                            Indemnified Party thereunder, shall contribute to the amount paid or payable by such Indemnified
                                            Party as a result of such losses, claims, damages or liabilities (1)&nbsp;in such proportion
                                            as is appropriate to reflect the relative benefits received by the Corporation or the Agents,
                                            as applicable on the one hand and the Indemnified Party or parties on the other hand from
                                            the distribution of the Placement Shares or (2)&nbsp;if the allocation provided in Section&nbsp;11(d)(1)&nbsp;is
                                            not permitted by applicable law, in such proportion as is appropriate to reflect not only
                                            the relative benefits referred to in Section&nbsp;11(d)(1)&nbsp;but also the relative fault
                                            of the Corporation or the Agents, as applicable, on the one hand and of the Indemnified Party
                                            or parties on the other hand in connection with the statements or omissions that resulted
                                            in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations.
                                            The relative benefits received by the Corporation on the one hand and the Agents on the other
                                            hand in connection with the distribution of the Placement Shares shall be deemed to be in
                                            the same respective proportions as the Net Proceeds from the distribution of the Placement
                                            Shares received by the Corporation and the total Placement Fees received by the Agents. The
                                            relative fault of the Corporation on the one hand and the Agents on the other hand shall
                                            be determined by reference to, among other things, whether the untrue or alleged untrue statement
                                            of a material fact or the omission or alleged omission to state a material fact relates to
                                            information supplied by the Corporation or by the Agents and the parties&rsquo; relative
                                            intent, knowledge, access to information and opportunity to correct or prevent such statement
                                            or omission.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">The Corporation and the Agents agree that
                                            it would not be just or equitable if contribution pursuant to this Section&nbsp;11 were determined
                                            by pro rata allocation (even if the Agents were treated as one entity for such purpose) or
                                            by any other method of allocation that does not take account of the equitable considerations
                                            referred to in Section&nbsp;11(d). The amount paid or payable by an Indemnified Party as
                                            a result of the losses, claims, damages and liabilities referred to in Section&nbsp;11(d)&nbsp;shall
                                            be deemed to include, subject to the limitations set forth above, any legal or other expenses
                                            reasonably incurred by such Indemnified Party in connection with defending, settling and/or
                                            satisfying any such action or claim. Notwithstanding the provisions of this Section&nbsp;11,
                                            no Agent shall be required to contribute any amount in excess of the Placement Fees or any
                                            portion thereof actually received by such Agent. No person guilty of fraudulent misrepresentation
                                            (within the meaning of Section&nbsp;11(f)&nbsp;of the Securities Act) shall be entitled to
                                            contribution from any person who was not guilty of such fraudulent misrepresentation. The
                                            remedies provided for in this Section&nbsp;11 are not exclusive and shall not limit any rights
                                            or remedies which may otherwise be available to any Indemnified Party at law or in equity.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 51; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">The indemnity and contribution provisions
                                            contained in this Section&nbsp;11 shall remain operative and in full force and effect regardless
                                            of (1)&nbsp;any termination of this Agreement, (2)&nbsp;any investigation made by or on behalf
                                            of any Agent, and any of their respective officers, employees or agents, any person controlling
                                            any Agent, or any affiliate of any Agent, or by or on behalf of the Corporation, its officers
                                            or directors or any person controlling the Corporation and (3)&nbsp;acceptance of and payment
                                            for any of the Placement Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">The Indemnifying Party hereby acknowledges
                                            and agrees that, with respect to this Section&nbsp;11, the Agents are contracting on their
                                            own behalf and as agents for their affiliates, directors, officers, employees and agents
                                            and their respective affiliates, directors, officers, employees and agents (collectively,
                                            the &ldquo;<B>Beneficiaries</B>&rdquo;). In this regard, each of the Agents will act as trustee
                                            for the Beneficiaries of the covenants of the Indemnifying Party under this Section&nbsp;11
                                            with respect to the Beneficiaries and accepts these trusts and will hold and enforce those
                                            covenants on behalf of the Beneficiaries.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>12.</B></TD><TD><B><U>Representations and Agreements to Survive Delivery</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All representations and warranties
of the Corporation herein or in certificates delivered pursuant hereto shall remain operative and in full force and effect, as of their
respective dates, regardless of any investigation made by or on behalf of the Agents, or the Corporation (or any of their respective
officers, directors or controlling persons), and shall survive following termination of this Agreement pursuant to Section&nbsp;13.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>13.</B></TD><TD><B><U>Termination</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">The Corporation shall have the right to
                                            terminate this Agreement in its sole discretion at any time by giving written notice to the
                                            Agents as hereinafter specified. Any such termination shall be without liability of any party
                                            to any other party, except that the provisions of Section&nbsp;8(h), Section&nbsp;11, Section&nbsp;12,
                                            Section&nbsp;13(f), Section&nbsp;15, Section&nbsp;18, Section&nbsp;19 and Section&nbsp;20
                                            hereof shall remain in full force and effect notwithstanding such termination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">The Agents shall have the right to terminate
                                            its obligations under this Agreement in their sole discretion at any time after the date
                                            of this Agreement by giving written notice to the Corporation as hereinafter specified. Any
                                            such termination shall be without liability of any party to any other party except that the
                                            provisions of Section&nbsp;8(h), Section&nbsp;11, Section&nbsp;12, Section&nbsp;13(f), Section&nbsp;15,
                                            Section&nbsp;18, Section&nbsp;19 and Section&nbsp;20 hereof shall remain in full force and
                                            effect notwithstanding such termination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 52; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Unless previously terminated pursuant
                                            to this Section&nbsp;13, this Agreement shall automatically terminate upon the earliest of
                                            (i)&nbsp;June&nbsp;5, 2027, (ii)&nbsp;the date on which the issuance and sale of the Maximum
                                            Amount of Placement Shares through the Agents on the terms and subject to the conditions
                                            set forth herein has been completed, (iii)&nbsp;the date on which the Registration Statement
                                            ceases to be useable for sales of Shelf Securities pursuant to General Instruction I.B.1
                                            of Form&nbsp;S-3, and (iv)&nbsp;the date on which notice from the SEC that the Registration
                                            Statement has ceased to be effective in accordance with the Securities Act has been received
                                            by the Corporation; provided that any such termination shall in all cases be deemed to provide
                                            that Section&nbsp;8(h), Section&nbsp;11, Section&nbsp;12, Section&nbsp;13(f), Section&nbsp;15,
                                            Section&nbsp;18, Section&nbsp;19 and Section&nbsp;20 shall remain in full force and effect.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">Notwithstanding the foregoing, the Canadian
                                            Offering contemplated by this Agreement shall automatically terminate and no issuance or
                                            sales of Placement Shares may occur thereunder on the earliest to occur of (i)&nbsp;July&nbsp;5,
                                            2026, (ii)&nbsp;the date on which the issuance and sale of Placement Shares through the Canadian
                                            Agent in the Canadian Offering equals US$50,000,000 (or the equivalent in Canadian currency),
                                            (iii)&nbsp;the date which notice from the Ontario Securities Commission that the Canadian
                                            Base Prospectus has ceased to be effective in accordance with applicable Canadian securities
                                            laws has been received by the Corporation or (iv)&nbsp;as contemplated by Sections 13(a),
                                            13(b)&nbsp;or 13(c)&nbsp;hereof; provided, however, that such termination of the Canadian
                                            Offering as contemplated by subsection (i), (ii)&nbsp;and (iii)&nbsp;of this Section&nbsp;13(d)&nbsp;shall
                                            in no case affect the U.S. Offering and this Agreement shall continue to remain in full force
                                            and effect with respect thereto.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">This Agreement shall remain in full force
                                            and effect unless terminated pursuant to Sections&nbsp;13(a), 13(b), 13(c)&nbsp;or otherwise
                                            by mutual agreement of the parties; provided that any such termination shall in all cases
                                            be deemed to provide that Section&nbsp;8(h), Section&nbsp;11, Section&nbsp;12, Section&nbsp;13(f),
                                            Section&nbsp;15, Section&nbsp;18, Section&nbsp;19 and Section&nbsp;20 shall remain in full
                                            force and effect.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">Any termination of this Agreement shall
                                            be effective on the date specified in such notice of termination; provided that such termination
                                            shall not be effective until the close of business on the date of receipt of such notice
                                            by the Agents or the Corporation, as the case may be. If such termination shall occur prior
                                            to the Settlement Date for any sale of Placement Shares, such Placement Shares shall settle
                                            in accordance with the provisions of this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">In the event that the Corporation terminates
                                            this Agreement, as permitted under Section&nbsp;13(a), the Corporation shall be under no
                                            continuing obligation, either pursuant to this Agreement or otherwise to utilize the services
                                            of the Agents in connection with any sale of securities of the Corporation or to pay any
                                            compensation to the Agents other than compensation with respect to sales of Placement Shares
                                            subscribed on or before the termination date and the Corporation shall be free to engage
                                            other placement agents and underwriters from and after the termination date with no continuing
                                            obligation to the Agents.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 53; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>14.</B></TD><TD><B><U>Notices</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as expressly set out
herein, all notices or other communications required or permitted to be given by any party to any other party pursuant to the terms of
this Agreement shall be in writing (including by electronic means) and if sent to the Agents, shall be delivered to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">BMO Capital Markets Corp.<BR>
151 W42nd Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">New York, NY 10036</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.75in; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity
    Syndicate Department</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With a
    copy to the Legal Department</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">-and-</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">BMO Nesbitt Burns Inc.<BR>
First Canadian Place, 4<SUP>th</SUP> Floor<BR>
100 King Street West<BR>
Toronto, ON M5X 1H3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.75in; text-align: justify; font-size: 10pt">Attention:</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">Andrew Warkentin</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">Email:</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">[***]</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">With a copy (which shall not constitute
notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Torys LLP<BR>
79 Wellington Street West, Suite&nbsp;3000<BR>
Toronto, ON M5K 1N2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.75in; text-align: justify; font-size: 10pt">Attention:</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">Robbie Leibel / Christopher Bornhorst</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">Email:</TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><U>rleibel@torys.com</U> / <U>cbornhorst@torys.com</U></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">or if sent to the Corporation, shall
be delivered to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Canopy Growth Corporation<BR>
1 Hershey Drive<BR>
Smiths Falls, ON K7A 0A8</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.75in; text-align: justify; font-size: 10pt">Attention:</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">Tom Stewart</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">Email:</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">[***]</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">With a copy (which shall not constitute
notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Cassels Brock&nbsp;&amp; Blackwell
LLP<BR>
Bay Adelaide Centre &ndash; North Tower<BR>
40 Temperance St., Suite&nbsp;3200<BR>
Toronto, ON M5H 0B4</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.75in; text-align: justify; font-size: 10pt">Attention:</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">Jonathan Sherman</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">Email:</TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><U>jsherman@cassels.com</U></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 54; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">-and-</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Paul Hastings LLP<BR>
200 Park Avenue<BR>
New York, NY 10166</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.75in; text-align: justify; font-size: 10pt">Attention:</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">Yariv Katz</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">Email:</TD>
    <TD STYLE="text-align: justify; font-size: 10pt"><U>yarivkatz@paulhastings.com</U></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each party to this Agreement
may change such address for notices by sending to the other parties to this Agreement written notice of a new address for such purpose.
Each such notice or other communication shall be deemed given (i)&nbsp;when delivered personally on or before 5:00 p.m., Eastern time,
on a Business Day or, if such day is not a Business Day (or if delivered after 5:00 p.m.&nbsp;Eastern Time on a Business Day), on the
next succeeding Business Day, (ii)&nbsp;on the next Business Day after timely delivery to a nationally-recognized overnight courier,
(iii)&nbsp;on the Business Day actually received if deposited in the mail (certified or registered mail, return receipt requested, postage
prepaid), and (iv)&nbsp;if sent by email, on the Business Day on which receipt is confirmed by the individual to whom the notice is sent,
other than via auto-reply.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>15.</B></TD><TD><B><U>Consent to Jurisdiction</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Corporation irrevocably
(i)&nbsp;agrees that any legal suit, action or proceeding against the Corporation brought by any Agent or by any person who controls
any Agent arising out of or based upon this Agreement or the transactions contemplated thereby may be instituted in any court in the
Province of Ontario, (ii)&nbsp;waives, to the fullest extent it may effectively do so, any objection which it may now or hereafter have
to the laying of venue of any such proceeding and (iii)&nbsp;submits to the exclusive jurisdiction of such courts in any such suit, action
or proceeding. To the extent that the Corporation has or hereafter may acquire any immunity from jurisdiction of any court or from any
legal process (whether through service of notice, attachment prior to judgment, attachment in aid of execution, execution or otherwise)
with respect to itself or its property, it hereby irrevocably waives such immunity in respect of its obligations under the above-referenced
documents, to the extent permitted by law. The provisions of this Section&nbsp;15 shall survive any termination of this Agreement, in
whole or in part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>16.</B></TD><TD><B><U>Successors and Assigns</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement shall inure
to the benefit of and be binding upon the Corporation and the Agents and their respective successors and the affiliates, controlling
persons, officers and directors referred to in Section&nbsp;11 hereof. References to any of the parties contained in this Agreement shall
be deemed to include the successors and permitted assigns of such party. Nothing in this Agreement, express or implied, is intended to
confer upon any party other than the parties hereto or their respective successors and permitted assigns any rights, remedies, obligations
or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. No party may assign its rights or
obligations under this Agreement without the prior written consent of the other parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 55; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>17.</B></TD><TD><B><U>Adjustments for Share Splits or Consolidations</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The parties acknowledge and agree that all share
related numbers contained in this Agreement shall be adjusted to take into account any share split, share dividend, share consolidation
or similar event effected with respect to the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>18.</B></TD><TD><B><U>Entire Agreement; Termination of Prior Agreement; Amendment;
                                            Severability</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement (including
all schedules and exhibits attached hereto and Placement Notices issued pursuant hereto) constitutes the entire agreement and supersedes
all other prior and contemporaneous agreements and undertakings, both written and oral, among the parties hereto with regard to the subject
matter hereof. The execution and delivery of this Agreement shall terminate the Equity Distribution Agreement, dated February&nbsp;28,
2025 (as amended on May&nbsp;30, 2025), by and among the Company and the Agents (the &ldquo;<B>Old EDA</B>&rdquo;) by mutual agreement
of the parties pursuant to Section&nbsp;13(d)&nbsp;of the Old EDA. For the avoidance of doubt, the parties acknowledge and agree that
the Equity Distribution Agreement, dated June&nbsp;6, 2024, by and among the Company and the Agents and the Old EDA relate to separate
offerings from the Offerings contemplated hereby, and such separate offerings have terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Neither this Agreement nor
any term hereof may be amended except pursuant to a written instrument executed by the Corporation and the Agents. In the event that
any one or more of the provisions contained herein, or the application thereof in any circumstance, is held invalid, illegal or unenforceable,
the validity, legality and enforceability of any such provision in every other respect and of the remaining provisions contained herein
shall not be affected or impaired thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>19.</B></TD><TD><B><U>Applicable Law</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement and any claim,
controversy or dispute relative to or arising out of this Agreement shall be governed by and interpreted in accordance with the laws
of the Province of Ontario and the federal laws of Canada applicable in the Province of Ontario. Each of the parties hereto irrevocably
attorns to the jurisdiction of the courts of the Province of Ontario.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>20.</B></TD><TD><B><U>Waiver of Jury Trial</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Corporation and the Agents
hereby irrevocably waive any right either may have to a trial by jury in respect of any claim based upon or arising out of this Agreement
or any transaction contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>21.</B></TD><TD><B><U>Absence of Fiduciary Duties</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The parties acknowledge that
they are sophisticated in business and financial matters and that each of them is solely responsible for making its own independent investigation
and analysis of the transactions contemplated by this Agreement. They further acknowledge that the Agents have not been engaged by the
Corporation to provide, and have not provided, financial advisory services in connection with the terms of the Offerings nor have the
Agents assumed at any time a fiduciary relationship to the Corporation in connection with such Offerings. The Corporation hereby waives,
to the fullest extent permitted by law, any claims it may have against the Agents for breach of fiduciary duty or alleged breach of fiduciary
duty and agrees the Agents shall have no liability (whether direct or indirect) to the Corporation in respect of such a fiduciary duty
claim or to any person asserting a fiduciary duty claim on behalf of or in right of the Corporation, including shareholders, employees
or creditors of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 56; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>22.</B></TD><TD><B><U>Judgment Currency</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">The
Corporation agrees to indemnify the U.S. Agent, its directors, officers, affiliates and each person, if any, who controls such Agent
within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act, against any loss incurred by the
U.S. Agent as a result of any judgment or order being given or made for any amount due hereunder and such judgment or order being expressed
and paid in a currency (the &ldquo;<B>judgment currency</B>&rdquo;) other than U.S. dollars and as a result of any variation as between
(i)&nbsp;the rate of exchange at which the U.S. dollar amount is converted into the judgment currency for the purpose of such judgment
or order, and (ii)&nbsp;the rate of exchange at which such indemnified person is able to purchase U.S. dollars with the amount of the
judgment currency actually received by the indemnified person. </FONT>If the United States dollars so purchased are greater than the
sum originally due to the indemnified person hereunder, the U.S. Agent agrees to promptly pay to the Corporation an amount equal to the
excess of the United States dollars purchased over the sum originally due to such indemnified person hereunder. The foregoing indemnity
shall constitute a separate and independent obligation of the Corporation and shall continue in full force and effect notwithstanding
any such judgment or order as aforesaid. The term &ldquo;rate of exchange&rdquo; shall include any premiums and costs of exchange payable
in connection with the purchase of, or conversion into, the relevant currency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>23.</B></TD><TD><B><U>Compliance with USA Patriot Act</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with the requirements
of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October&nbsp;26, 2001)), the Agents are required to obtain, verify
and record information that identifies their respective clients, including the Corporation, which information may include the name and
address of their respective clients, as well as other information that will allow the Agents to properly identify their respective clients.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>24.</B></TD><TD><B><U>Definitions</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As used in this Agreement,
the following terms have the respective meanings set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">&ldquo;<B>Agents</B>&rdquo; has the meaning
                                            given thereto on Page&nbsp;1 hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">&ldquo;<B>Agent Indemnified Parties</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;11(a)hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">&ldquo;<B>Agreement</B>&rdquo; has the
                                            meaning given thereto on Page&nbsp;1 hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">&ldquo;<B>Amendment Date</B>&rdquo; has
                                            the meaning given thereto in Section&nbsp;8(a)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">&ldquo;<B>Amended Registration Statement</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;6(b)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 57; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">&ldquo;<B>Applicable Time</B>&rdquo; means,
                                            with respect to any Placement Shares, the time of sale of such Placement Shares pursuant
                                            to this Agreement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">&ldquo;<B>Auditor Comfort Letters</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;8(p)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">&ldquo;<B>Authorizations</B>&rdquo; has
                                            the meaning given thereto in Section&nbsp;7(zz)hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">&ldquo;<B>Authorized Representative</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;2(a)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(j)</TD><TD STYLE="text-align: justify">&ldquo;<B>Base Prospectuses</B>&rdquo;
                                            means, collectively, the Canadian Base Prospectus and the U.S. Base Prospectus;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(k)</TD><TD STYLE="text-align: justify">&ldquo;<B>Beneficiaries</B>&rdquo; has
                                            the meaning given thereto in Section&nbsp;11(g)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(l)</TD><TD STYLE="text-align: justify">&ldquo;<B>Business Day</B>&rdquo; means
                                            any day on which Nasdaq and TSX are open for business;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(m)</TD><TD STYLE="text-align: justify">&ldquo;<B>Canadian Agent</B>&rdquo; has
                                            the meaning given thereto on Page&nbsp;1 hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(n)</TD><TD STYLE="text-align: justify">&ldquo;<B>Canadian Base Prospectus</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;6(a)hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(o)</TD><TD STYLE="text-align: justify">&ldquo;<B>Canadian Marketplace</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;3(a)hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(p)</TD><TD STYLE="text-align: justify">&ldquo;<B>Canadian Offering</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;1(a)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(q)</TD><TD STYLE="text-align: justify">&ldquo;<B>Canadian Preliminary Base Prospectus</B>&rdquo;
                                            means the preliminary short form base shelf prospectus of the Corporation dated May&nbsp;14,
                                            2024 and filed with the Canadian Qualifying Authorities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(r)</TD><TD STYLE="text-align: justify">&ldquo;<B>Canadian Prospectus</B>&rdquo;
                                            means the Canadian Prospectus Supplement (and any additional Canadian prospectus supplement
                                            prepared in accordance with the provisions of this Agreement and filed with the Canadian
                                            Qualifying Authorities in accordance with Canadian Securities Laws) together with the Canadian
                                            Base Prospectus;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(s)</TD><TD STYLE="text-align: justify">&ldquo;<B>Canadian Prospectus Supplement</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;6(a)hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(t)</TD><TD STYLE="text-align: justify">&ldquo;<B>Canadian Qualifying Authorities</B>&rdquo;
                                            means the securities regulatory authorities in the Canadian Qualifying Jurisdictions;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(u)</TD><TD STYLE="text-align: justify">&ldquo;<B>Canadian Qualifying Jurisdictions</B>&rdquo;
                                            means each of the provinces and territories of Canada;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify">&ldquo;<B>Canadian Securities Laws</B>&rdquo;
                                            means securities laws and the applicable rules&nbsp;and regulations under such laws, together
                                            with applicable published national, multilateral and local policy statements, instruments,
                                            notices and blanket orders of the Canadian Qualifying Authorities in each of the Canadian
                                            Qualifying Jurisdictions as modified by the French Translation Exemption;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 58; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(w)</TD><TD STYLE="text-align: justify">&ldquo;<B>Canadian Shelf Procedures</B>&rdquo;
                                            means NI 44-101 and NI 44-102;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(x)</TD><TD STYLE="text-align: justify">&ldquo;<B>Cannabis Act</B>&rdquo; means
                                            the <I>Cannabis Act</I> S.C. 2018, c. 16;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(y)</TD><TD STYLE="text-align: justify">&ldquo;<B>Canopy USA</B>&rdquo; means
                                            Canopy USA, LLC;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(z)</TD><TD STYLE="text-align: justify">&ldquo;<B>Canopy USA Structure</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;7(bb)hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(aa)</TD><TD STYLE="text-align: justify">&ldquo;<B>CFO Certificate</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;8(q)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(bb)</TD><TD STYLE="text-align: justify">&ldquo;<B>CFPOA</B>&rdquo; has the meaning
                                            given thereto in Section&nbsp;7(w)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(cc)</TD><TD STYLE="text-align: justify">&ldquo;<B>Code</B>&rdquo; has the meaning
                                            given thereto in Section&nbsp;7(ccc) hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(dd)</TD><TD STYLE="text-align: justify">&ldquo;<B>Consents</B>&rdquo; has the
                                            meaning given thereto in Section&nbsp;7(e)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ee)</TD><TD STYLE="text-align: justify">&ldquo;<B>Corporation</B>&rdquo; has
                                            the meaning given thereto on Page&nbsp;1 hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ff)</TD><TD STYLE="text-align: justify">&ldquo;<B>Corporation Financial Information</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;7(l)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(gg)</TD><TD STYLE="text-align: justify">&ldquo;<B>Corporation Indemnified Parties</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;11(b)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(hh)</TD><TD STYLE="text-align: justify">&ldquo;<B>Current Report</B>&rdquo; has
                                            the meaning given thereto in Section&nbsp;8(g)&nbsp;thereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">&ldquo;<B>Designated News Release</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;6(a)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(jj)</TD><TD STYLE="text-align: justify">&ldquo;<B>Disclosure Package</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;7(b)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(kk)</TD><TD STYLE="text-align: justify">&ldquo;<B>Earnings Announcement</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;8(g)hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ll)</TD><TD STYLE="text-align: justify">&ldquo;<B>EDGAR</B>&rdquo; means the
                                            SEC&rsquo;s Electronic Data Gathering Analysis and Retrieval System;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(mm)</TD><TD STYLE="text-align: justify">&ldquo;<B>Effective Date</B>&rdquo; shall
                                            mean each date and time that the Registration Statement and any post-effective amendment
                                            or amendments thereto became or becomes effective;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(nn)</TD><TD STYLE="text-align: justify">&ldquo;<B>Environmental Law</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;7(hhh) hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(oo)</TD><TD STYLE="text-align: justify">&ldquo;<B>Exchange Act</B>&rdquo; means
                                            the United States Securities Exchange Act of 1934, as amended and the rules&nbsp;and regulations
                                            thereunder;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(pp)</TD><TD STYLE="text-align: justify">&ldquo;<B>Exchangeable Shares</B>&rdquo;
                                            means the non-voting and non-participating exchangeable shares of the Corporation;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(qq)</TD><TD STYLE="text-align: justify">&ldquo;<B>Execution Time</B>&rdquo; means
                                            the date and time that this Agreement is executed and delivered by the parties hereto;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 59; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(rr)</TD><TD STYLE="text-align: justify">&ldquo;<B>FCPA</B>&rdquo; has the meaning
                                            given thereto in Section&nbsp;7(w)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ss)</TD><TD STYLE="text-align: justify">&ldquo;<B>Federal Cannabis Laws</B>&rdquo;
                                            means any U.S. federal laws, civil, criminal or otherwise, as such relate, either directly
                                            or indirectly, to the cultivation, harvesting, production, distribution, sale and possession
                                            of cannabis, marijuana or related substances or products containing or relating to the same,
                                            including, without limitation, the Controlled Substances Act, 21 U.S.C. Ch. 13 (including,
                                            but not limited to, the prohibition on drug trafficking under 21 U.S.C. &sect; 841(a), et
                                            seq.), the conspiracy statute under 18 U.S.C. &sect; 846, the bar against aiding and abetting
                                            the conduct of an offense under 18 U.S.C. &sect; 2, the bar against misprision of a felony
                                            (concealing another&rsquo;s felonious conduct) under 18 U.S.C. &sect; 4, the bar against
                                            being an accessory after the fact to criminal conduct under 18 U.S.C. &sect; 3, and federal
                                            money laundering statutes under 18 U.S.C. &sect;&sect; 1956, 1957, and 1960 and the regulations
                                            and rules&nbsp;promulgated under any of the foregoing;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(tt)</TD><TD STYLE="text-align: justify">&ldquo;<B>FINRA</B>&rdquo; means the
                                            Financial Industry Regulatory Authority,&nbsp;Inc.;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(uu)</TD><TD STYLE="text-align: justify">&ldquo;<B>French Translation Exemption</B>&rdquo;
                                            means the exemption relief decision dated May&nbsp;6, 2024 obtained by the Corporation from
                                            the Autorit&eacute; des march&eacute;s financiers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(vv)</TD><TD STYLE="text-align: justify">&ldquo;<B>Governmental Authorities</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;7(e)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ww)</TD><TD STYLE="text-align: justify">&ldquo;<B>Hazardous Substances</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;7(hhh) hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(xx)</TD><TD STYLE="text-align: justify">&ldquo;<B>Health Canada</B>&rdquo; has
                                            the meaning given thereto in Section&nbsp;7(e)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(yy)</TD><TD STYLE="text-align: justify">&ldquo;<B>Immaterial Subsidiary</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;7(d)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(zz)</TD><TD STYLE="text-align: justify">&ldquo;<B>Indemnified Party</B>&rdquo;
                                            and &ldquo;<B>Indemnifying Party</B>&rdquo; each has the meaning given thereto in Section&nbsp;11(c)&nbsp;
                                            hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(aaa)</TD><TD STYLE="text-align: justify">&ldquo;<B>Initial Registration Statement</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;6(b)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(bbb)</TD><TD STYLE="text-align: justify">&ldquo;<B>Initial Auditor Comfort Letters</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;8(p)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ccc)</TD><TD STYLE="text-align: justify">&ldquo;<B>Intellectual Property</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;7(eee)hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ddd)</TD><TD STYLE="text-align: justify">&ldquo;<B>Investment Entities</B>&rdquo;
                                            means Canopy USA, Canopy USA I Limited Partnership, Canopy USA II Limited Partnership and
                                            Canopy USA III Limited Partnership;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(eee)</TD><TD STYLE="text-align: justify">&ldquo;<B>Issuer Free Writing Prospectus</B>&rdquo;
                                            means an issuer free writing prospectus, as defined in Rule&nbsp;433;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(fff)</TD><TD STYLE="text-align: justify">&ldquo;<B>IT Systems</B>&rdquo; has
                                            the meaning given thereto in Section&nbsp;7(eee) hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 60; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ggg)</TD><TD STYLE="text-align: justify">&ldquo;<B>judgement currency</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;22hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(hhh)</TD><TD STYLE="text-align: justify">&ldquo;<B>Lien</B>&rdquo; has the meaning
                                            given thereto in Section&nbsp;7(d)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">&ldquo;<B>Material Adverse Effect</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;7(d)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(jjj)</TD><TD STYLE="text-align: justify">&ldquo;<B>material change</B>&rdquo;
                                            has the meaning given thereto under Canadian Securities Laws;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(kkk)</TD><TD STYLE="text-align: justify">&ldquo;<B>material fact</B>&rdquo; has
                                            the meaning given thereto under Canadian Securities Laws;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(lll)</TD><TD STYLE="text-align: justify">&ldquo;<B>Material Subsidiary</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;7(d)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(mmm)</TD><TD STYLE="text-align: justify">&ldquo;<B>Maximum Amount</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;1(a)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(nnn)</TD><TD STYLE="text-align: justify">&ldquo;<B>Money Laundering Laws</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;7(x)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ooo)</TD><TD STYLE="text-align: justify">&ldquo;<B>Nasdaq</B>&rdquo; means The
                                            Nasdaq Stock Market LLC;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ppp)</TD><TD STYLE="text-align: justify">&ldquo;<B>Net Proceeds</B>&rdquo; has
                                            the meaning given thereto in Section&nbsp;5(a)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(qqq)</TD><TD STYLE="text-align: justify">&ldquo;<B>NI 21-101</B>&rdquo; means
                                            National Instrument 21-101 &mdash; <I>Marketplace Operation</I>;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(rrr)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&ldquo;</FONT><B>NI
                                            33-105</B>&rdquo; means National Instrument 33-105 &mdash; <I>Underwriting Conflicts;</I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(sss)</TD><TD STYLE="text-align: justify">&ldquo;<B>NI 44-101</B>&rdquo; means
                                            National Instrument 44-101 &mdash; <I>Short Form&nbsp;Prospectus Distributions</I>;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ttt)</TD><TD STYLE="text-align: justify">&ldquo;<B>NI 44-102</B>&rdquo; means
                                            National Instrument 44-102 &mdash; <I>Shelf Distributions</I>;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(uuu)</TD><TD STYLE="text-align: justify">&ldquo;<B>NI 51-102</B>&rdquo; means
                                            National Instrument 51-102 &mdash; <I>Continuous Disclosure Obligations</I>;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(vvv)</TD><TD STYLE="text-align: justify">&ldquo;<B>Offerings</B>&rdquo; has the
                                            meaning given thereto in Section&nbsp;1(a)hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(www)</TD><TD STYLE="text-align: justify">&ldquo;<B>Personal Data</B>&rdquo; has
                                            the meaning given thereto in Section&nbsp;7(eee) hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(xxx)</TD><TD STYLE="text-align: justify">&ldquo;<B>PFIC</B>&rdquo; has the meaning
                                            given thereto in Section&nbsp;7(ccc);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(yyy)</TD><TD STYLE="text-align: justify">&ldquo;<B>Placement</B>&rdquo; has the
                                            meaning given thereto in Section&nbsp;2(a)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(zzz)</TD><TD STYLE="text-align: justify">&ldquo;<B>Placement Fee</B>&rdquo; has
                                            the meaning given thereto in Section&nbsp;2(b)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(aaaa)</TD><TD STYLE="text-align: justify">&ldquo;<B>Placement Notice</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;2(a)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(bbbb)</TD><TD STYLE="text-align: justify">&ldquo;<B>Placement Shares</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;2(a)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(cccc)</TD><TD STYLE="text-align: justify">&ldquo;<B>POS AM</B>&rdquo; has the
                                            meaning given thereto in Section&nbsp;6(b)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(dddd)</TD><TD STYLE="text-align: justify">&ldquo;<B>Privacy Requirements</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;7(eee) hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 61; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(eeee)</TD><TD STYLE="text-align: justify">&ldquo;<B>Prospectus Delivery Period</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;7(a)(ii)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ffff)</TD><TD STYLE="text-align: justify">&ldquo;<B>Prospectus Supplements</B>&rdquo;
                                            means, collectively, the Canadian Prospectus Supplement and the U.S. Prospectus Supplement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(gggg)</TD><TD STYLE="text-align: justify">&ldquo;<B>Prospectuses</B>&rdquo; means,
                                            collectively, the Canadian Prospectus and the U.S. Prospectus;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(hhhh)</TD><TD STYLE="text-align: justify">&ldquo;<B>Public Record</B>&rdquo;
                                            means all documents incorporated by reference in the Canadian Prospectus and all information
                                            filed by or on behalf of the Corporation with the Canadian Qualifying Authorities after December&nbsp;31,
                                            2024, in compliance, or intended compliance, with Canadian Securities Laws;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(iiii)</TD><TD STYLE="text-align: justify">&ldquo;<B>Receipt</B>&rdquo; has the
                                            meaning given thereto in Section&nbsp;6(a)hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(jjjj)</TD><TD STYLE="text-align: justify">&ldquo;<B>Registration Statement</B>&rdquo;
                                            means the POS AM, including exhibits and financial statements and any prospectus supplement
                                            relating to the Shelf Securities that is included therein or filed with the SEC pursuant
                                            to Rule&nbsp;424(b)&nbsp;and deemed part of such registration statement pursuant to Rule&nbsp;430B,
                                            as amended on each Effective Date and, in the event any post-effective amendment to the POS
                                            AM becomes effective, shall also mean such registration statement as so amended;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(kkkk)</TD><TD STYLE="text-align: justify">&ldquo;<B>Relevant Security</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;7(gg) hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(llll)</TD><TD STYLE="text-align: justify">&ldquo;<B>Representation Date</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;8(n)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(mmmm)</TD><TD STYLE="text-align: justify">&ldquo;<B>Reviewing Authority</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;6(a)hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(nnnn)</TD><TD STYLE="text-align: justify">&ldquo;<B>Rule&nbsp;134</B>&rdquo;,
                                            &ldquo;<B>Rule&nbsp;158</B>,&rdquo;, &ldquo;<B>Rule&nbsp;164</B>,&rdquo; &ldquo;<B>Rule&nbsp;172</B>,&rdquo;
                                            &ldquo;<B>Rule&nbsp;173</B>,&rdquo; &ldquo;<B>Rule&nbsp;401</B>&rdquo;, &ldquo;<B>Rule&nbsp;405</B>,&rdquo;
                                            &ldquo;<B>Rule&nbsp;415</B>,&rdquo; &ldquo;<B>Rule&nbsp;424</B>,&rdquo; &ldquo;<B>Rule&nbsp;430B</B>&rdquo;
                                            and &ldquo;<B>Rule&nbsp;433</B>&rdquo; refer to such rules&nbsp;under the Securities Act;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(oooo)</TD><TD STYLE="text-align: justify">&ldquo;<B>Rule&nbsp;3-09 Financial
                                            Statements</B>&rdquo; means the financial statements for equity investee(s)&nbsp;of the Corporation,
                                            if any, that are required by Rule&nbsp;3-09 of Regulation S-X;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(pppp)</TD><TD STYLE="text-align: justify">&ldquo;<B>Rules&nbsp;and Regulations</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;6(b)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(qqqq)</TD><TD STYLE="text-align: justify">&ldquo;<B>Sanctioned Territory</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;7(y)(i)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(rrrr)</TD><TD STYLE="text-align: justify">&ldquo;<B>Sanctions</B>&rdquo; has
                                            the meaning given thereto in Section&nbsp;7(y)(i)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ssss)</TD><TD STYLE="text-align: justify">&ldquo;<B>Sarbanes-Oxley</B>&rdquo;
                                            means the Sarbanes-Oxley Act of 2002, as amended;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(tttt)</TD><TD STYLE="text-align: justify">&ldquo;<B>SEC</B>&rdquo; means the
                                            United States Securities and Exchange Commission;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 62; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(uuuu)</TD><TD STYLE="text-align: justify">&ldquo;<B>Securities Act</B>&rdquo;
                                            means the United Stated Securities Act of 1933, as amended, and the rules&nbsp;and regulations
                                            of the SEC promulgated thereunder;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(vvvv)</TD><TD STYLE="text-align: justify">&ldquo;<B>SEDAR</B>+&rdquo; means the
                                            System for Electronic Data Analysis and Retrieval +;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(wwww)</TD><TD STYLE="text-align: justify">&ldquo;<B>Settlement Date</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;5(a)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(xxxx)</TD><TD STYLE="text-align: justify">&ldquo;<B>Shares</B>&rdquo; has the
                                            meaning given thereto in Section&nbsp;1 hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(yyyy)</TD><TD STYLE="text-align: justify">&ldquo;<B>Shelf Securities</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;6(a)hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(zzzz)</TD><TD STYLE="text-align: justify">&ldquo;<B>Specified Person</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;7(y)(i)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(aaaaa)</TD><TD STYLE="text-align: justify">&ldquo;<B>Staff Notice</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;7(bb) hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(bbbbb)</TD><TD STYLE="text-align: justify">&ldquo;<B>Stock Plan</B>&rdquo; has
                                            the meaning given thereto in Section&nbsp;7(nnn)hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ccccc)</TD><TD STYLE="text-align: justify">&ldquo;<B>Subsidiaries</B>&rdquo;
                                            means the Material Subsidiaries and the Immaterial Subsidiaries but excludes, for greater
                                            certainty, the Investment Entities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ddddd)</TD><TD STYLE="text-align: justify">&ldquo;<B>Trading Day</B>&rdquo; means
                                            any day on which either Nasdaq or the TSX are open for trading;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(eeeee)</TD><TD STYLE="text-align: justify">&ldquo;<B>TSX</B>&rdquo; means the
                                            Toronto Stock Exchange;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(fffff)</TD><TD STYLE="text-align: justify">&ldquo;<B>United States Marketplace</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;3(a)hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ggggg)</TD><TD STYLE="text-align: justify">&ldquo;<B>U.S. Agent</B>&rdquo; has
                                            the meaning given thereto on Page&nbsp;1 hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(hhhhh)</TD><TD STYLE="text-align: justify">&ldquo;<B>U.S. Base Prospectus</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;6(b)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(iiiii)</TD><TD STYLE="text-align: justify">&ldquo;<B>U.S. GAAP</B>&rdquo; has
                                            the meaning given thereto in Section&nbsp;7(l)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(jjjjj)</TD><TD STYLE="text-align: justify">&ldquo;<B>U.S. Offering</B>&rdquo;
                                            has the meaning given thereto in Section&nbsp;1(a)&nbsp;hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(kkkkk)</TD><TD STYLE="text-align: justify">&ldquo;<B>U.S. Prospectus</B>&rdquo;
                                            means the U.S. Base Prospectus, as supplemented by the U.S. Prospectus Supplement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(lllll)</TD><TD STYLE="text-align: justify">&ldquo;<B>U.S. Prospectus Supplement</B>&rdquo;
                                            means the most recent U.S. prospectus supplement to the U.S. Base Prospectus relating to
                                            the Placement Shares that was filed pursuant to Rule&nbsp;424(b);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(mmmmm)</TD><TD STYLE="text-align: justify">&ldquo;<B>U.S. Securities Laws</B>&rdquo;
                                            means collectively, Sarbanes-Oxley, the Securities Act, the Exchange Act, the Rules&nbsp;and
                                            Regulations, the auditing principles, rules, standards and practices applicable to auditors
                                            of &ldquo;issuers&rdquo; (as defined in Sarbanes-Oxley) promulgated or approved by the Public
                                            Company Accounting Oversight Board and, as applicable, the rules&nbsp;of Nasdaq; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 63; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(nnnnn)</TD><TD STYLE="text-align: justify">&ldquo;<B>WKSI</B>&rdquo; means a
                                            &ldquo;well-known seasoned issuer&rdquo; (as such term is defined in Rule&nbsp;405 under
                                            the Securities Act).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>25.</B></TD><TD><B><U>Counterparts</U></B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">This
Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute
one and the same instrument. </FONT>Counterparts may be delivered via facsimile, email (including pdf or any electronic signature complying
with applicable law, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been
duly and validly delivered and be valid and effective for all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Remainder of Page&nbsp;Intentionally Left
Blank]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 64; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the foregoing accurately
reflects your understanding and agreement with respect to the matters described herein please indicate your agreement by countersigning
this Agreement in the space provided below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yours very truly,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CANOPY GROWTH CORPORATION</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify">&nbsp;</TD>
<TD STYLE="text-align: justify">&nbsp;</TD>
<TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
<TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Tom Stewart</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 49%">&nbsp;</TD>
<TD STYLE="width: 2%">&nbsp;</TD>
<TD STYLE="width: 3%">&nbsp;</TD>
<TD STYLE="width: 5%">Name:</TD>
<TD STYLE="width: 41%">Tom Stewart</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>Title:</TD>
<TD>Interim Chief Financial Officer</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">ACCEPTED as of the date first-above written:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BMO CAPITAL MARKETS CORP.</B></FONT></TD>
<TD>&nbsp;</TD>
<TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BMO NESBITT BURNS INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD COLSPAN="3">&nbsp;</TD>
<TD>&nbsp;</TD>
<TD COLSPAN="3">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
<TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Eric Benedict</FONT></TD>
<TD STYLE="text-align: justify">&nbsp;</TD>
<TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
<TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Andrew Warkentin</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 3%">&nbsp;</TD>
<TD STYLE="width: 5%">Name:</TD>
<TD STYLE="width: 41%">Eric Benedict</TD>
<TD STYLE="width: 2%">&nbsp;</TD>
<TD STYLE="width: 3%">&nbsp;</TD>
<TD STYLE="width: 5%">Name:</TD>
<TD STYLE="width: 41%">Andrew Warkentin</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>Title:</TD>
<TD>Co-Head of Global Equity Capital Markets</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>Title:</TD>
<TD>Managing Director, Diversified Industries</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 65 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Schedule
1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Authorized Representatives of the Corporation
are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 5pt; width: 23%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Name and Office/Title</U></FONT></TD>
    <TD STYLE="padding-bottom: 5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 5pt; width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>E-mail Address</U></FONT></TD>
    <TD STYLE="padding-bottom: 5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 5pt; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Telephone Number</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Luc Mongeau/Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tom Stewart/Interim Chief Financial Officer</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christelle Gedeon/Chief Legal Officer</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Authorized Representatives of BMO Capital
Markets Corp. are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 5pt; width: 23%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Name and Office/Title</U></FONT></TD>
    <TD STYLE="padding-bottom: 5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 5pt; width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>E-mail Address</U></FONT></TD>
    <TD STYLE="padding-bottom: 5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 5pt; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Telephone Number</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eric Benedict/Co-Head of Global Equity and Capital
    Markets</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Authorized Representatives of BMO Nesbitt
Burns Inc. are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 5pt; width: 23%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Name and Office/Title</U></FONT></TD>
    <TD STYLE="padding-bottom: 5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 5pt; width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>E-mail Address</U></FONT></TD>
    <TD STYLE="padding-bottom: 5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 5pt; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Telephone Number</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew Warkentin/Managing Director, Diversified Industries</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[***]</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 66 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Exhibit&nbsp;A<BR>
OFFICER&rsquo;S CERTIFICATE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To:</FONT></TD>
    <TD STYLE="width: 90%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BMO Capital
    Markets Corp. and BMO Nesbitt Burns Inc. (together, the &ldquo;<B>Agents</B>&rdquo;)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Re:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity Distribution Agreement
    dated August&nbsp;29, 2025 (the &ldquo;<B>Distribution Agreement</B>&rdquo;) between Canopy Growth Corporation (the &ldquo;<B>Corporation</B>&rdquo;)
    and the Agents</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&#9632;], 202[&#9632;]</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">I, <B>[name of executive
officer]</B>, the <B>[title of executive officer]</B> of the Corporation, do hereby certify in such capacity and not in my personal capacity,
on behalf of the Corporation pursuant to Section&nbsp;8(n)&nbsp;of the Distribution Agreement, and without personal liability, that,
to the best of my knowledge:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">Except as set forth in the Registration
                                            Statement, the Prospectuses and the Disclosure Package, the representations and warranties
                                            of the Corporation in Section&nbsp;7 of the Distribution Agreement are true and correct on
                                            and as of the date hereof with the same force and effect as if expressly made on and as of
                                            the date hereof, except for those representations and warranties that speak solely as of
                                            a specific date and which were true and correct as of such date[<B><U>Include for Officer&rsquo;s
                                            Certificates delivered after the Corporation has filed its Annual Report on Form&nbsp;10-K
                                            for the fiscal year ended March&nbsp;31, 2026:</U></B>; provided that all references to &ldquo;Material
                                            Subsidiary&rdquo; or &ldquo;Material Subsidiaries&rdquo; shall be updated to refer to the
                                            material subsidiaries of the Corporation as of the date of the Corporation&rsquo;s most recent
                                            annual audited balance sheet, which material subsidiaries are set out in Annex 1 to this
                                            Officer&rsquo;s Certificate]; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">The Corporation has complied with all
                                            agreements and satisfied all conditions on its part to be performed or satisfied pursuant
                                            to the Distribution Agreement at or prior to the date hereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless otherwise defined, all capitalized terms
used herein shall have the meanings ascribed thereto in the Distribution Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date</FONT></TD>
<TD STYLE="border-bottom: Black 1pt solid; width: 44%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
<TD STYLE="width: 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
<TD STYLE="border-bottom: Black 1pt solid; width: 46%; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>Name</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>Title:</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 67 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Annex 1 to Officer&rsquo;s Certificate</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Updated List of Material Subsidiaries</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="padding-bottom: 2pt; vertical-align: top; width: 50%; border: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Entity
    Name</B></FONT></TD>
    <TD STYLE="padding-bottom: 2pt; vertical-align: top; width: 25%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Canopy
    Ownership %</B></FONT></TD>
    <TD STYLE="padding-bottom: 2pt; vertical-align: top; width: 25%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jurisdiction
    of <BR>
    Incorporation or <BR>
    Organization</B></FONT></TD></TR>
  <TR>
    <TD STYLE="padding-bottom: 2pt; white-space: nowrap; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; white-space: nowrap; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding-bottom: 2pt; white-space: nowrap; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; white-space: nowrap; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding-bottom: 2pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; white-space: nowrap; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding-bottom: 2pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; white-space: nowrap; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding-bottom: 2pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; white-space: nowrap; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding-bottom: 2pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; white-space: nowrap; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding-bottom: 2pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; white-space: nowrap; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding-bottom: 2pt; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; white-space: nowrap; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt; white-space: nowrap; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 68 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Exhibit&nbsp;B<BR>
MATTERS TO BE COVERED BY<BR>
INITIAL OPINION OF CORPORATION&rsquo;S CANADIAN COUNSEL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 69 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Exhibit&nbsp;C</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>CFO
CERTIFICATE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Canopy Growth Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Chief Financial Officer&rsquo;s Certificate</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 70 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Exhibit&nbsp;D</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MATERIAL SUBSIDIARIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 71 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Exhibit&nbsp;E</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>IMMATERIAL SUBSIDIARIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 72; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>tm2524672d1_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 5.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"><IMG SRC="tm2524672d1_ex5-1img001.jpg" ALT=""></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">August&nbsp;29, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Canopy Growth Corporation</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1 Hershey Drive</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Smiths Falls, Ontario</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">K7A 0A8 Canada</P></TD>
    <TD STYLE="width: 50%; font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Sirs/Mesdames:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-bottom: Black 0.5pt solid"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>Re:</B></TD><TD STYLE="text-align: justify"><B>Canopy Growth Corporation (the &ldquo;Company&rdquo;) &ndash; Public Offering of Common Shares of the
Company (the &ldquo;Common Shares&rdquo;)</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have acted as counsel to the Company, a corporation
incorporated under the federal laws of Canada (the &ldquo;<B>Company</B>&rdquo;), in connection with the issue and sale, from time to
time, by the Company of such number of Common Shares (the &ldquo;<B>Placement Shares</B>&rdquo;) having an aggregate offering price of
up to US$200,000,000 (or the equivalent in Canadian dollars determined using the daily exchange rate posted by the Bank of Canada on the
date the Placement Shares are sold) in each of the provinces and territories of Canada (the &ldquo;<B>Canadian Offering</B>&rdquo;) and
in the United States, <I>provided however</I>, that in no event will the Company sell Placement Shares in the in the Canadian Offering
for aggregate gross sales proceeds exceeding US$50,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has prepared and filed with the Securities
and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;) a registration statement (File No.&nbsp;333-279949) on Form&nbsp;S-3 on June&nbsp;5,
2024, and amended on May&nbsp;29, 2025 and May&nbsp;30, 2025 (as amended, the &ldquo;<B>Registration Statement</B>&rdquo;) under the&nbsp;<I>United
States Securities Act of 1933</I>, as amended (the &ldquo;<B>Act</B>&rdquo;), and that the Registration Statement includes the United
States Base Prospectus dated June&nbsp;5, 2024 (which document is referred to as the &ldquo;<B>U.S. Base Prospectus</B>&rdquo;). The U.S.
Base Prospectus as supplemented by a prospectus supplement thereto dated the date hereof, filed with the SEC is referred to as the &ldquo;<B>U.S.
Final Prospectus</B>&rdquo;. We understand that, in addition to a concurrent distribution in Canada, the Placement Shares will be distributed
in the United States pursuant to the U.S. Final Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This opinion letter is being furnished in accordance
with the requirements of Item 601 of Regulation S-K under the Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>1.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>EXAMINATIONS AND INVESTIGATIONS</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Documents. </I>We have examined and relied
upon originals or copies, certified or otherwise identified to our satisfaction, of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">a certificate of compliance (the &ldquo;<B>Certificate of Compliance</B>&rdquo;) dated August&nbsp;28,
2025 issued for the Company under the <I>Canada Business Corporations Act</I> (the &ldquo;<B>CBCA</B>&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">the articles of the Company, as amended;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">the by-laws of the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">certain resolutions of the Company&rsquo;s board of directors relating to the Registration Statement,
U.S. Final Prospectus and the Placement Shares;</TD></TR></TABLE>

<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2524672d1_ex5-1img002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">a certificate, dated the date of this opinion, of an officer of the Company (the &ldquo;<B>Officer&rsquo;s
Certificate</B>&rdquo;), including copies of each of the items in paragraphs (b), (c), and (d)&nbsp;above;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">the equity distribution agreement dated August&nbsp;29, 2025 among the Company and BMO Capital Markets
Corp. and BMO Nesbitt Burns Inc. (the &ldquo;<B>Distribution Agreement</B>&rdquo;); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">the Registration Statement and the U.S. Final Prospectus.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Minute Books</I>. Except for the corporate
records forming part of the Officer&rsquo;s Certificate and such other corporate records as we deemed necessary, we have not reviewed
the minute books of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>ASSUMPTIONS</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><I>Authenticity</I>. We have assumed: (i)&nbsp;the legal capacity of all individuals signing documents;
(ii)&nbsp;the genuineness of all signatures; (iii)&nbsp;the authenticity and completeness of all documents submitted to us as originals;
(iv)&nbsp;the conformity to authentic original documents of all documents submitted to us as copies; and (v)&nbsp;the continuing accuracy
of the Certificate of Compliance as of the date of this opinion as if issued on that date.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><I>Enforceability,&nbsp;etc</I>. We have assumed that: (i)&nbsp;each party to the Distribution Agreement,
other than the Company: (A)&nbsp;is existing under the laws of its jurisdiction of formation, as applicable; (B)&nbsp;has the requisite
power and capacity to carry on business, own properties and assets, and execute, deliver, and perform its obligations under the Distribution
Agreement and to carry out the transactions contemplated under the Distribution Agreement; (C)&nbsp;has taken all necessary action to
authorize the execution and delivery of, and the performance of its obligations under, the Distribution Agreement; and (D)&nbsp;has duly
executed and delivered the Distribution Agreement; (ii)&nbsp;the exercise, by each party other than the Company, of its rights and the
performance of its obligations under the Distribution Agreement is not contrary to its constating documents or governing legislation;
(iii)&nbsp;the Distribution Agreement constitutes a legal, valid, and binding obligation of each party to it other than the Company, enforceable
against that party in accordance with its terms; (iv)&nbsp;the representations and warranties of each party to the Distribution Agreement
other than the Company are true and correct and accurate in all respects; and (v)&nbsp;to the extent that the Distribution Agreement is
to be performed in any jurisdiction other than the Provinces (as defined below), such performance will not be illegal under the laws of
that jurisdiction.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify"><I>Public records</I>. We have assumed the completeness, accuracy, and currency of: (i)&nbsp;the indices
and filing systems maintained at the public offices where we searched or made inquiries; (ii)&nbsp;all documents supplied or otherwise
conveyed to us by public officials; and all facts set out in those documents and in official public records.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify"><I>Trading restrictions</I>. We have assumed that, at the time of any distribution of or trade in securities
of the Company referred to in this opinion, no order, ruling, or decision granted by a securities commission, court of competent jurisdiction,
or regulatory or administrative body having jurisdiction is in effect that would: (i)&nbsp;restrict any distribution of or trade in those
securities; or (ii)&nbsp;affect any person or company who engaged in any such distribution or trade (including, without limitation, any
cease trade orders).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>3.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>RELIANCE</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><I>Matters of fact in the Officer&rsquo;s Certificate</I>. We have relied solely upon the Officer&rsquo;s
Certificate as to the matters of fact set out in such certificate, without independently verifying those facts.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><I>Company Status</I>. In expressing the opinion in section 5(a), we have relied and our opinion is based
solely upon the Certificate of Compliance and the Officer&rsquo;s Certificate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: right; width: 100%">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>4.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>LAWS ADDRESSED</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The opinions we express are limited to the laws
of the Provinces of Ontario, British Columbia and Alberta (together, the &ldquo;<B>Provinces</B>&rdquo;) and the federal laws of Canada
applicable in the Provinces. For the purposes of this opinion, the term &ldquo;<B>Securities Laws</B>&rdquo; means the <I>Securities Act</I>
(Ontario), together with the regulations and rules&nbsp;made under that act, the <I>Securities Act</I> (British Columbia), together with
the regulations, rules&nbsp;and forms made under that act and the blanket rulings and orders issued by the British Columbia Securities
Commission and the <I>Securities Act</I> (Alberta), together with the regulations and rules&nbsp;under that act and the blanket rulings
and orders issued by the Alberta Securities Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are solicitors qualified to carry on the practice
of law in the Provinces only, and we express no opinion as to any laws, or matters governed by any laws, other than the laws of the Provinces
and the federal laws of Canada applicable therein. The opinions herein are limited to the laws of the Provinces and the federal laws of
Canada applicable therein in effect as of the date hereof and we assume no obligation to update these opinions to take into account any
changes in such laws after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>5.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>OPINIONS</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based upon and subject to the foregoing and subject
to the qualifications expressed below, we are of the opinion that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">The Company is a corporation existing under the CBCA.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">The Placement Shares have been duly authorized by the Company, and all necessary corporate action has
been taken for the issuance and delivery of the Placement Shares against payment therefor as contemplated in the Distribution Agreement.
When delivered against payment of the purchase price therefor in accordance with the Distribution Agreement, such Placement Shares will
be validly issued, fully paid and non-assessable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>6.</B></TD><TD STYLE="text-align: justify"><FONT STYLE="text-transform: uppercase"><B>USE OF OPINION</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We hereby consent to the filing of this opinion
letter as Exhibit&nbsp;5.1 to the Company&rsquo;s Current Report on Form&nbsp;8-K to be filed with the Commission on or about the date
hereof, which will be incorporated by reference in the Registration Statement, and to the reference to our firm under the heading &ldquo;Legal
Matters&rdquo; in the U.S. Final Prospectus, which is a part of the Registration Statement. In giving such consent, we do not hereby admit
that we are within the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules&nbsp;or regulations
of the Commission thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yours truly,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>/s/ CASSELS BROCK&nbsp;&amp; BLACKWELL LLP</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>CASSELS BROCK&nbsp;&amp; BLACKWELL LLP</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>tm2524672d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT><B>Exhibit&nbsp;99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Canopy Growth Establishes New US$200 Million
At-The-Market Program to Strengthen the Company&rsquo;s Financial Position</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>SMITHS FALLS, ON. August&nbsp;29, 2025</B>
-- Canopy Growth Corporation (&ldquo;<B>Canopy Growth</B>&rdquo; or the &ldquo;<B>Company</B>&rdquo;) (TSX: WEED) (Nasdaq: CGC), a world-leading
cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today that the Company has established a new
at-the-market equity program (the &ldquo;<B>ATM Program</B>&rdquo;) that allows Canopy Growth to issue and sell up to US$200 million of
common shares of the Company (&ldquo;<B>Common Shares</B>&rdquo;) from treasury from time to time in concurrent public offerings in the
United States (the &ldquo;<B>U.S. Offering</B>&rdquo;) and Canada; <I>provided, however, </I>that (i)&nbsp;sales of Common Shares in the
ATM Program in Canada is limited to aggregate gross sales proceeds to the Company of up to US$50 million (or its Canadian dollar equivalent)
(the &ldquo;<B>Canadian Offering</B>&rdquo;); and (ii)&nbsp;in no event will the combined gross sales proceeds of the ATM Program in the
United States and Canada exceed US$200 million. Any Common Shares sold in the ATM Program will be sold in transactions made directly on
the Nasdaq or the TSX or on any other available U.S. or Canadian trading market for the Common Shares. The volume and timing of sales
under the ATM Program, if any, will be determined in the Company&rsquo;s sole discretion and are subject to customary conditions precedent.
The Common Shares will be distributed at market prices prevailing at the time of each sale or at certain other prices and, as a result,
prices may vary as between purchasers and during the period of distribution under the ATM Program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Canopy Growth intends to use the net proceeds
from the ATM Program, if any, for investments in businesses and/or to fund any potential future acquisitions and for working capital and
general corporate purposes, including the potential repayment of indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sales of Common Shares under the ATM Program will
be made pursuant to the terms of an equity distribution agreement dated August&nbsp;29, 2025 (the &ldquo;<B>Distribution Agreement</B>&rdquo;)
entered into among the Company, BMO Nesbitt Burns Inc., as Canadian agent, and BMO Capital Markets Corp., as U.S. agent (collectively,
the &ldquo;<B>Agents</B>&rdquo;). The ATM Program will be effective until the earliest of (A)&nbsp;June&nbsp;5, 2027; (B)&nbsp;the issuance
and sale of Common Shares having an aggregate offering price of US$200,000,000 on the terms and subject to the conditions set forth in
the Distribution Agreement; (C)&nbsp;the date on which the Registration Statement (as defined below) ceases to be useable for sales of
Shelf Securities (as defined in the Distribution Agreement) pursuant to General Instruction I.B.1 of Form&nbsp;S-3; (D)&nbsp;the date
on which the Company receives notice from the U.S. Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;) that the Registration
Statement has ceased to be effective in accordance with applicable U.S. securities laws; and (E)&nbsp;the date on which the Distribution
Agreement is terminated by the parties, in each case, subject to the terms of the Distribution Agreement. Notwithstanding the foregoing,
the Canadian Offering will automatically terminate on the earliest to occur of (1)&nbsp;July&nbsp;5, 2026, (2)&nbsp;the date on which
the issuance and sale of Common Shares in the Canadian Offering equals US$50,000,000 (or the equivalent in Canadian currency), (3)&nbsp;the
date on which the Company receives notice from the Ontario Securities Commission that the Canadian Shelf Prospectus (as defined below)
has ceased to be effective in accordance with applicable Canadian securities laws, or (4)&nbsp;the date on which the Distribution Agreement
is terminated pursuant to clauses (A)&nbsp;through (E)&nbsp;above; <I>provided, however</I>, that a termination of the Canadian Offering
as contemplated by clauses (1), (2)&nbsp;and (3)&nbsp;above will in no case affect the U.S. Offering, and the Distribution Agreement will
continue to remain in full force and effect with respect to the U.S. Offering. The Distribution Agreement replaces the equity distribution
agreement, dated February&nbsp;28, 2025, as amended, among the Company and the Agents, which terminated upon the Company&rsquo;s entry
into the Distribution Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The offering of Common Shares under the ATM Program
is qualified by a prospectus supplement dated August&nbsp;29, 2025 (the &ldquo;<B>Canadian Prospectus Supplement</B>&rdquo;) to the Company&rsquo;s
Canadian short form base shelf prospectus dated June&nbsp;5, 2024 (the &ldquo;<B>Canadian Shelf Prospectus</B>&rdquo;), each filed with
the securities commissions in each of the provinces and territories of Canada, and pursuant to a prospectus supplement dated August&nbsp;29,
2025 (the &ldquo;<B>U.S. Prospectus Supplement</B>&rdquo;) to the Company&rsquo;s U.S. base prospectus (the &ldquo;<B>U.S. Base Prospectus</B>&rdquo;)
included in its registration statement on Form&nbsp;S-3 initially filed with the SEC on June&nbsp;5, 2024, and amended on May&nbsp;29,
2025 and May&nbsp;30, 2025 (as amended, the &ldquo;<B>Registration Statement</B>&rdquo;). The Distribution Agreement, Canadian Prospectus
Supplement and Canadian Shelf Prospectus are available on the SEDAR+ website at&nbsp;<U>www.sedarplus.com</U>, and the U.S. Prospectus
Supplement, the U.S. Base Prospectus and the Registration Statement are available on EDGAR on the SEC&rsquo;s website at&nbsp;<U>www.sec.gov</U>.&nbsp;Alternatively,
these documents may be requested from the Agents by contacting, (i)&nbsp;in Canada: BMO Nesbitt Burns Inc. by mail at Brampton Distribution
Centre, 9195 Torbram Road, Brampton, Ontario, L6S 6H2, attn: The Data Group of Companies, by email at <U>torbramwarehouse@datagroup.ca</U>
or by telephone at 905-791-3151 ext. 4312; and (ii)&nbsp;in the United States: BMO Capital Markets Corp. by mail at 151 W 42nd Street,
32nd Floor, New York, NY 10036, attn: Equity Syndicate Department, by email at <U>bmoprospectus@bmo.com</U>, or by telephone at 800-414-3627.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No securities regulatory authority has either
approved or disapproved of the contents of this news release. This news release is for informational purposes only and does not constitute
an offer to sell or the solicitation of an offer to buy the Common Shares, nor shall there be any sale of the Common Shares in any jurisdiction
in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any
such jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>More Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Alex Thomas</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Director, Communications</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>media@canopygrowth.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Investor Contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Tyler Burns</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Director,&nbsp;Investor Relations</P>

<P STYLE="text-decoration: underline; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">tyler.burns@canopygrowth.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Canopy Growth</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Canopy Growth is a world leading cannabis company
dedicated to unleashing the power of cannabis to improve lives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Through an unwavering commitment to consumers,
Canopy Growth delivers innovative products from owned and licensed brands including Tweed, 7ACRES, DOJA, Deep Space and Claybourne,&nbsp;as
well as category defining vaporization devices by Storz&nbsp;&amp; Bickel. In addition, Canopy Growth serves medical cannabis patients
globally with principal operations in Canada, Europe and Australia.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Canopy Growth has also established a comprehensive
ecosystem to realize the opportunities presented by the U.S. THC market through an unconsolidated, non-controlling interest in Canopy
USA, LLC (&ldquo;<B>Canopy USA</B>&rdquo;). Canopy USA&rsquo;s portfolio includes ownership of Acreage Holdings,&nbsp;Inc., a vertically
integrated multi-state cannabis operator with operations throughout the U.S. Northeast and Midwest, as well as ownership of Wana Wellness,
LLC, The Cima Group, LLC, and Mountain High Products, LLC, a leading North American edibles brand, and majority ownership of Lemurian
Inc., a California-based producer of high-quality cannabis extracts and clean vape technology.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At Canopy Growth, we&rsquo;re shaping a future
where cannabis is embraced for its potential to enhance well-being and improve lives. With high-quality products, a commitment to responsible
use, and a focus on enhancing the communities where we live and work, we&rsquo;re paving the way for a better understanding of all that
cannabis can offer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For more information visit www.canopygrowth.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This news release contains &ldquo;forward-looking
statements&rdquo; within the meaning of the United States Private Securities Litigation Reform Act of 1995 and &ldquo;forward-looking
information&rdquo; within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking statements
and information can be identified by the use of words such as &ldquo;plans&rdquo;, &ldquo;expects&rdquo; or &ldquo;does not expect&rdquo;,
 &ldquo;is expected&rdquo;, &ldquo;estimates&rdquo;, &ldquo;intends&rdquo;, &ldquo;anticipates&rdquo; or &ldquo;does not anticipate&rdquo;,
or &ldquo;believes&rdquo;, or variations of such words and phrases or state that certain actions, events or results &ldquo;may&rdquo;,
 &ldquo;could&rdquo;, &ldquo;would&rdquo;, &ldquo;might&rdquo; or &ldquo;will&rdquo; be taken, occur or be achieved. Forward-looking statements
or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements
of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied
by the forward-looking statements or information contained in this news release. Examples of such statements and uncertainties include
statements with respect to the offer and sale of Common Shares under the ATM Program, including the timing and amounts thereof, and the
use of any proceeds from the ATM Program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Risks, uncertainties and other factors involved
with forward-looking information or statements could cause actual events, results, performance, prospects and opportunities to differ
materially from those expressed or implied by such forward-looking information, including negative operating cash flow; uncertainty of
additional financing; use of proceeds; volatility in the price of the Common Shares; risks relating to the overall macroeconomic environment,
which may impact customer spending, costs and margins, including tariffs (and related retaliatory measures), the levels of inflation,
and interest rates; expectations regarding future investment, growth and expansion of operations; regulatory and licensing risks; changes
in general economic, business and political conditions, including changes in the financial and stock markets; legal and regulatory risks
inherent in the cannabis industry, including the global regulatory landscape and enforcement related to cannabis; additional dilution;
political risks and risks relating to regulatory change; risks relating to anti-money laundering laws; compliance with extensive government
regulation and the interpretation of various laws regulations and policies; public opinion and perception of the cannabis industry; and
such other risks contained in the public filings of the Company filed with Canadian securities regulators and available under the Company&rsquo;s
profile on SEDAR+ at <U>www.sedarplus.com</U> and with the SEC through EDGAR at <U>www.sec.gov/edgar</U><FONT STYLE="color: blue">,</FONT>
including under the heading &ldquo;Risk Factors&rdquo; in the Company&rsquo;s annual report on Form&nbsp;10-K for the year ended March&nbsp;31,
2025, its subsequently filed quarterly reports on Form&nbsp;10-Q and the Canadian Prospectus Supplement, Canadian Shelf Prospectus, U.S.
Prospectus Supplement and U.S. Base Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In respect of the forward-looking statements and
information, the Company has provided such statements and information in reliance on certain assumptions that they believe are reasonable
at this time. Although the Company believes that the assumptions and factors used in preparing the forward-looking information or forward-looking
statements in this news release are reasonable, undue reliance should not be placed on such information or statements and no assurance
can be given that such events will occur in the disclosed time frames or at all. Should one or more of the foregoing risks or uncertainties
materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially
from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to
identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause
results not to be as anticipated, estimated or intended. The forward-looking information and forward-looking statements included in this
news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking
information or forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities
laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>cgc-20250829.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaiJGbOdzZR+mYkxtmB/bUk6jyIgT9AI1i2EgMrGUSgK -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:CGC="http://canopygrowth.com/20250829" elementFormDefault="qualified" targetNamespace="http://canopygrowth.com/20250829">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://canopygrowth.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="cgc-20250829_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="cgc-20250829_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>cgc-20250829_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>cgc-20250829_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="cgc-20250829.xsd#Cover" roleURI="http://canopygrowth.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://canopygrowth.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm2524672d1_ex5-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2524672d1_ex5-1img001.jpg
M_]C_X  02D9)1@ ! 0$       #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  E )8# 2(  A$! Q$!_\0
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MMB:E!PI5%*K3IXEPG3JV4E"3ITY64I1\TGI_?1P<C/&,?_7ZXQVSZ@^E /0
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MC/Q6=/T'QCX;USP#8?$C2DU#6);W4_"^J:?<ZII_SM_P;F?L'_$;X]?L(?\
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MJUOKGP<^)^O:[X-\6IJ>F2WL&M:;!X[\(Z9J<EP5L[#2[8_9E^U/A5_P<?\
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M5M5NK2WT^[U+4=&\/V&GZ;>:A>6-I:V=U>7%M)/<VMK;6\SR1P1J/GOXB?\
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.N[YI*_H[+_A]WU.D_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>tm2524672d1_ex5-1img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2524672d1_ex5-1img002.jpg
M_]C_X  02D9)1@ ! 0$       #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !6 O8# 2(  A$! Q$!_\0
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MU&[COKVZU7PXFFIH]_=7UY''=7<]W9R2W%TBW$KO*H<6[_X:?#K5)/#<FI>
MO!>H2>$==N_%'A22^\+Z+>/X:\37]W/J%]XB\/O/92'1M>O+^ZN;VYU;3Q;Z
MC<7ES<7,UP\\[R/PW@_XWVNJ6G@>V^)G@GQ7\!?&OQ)\8Z[X&\#?#GXG:O\
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M?VH?"?PW\0> O"OQ(^(FM:]9_ [3=1^!.@>*M6DT\:?\3_!UY\<(?'-_XO\
M#6G+'XE\6^"?AEX:\?\ B;2=+GAT:WTW4O'D]MX,N-^__;>\$:;\3;OP;/\
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M2G:M:$^2=22;I^WY&TZDE*:45R*,74O>+^%OV._V7?&/P \1?%[Q7XB'PO\
M"%A\2=,^&NFVOP?^!5EXJL/A1I7B3P OC4>+/C9):^*KI;R7XK_'2?Q;I3?$
M6X73GO5T;X=^ =,U[QC\1_$.FZEXTU3YW\9_\$]_BW\;IOVBKGXD_$+X<?!_
M4?CE\'=1\ ^(K_\ 9LL?B5I6D_$[XT6FJ?#K4OA[^U;\2_"VM^-=&N-$\<_"
MW3_A;X<\%>#_  QX2\7WOCB/P/J.O:%JO[0NJ0V/P\_X0#]=B0%+[LKC YXZ
M\'.0,#GK@="<8J!I8UC5GD0;FQR<@9'(!) STXSR/3.!7URK3JSKQE2HU9^S
MO6C24)T_924X1I.4E3I-37._:3E4<G*5N?EE&G@L/*E3P\G4E3BJDE2=:4E4
M4V[RJ*G>I)6E[JA3]G%*,5[MXO\ );PE^P)\3_!]UHOQ/\)77P+^&/C[X=_'
MWP[\>OA;\ OA]I?C*W_9BT[7=-^!'Q@_9U^(LNIL1I>O:-XP^.G@;XW^-=8U
M_P :>#/!FD:/X.\6Z1\-M<UCX>?%_6?#7Q#USXR?2GAW]EGQW;_LL_'_ .#V
MI_%]_#?QE_:.3]H?7?$?QD\ Z!/IMM\./'WQZ3Q+%IFM_#S0+K6X]0GM?A#9
M:OX?TWPW<7^O:=J_BF3PG%XAU.XT75-:N;>P^V$<,S@L#R,8/3)YSSQUP.._
M&>SY6VHQ)' SD\8.0/FR5  !_O<<\@ U-3%5ZR;:H1YZM*JW2H>SDY4)JM1B
MWRWG3A7<JT8\C<J\ZE1SKN=HJE@\+2YG#VC@H5(N,Z_-3BY1<9SY>?EA4G32
MA*4IQBJ<8PY:*B[_ (GZ5_P2Y\41_"_X\>"=)7]GSX+Z)\5M#_91\,+\#?A-
MX:\=7_P)\7:=^R_\2+SQIXBN/B8=1UGPUXD,'[1O@:6P^!WBS1?#MCYG@KX=
M:3IEMXGU_P"/EK9VFB6?LW@[]A/XA>'?V7OVC?@'IWBCP%\-;']J/XQ3>(_$
M'@GX7KXLMO OP-^"?Q'T_P"%W@O]H/X:_!O7KZ73];D\:>/?!WAOXL>-M%^(
M4/AWP%IVA_'#XQ:AXRM_!EI%HLIUK]0RZBW,F]"0IYW IPV.,L!C)&"6'?H1
M4F_$:MD#(4EN/FR,'DOC Z=<'C!X-:3Q^,J1FIRIOFJ4ZUG0;7/3:<%[U/WN
M6251JISUN9:TU"T7A2R_!0E&I&,E)49I2]O%?NJMXR>E9J/-'W.>'+144^6J
MZE[?,_Q4^ MW\3/&G[.6GK?:%H_P3^"GC2?XIZ]X$M;%U?Q?XT\#^'_[%^!/
MALZ7'$N@P> O /B+6[SXO;-D&J:9\3OA?\'+O0T%C:ZR8_I]5VC/TZ\8Y/OC
MH2.@[ ]*KK*'8#.2>BDJ2?P#DD=\=<'CO5G/'+9ST.!@_3 (SUPN22/TY8\S
MC3A+6--5.2ZES*56I*M4G)RC&4IU*DW*4WS-VC"ZC",8^A1C34JDX:RFX\[4
MH2BE"$*<(QY)S48Q@DXPNDFY22O)MOHHHIRBE%I:*VRVU:Z??][[LZ!C]/P/
M\UK\W?A[_P I:?VL_P#LP+]@G_U?7_!0ROTB?I^!_FM?F[\/?^4M/[6?_9@7
M[!/_ *OK_@H977@]LW_[$N*_]2<*<U7XZ/\ V$4__29'Z1K]T?C_ #-.I!T_
M%OYFEKCAO_X%^$DCI"O+?C/X,\1?$/X;>*/!?A76O">A:OXAM(-/%UX]^'=K
M\6/ M]ITEY;-K7A_QE\/+KQ!X2'BKPOXET9;[0-;TRU\4^';^2PU*>73]8L;
MR**8>I5#(RKG<V.!@<].F0,<XZ'&[&1]WBK;<6IK>#YEHW9I;V2;=O)-]E<B
M:4H2C+2,HM/7ET>C]ZZMZW2/R^\&?\$]?$WPU\ ?#^W^&_Q9^'?@GXH?#']H
MW7OVB_ EOX>^ E]I7[+G@6\\5_ OQ%^SMXE^&7P]_9HTGXU6.L>!/AGJG@KQ
M7XB\?MH>@?'.&[_X7[KVO_$VXO;K1?$&M_#^^ZWX<?L#)X7TWP3I?C3XM:IX
MX'A[X.?MS?"7Q;J5KX.T[P?J/C1OVWOCK\-?C7XB\5VOV/6]5TSPK?\ @Q_
M%WH%IIUGI.H:;K=QX@36;=?#=MI*>'[S]$TD4\!A@GC((R!@$==I]/O<=-I!
M%2<<;B01V+#!R"._4 9X(]\9JOK=>=U*JM9QG94Z<6IN/N6:49*,$FX0]E3U
M;G:<W*9QQR_"))QINRC97JSDFM?>;YY)MW7/)3DY)1C*T4HGY&^-?^":/C/Q
M]HGPMF\0_'GPU>^.?"OP/M_V:/B9?)\,OB_X<^&_Q2^#.CZMJ=WX9@;X=> ?
MVK?!.IZ1XWL-(UG5])UO5/$_C[XB?#WQ/)KNMW%[\*;6SDT?2=%^\_C+\+?&
MGBSX:V/@#X4>)?AKX-@@^SZ1J>D?%KX/3_'/X:^)? \>A:AHMQX,\0^ X/B-
M\+M1N[5O/TR_M;RV\:V<B3Z-!:ZA;:KIE[J-E<^^KC() X &0<@D$GGG&5Y/
M<Y)/ H.,<DXSWP/;DD^G1@0O&?8U/&8BM&DJM=5(4$_8PFH2IP4Y.4DJ<JDJ
M?*YMR]UZ2;?M)2U50P.'I*M[*$J<L3&,:\X2FJD^5./-[11YE/E=G:*NK/E5
MC\HF_P""?_QM\,Z'^SKX&^&_[1GPKA^%GP &K^,[;X4_%3]F3Q-XY\ :S\;]
M3^(NJ?$;0/'5CH'P_P#VG/@MI^@?#KX&W>J'2/V7/@1=0^(_ WP/ATWPOXA@
MN?%/CCX:_!_Q9\./8-:_8GU;5O'VI67_  MJ"W_9K\0_M#^#_P!J_P 0_!(_
M#R.;QA<?&OP1XG\(_$C1+72?C&OC&./2OA/+\9_ ?ACXUZIX-F^&FI^-;KQX
M-9TJW^*MI\+=2M_AQI?W]@;B <9QG\#R 00<D$CCH3GMBD)51DMU(^;<!RQP
M &_$=!DD@GK0\;B)J4I5*:LY*7[G#*[YY5.:;BFG552;FJLH*LFTFURP1$<O
MPJNHPJ-<T6DZU9J*C&-/V<$W=494TXRHQE[&;<FXMRDU^<.@?L5>/?!6I>#!
MI/Q<TCQ%\._V;=7^,'Q%_9#^%][\-X]%U7P+\3?B3X+^)_@C0W^)_P 3H_&N
MII\2_"/PR\&?&#XA_#?X<Z)I7@3X=75MX+UZRN_B1J_Q,\;Z%:>-)/3OVF_V
M8_&7[4O[*6E_ SQIXT^']CX^/B?]F+XA>*O$VM?"R?XA?"KQ+XN^ 'QK^$WQ
MSUW1]8^$L_CKP=>:U\._B-KGPSNO"VI>')O'FEW5IX9\27'F:A>S6?DW?V:&
M4Y8D@\#+!AW!P-V.2<#/.#\O4$4[<K$)DDXW_P 6-I) !.W&< XS@XY([G+Z
MQ4FZ4Y2A*<)NI":IPC-23DI<[C&+FG*;J5/:03G6?M)S3<6]H8:E3C.$/:*-
M2/(X^VG**B_=CR7E+DY8Q4*?*VHP2A&-DS\G]&_X)O\ C/P_\.OB]H7A+XW^
M!/@YXO\ BCXM^$?B-M(_9E^!_BO]G#]G2TM?A3=7\L]OJ_P:^&O[0]A\1]8U
M_P"*-AJTFA?%WQAH?[1/@W6/''AKP=\)?".HJ/!7@&^\+^+/,O$'_!/SQC8:
M)^S=^S9I-EXK\6^%=*^*/[3OC/\ :#_:-G7P1IG@WQ;^S=^U5\7OBG\9/C_^
MQ]X@\*^+/BEXS^-WB&'XOZ_J_P +O#E]J\-KJ:W6G>"].^(>O_%6V\5Z3/X4
M\2?M;YB[\<@@<9!P>N0&Y4D 9(!R 1NP&!+#(N<DG)R00'P%&><X "DYP<\@
M94G)%=2S/&1]V56-2*E&?LI4XN"JT\-+"4Y<J]Z7LJ$^6$)*2^&512E"G%<K
MRK!N+LG%\GLW4523DZ7MO;SC>3Y8.I47OU(N+4$HQ?+=GS%^TO\ LV6W[3>F
M?#'P;XE\<>)?"OPY\'?%3PS\5?&GAOPA<:GH6M?$+4?AW!J6O_"S2X_&NAZ[
MHNM^#;;P'\8(/ /QBM[[1H[G4=2\2_#7PUI4\L&@W.M6VH?-ND_\$_-?^&LU
MOJ/P1^.]]X?O_!7Q_P#&?Q_^#5K\8/"&O_'/P]X*U+XR_#?5?!?[0'A#Q8E_
M\5?!_B_QWX>^)WC?Q/XS^/%AJFE>-O /C;PA\7/%FL >)O$/PSU+5_AQJGZ7
MF6,!?FV]  0V2>I'*E@RD\@\C(R.1EX8'YE.W@@J<!@2 1D;25(XP&.,D#!!
M7//3Q.)I4XT85I1HPYFH2C3DI2DKSJ3E*/M:DY+27/*+<6]%<Z*F!PM:I*K*
ME'VDHJ/M(RE&:C'X(PM)PBEJXVBTI.]V]3\B[W_@F)XE/A7X7SZ3^T/.?B_\
M/O%W[9FL:AXYUKP9\0M'\'>,/#O[;/[3B?M0^/\ 3]1\#? []H7X%^+-/\2>
M&/%VC>$=&\.:O9_%B3P;=:?8>(;S7?AIJ5]JOA5O /J'C+]@"Y?0OB1H?P:^
M+^H_ ZS\5?"3]COX1^"],\*:%XGT_2?!?AC]D+QAX[\0Z;X7U&[\$?%;X?>.
M]:^'_P 2-$\9IX$\4^%?"/CWX<:U!X1T_4-+_P"$WU&U\07MHOZ1!EV[AG:I
MP>"Q)'K\N2.W&,GC).*52A#8))R2,C:>0,=@,#(&1P< 9)XK9YCC91IQ>)DX
M4N:5-.,'3IRG45:2C%Q45>I!.T8\T5%1348Q1C_9N!2GRT(WJ**E)5)\TU&F
MZ2ES1J7;<&XMIVD[MKFNS\OO _\ P37TK2? O@+X>^._BIJ7C+1-";]NE?&C
M:?H.NZ'?>++']N/QCXD\6>)M/TK7M>^)'COQ;X?D\"IXHOM'T?6]<\0^.?$F
MNVT-K?ZOK4.JI/=W.;JG_!.WX@?%*V\6:5^T+^TE;>.=/U7]EOQ'^ROX:N/A
ME\$]-^#&NZ%HNI^*/!?BG1OB=JFIQ_$#QOI^M?$NQO\ P3ILVO6^DZ)X6^&&
MJ7,%E_PBOPX\!:>-;TKQ)^JJ,",_Q9(&1R#U*]N%SP<\<CMRT.I)YY.,L5;#
M<97#;=I'3G)YP,9X*>88QU'4]O+GJ2<Y3<(.:;<9.2E*-XMN,6YRBI<J2:5K
MR/[+R]1IQ5!*$(Q@J?M)\C48N,5)>T]_EBWRKFT;;O)NQ\G?LJ?LT7O[/VD^
M.+KQ9XE\->.?B)\0-?L-0\2>-?#VA?%;0UU'0_#^E)IOA;0KR'XQ_'W]HWQ?
M=2:"USKES%=M\04L&767M[+0]-BM@T_(_##]EWXJ?"2_M/AQX3^.^BM^RCI^
MK^,=2TOX2:M\(FN_BSHV@>+[KQ!JK?"W2?CI:?$FPT&Q^%?A?5-?%EX.L1\%
M6^(VC^$-(T?PU<_$W4+NUEU^?[C.#@A@#ZD#)'? /0]0#T!SP1U:<X!P<GGU
MY (XP0>X(X(7TSC$3Q6(JSJ5*E7VLZTZ52K.M&%;FG0NJ%9*KSN%6BKQHU8^
M]2NU%M.RVC@<-"-&E"FX0H*:I^SG.#4)MN=.3BTYTYMWJ4Y^[/1\MT?D%X"_
MX)56?A#X0?$;X0:M\7+/Q/;:I\"[7]F[X2>-]5\(?$[5_''@'X412^'!J5CX
MOB\:_M%>-O /BK5?$D'@;P)+XB7X6>!?@!X/O-3\.17%EX*T[36T[1M)^DOC
M!^QI<_$W5OCCXFTCXBQ^%O$'Q/U7]D7QCX/DNO!+:_I'@;Q_^QU\5H_C/X!U
M/Q!IMOXO\.7WCSPOXB\::=H-MXM\-:?JO@+5I_#%GJFE:5XNTW4-4M-;T?[K
M; QN/IGD]<@#C\<#'))(')S1VZG!S^)'(P.2>F!M&3W''.E7,,96G.=3$2J5
M)MRFYVDW-\DKM.;WY(>[:"M&T4H2D9PR[ P@J<,.HQ@DH-.5TDFDN9J^G-H[
MR=[<S;21\(>,/V*+;XHZ-^UEHWQ-^(%U=R?M=_"WX>_#OQAJ?@+PTW@FZ\'Z
MEX)\#:OX6N?%/@]]5\4>-Y0M[K.K-XCT/P_K<VJ6^A"SCT75K[Q9!/=WUUVG
M[+/[,-[\!-,\>7WC#Q-X;\<_$7XA:IIS>(?''AK1_BWH,EYX9\/:?<6OA7P]
M=#XQ?M _M&^+I7T.ZU;Q/?07=OX\L].4^()X[#0M.,;W%U]? 'D=!VP><=NH
MST/(/0CCMA<#^?3CK],?GUH>+Q<Z+H2KS]C*5.3IIV@_8P5.DTHNS<(1BH\R
MDDEHHO5W' 82%95XT(>UBJB4[MO]\U*KS7>KE)7<])7;O?9>!_"G]FWX6_!;
M5=0UKP'#X\M[[4]+BT>\;Q9\8OC#\2+0V$5S%=JD&G?$GQWXLTZRNC/#%OU*
MRM;?4I8E-O)>/!))"WQC\1_^"9GAWXC:/XNG?XIZSX9^(.J?M4ZU^T3X9^(>
M@>%K:WU#1/!_C#Q;\+?$7Q%^ 7B'39O$,\/C?X;_ !"M?A9H"Z_#=WFDVZ>+
MM%\ ?$G3]%LO&'PS\)W5O^I>. /I[]*3 !)[GKR?7/3./\XZ4J6)Q="J\11Q
M-55I>SYJDN6I.2I<WLH-U(N+IP4Y1Y'!QE!\LKV4E4\#A:D80G0IN%/VG+"S
M45[:RJ-14G:4N56E>\6KQM=H_/>^_8GU_4/B'J2+\7;2V_9X\1?M$>$_VK]<
M^$[?#.&;XD/\8O!NL^$_&>DZ=I_QR_X36.*T^%4_Q+\"^&_B#?\ A:\^&&I^
M.9+IM5\%67Q1T_X776G>!-$NZA^QAK5K\!?#GPN\%?%/2]"\>> ?VEO%O[37
M@3Q[K?PWG\1>%K;Q9XH_:$\>_'"30_%OPYTOX@^$]0\3Z$FG_$+5_!NH2:=\
M1?"VI:A<16_BV"]TRY5M%3[[  _S^@]!["DVC!R"?J2?7D<G!Y/(YH6(Q*5E
M6=E*,OA6LH1G",IKF7/)1J5(N3M>,^7E7*FXCE^%BY-4DN;F3]Z5HJ<H3:@G
M=02G!3A9-QE=J34FE\.>)_V.AXGA^-WVGQ_%!<?&7]L3]E#]K.:9/!D<O_"/
M3?LPG]CJ1? L43^*-VIQ>,Y?V3A-#XHDN+&3PJ/'V1H7B!_":R>(_9OVB/@H
M?CQ\/O#_ (''B0^%&T'XX_LQ_&<:DND#7#=-^SA^TE\)_P!H7_A&39'5-($"
M^,3\+AX0&L?:IO\ A'?[<&OC2M;.F#1M0]^P.3W/4Y.:,#T_G[X_#!/'3G'0
M5C*52?(Y2O*FVZ=TFH7A&#24N9*/+%146K122C;=[1PU**J*,$O:\JJ--J4H
MQE*4;R5FVI2<K[MMMM['Y\^-?V*->\4_%;QMK5G\8(-'^"OQ>^/GP'_:@^+7
MPWN/AQ#JOQ!U#XR?LYQ? V/P%_P@'Q='C"PTOP5\/=6?]FKX/MXU\-:[\+/'
MWBVZ%IXQ/@WXB>!IO$>C3>#_ ![Q/_P2R\+^([_XBWLGQ7UF&+QO\:I->M;*
M;P=8W=MIO[,'C6Y^*6H?'+]DC55'B&VD\0>#_BCKG[27[3NK:;XWC?1-5\!'
MQW\*[33]!UB+X ^#6U3]9RH/X9QR>,^G\OIQTH*@Y!&0>H).#SGIT_\ K8'0
M5O#%XRG9QKM.,>1/DI:Q2LN=<C4Y6]V<FDIQC",H<L%?!Y;@Y.;E14G.3E=U
M*EUS6T34DXQ35XI-VE*4KMRT_-B/_@GUI]M^U!K7QM7QW'J_PV\4_%BP^/6M
M?"3Q/8?%74K_ $WXOZ5X/\/>'=*UGPAK^E?'S0/A=I?AVPU_P=X;^(%OI_BO
MX!>//%UEXD;6[+3_ !W:>$Y_#7AWPA[;\(_@?\3?@1X,_9Z^%G@/QCX5U7P5
MX'\6>/KKXS:CK?A.?3=8\7^#_$FC?$O6]$M/!UM9:]J,'A[Q%9?%'Q#X'O\
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M=#L5DTR&2\T6ZEO)S'^I-O<R2(2R%/F95!SE@&<*.5SDA5R3GJ,=#4AL[?\
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M?LH:?\/H=>M=9_:H^)/P_P#CAKGC/P)K&NP(_P 0/&>F>%O%/@KPGH>D> ?
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MQ@=.1^1Q^O-%%%_3X8O9=TNWW+9= MZ_>_U?X[]VQ PP3C !Q_+_ !IU%%6
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
'"BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 29, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 29,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38496<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Canopy Growth Corp<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001737927<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">Z4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1 Hershey Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Smiths Falls<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">ON<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">K7A
0A8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">855<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">558-9333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Shares, no par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CGC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2524672d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://canopygrowth.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cgc-20250829.xsd</File>
    <File>cgc-20250829_lab.xml</File>
    <File>cgc-20250829_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2524672d1_8k.htm">tm2524672d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2524672d1_8k.htm": {
   "nsprefix": "CGC",
   "nsuri": "http://canopygrowth.com/20250829",
   "dts": {
    "schema": {
     "local": [
      "cgc-20250829.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "cgc-20250829_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cgc-20250829_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2524672d1_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2025": 4
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://canopygrowth.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-08-29",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2524672d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-08-29",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2524672d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://canopygrowth.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001104659-25-085779-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-25-085779-xbrl.zip
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MJ9I!I3'X*GAGD./;"P,:8-QDZ(@("+T!-J$;#GDDRD,_H"(8U:(]G9^EARR
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M_!VFUK_@I$&P'#0TF)LX <*1[H+TSXU>-'F_OJ=3JMPRA0>Z,N]M0X_AFR)
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M#4\A2!A$<FJ9GMPBAG!#3EC?FU!/I4N+>X$"COR++10QH"0,J07,&V!):J3
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M\&K6H=[\J52N5I\>(;C3^A>3^3F6=2&.873D,8QEB<%G(N#3V>!\^?X7P3^
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M%I*15-[DMFC NA^=!4J[]]D+,U]!2$XJ!?; @/?G<WR^G-9(D@\#:+A3NG5
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M3]S/[^CVIMVG#42"M",@#U=9OKIG]?9'A]+Z_2NM/SZ4UC\)3VFQLZ?T@RL
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MGR+%TTXUJ[<9EO0>TWJD0&K'BCM3KF()+\:J8F&XM&BU!G\%WC5BGC ,J!V
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M,:HTCYQ(PDR*8$(!BPZ *!9EQ.I%X?OP1 **Z$@JP'JRK,3R,4?ZDXJ(%PA
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M;F#%R-E[2;Q\6R;AK4LB; (S>/KP_TYKZUUE/$"@]G9T&.L3_P+^K2S3B$]
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MR_243] 8ZP8(.RYIM;\2M(W=B'.T- M$0%.SYU5>\*8T.!4>]D1Z3BDG$9:
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M[@S!$J@)UWE O7'L^ZPQ_=M@%>E_00?$^MTG=UZ^>?T^?$1D,ESS] X-T46
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MF=)0C<F@UWV-WPNRU'9\NIW:C79%M+PD9:.Y?55RT>;89%106V:-\[^4Y[*
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MB@3VUL0.1;B:T)%0)DLQ4T+6KG]CKXR?%XW]0! 8(,\NQ<+,ABE[QU&V]>'
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M,/&NW[?2R>-#Z>0>EDX^/Y1./HF8X.)B]X&'G(D7Z(POFDSF0,[=3*Y_L=M
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MGNL$DSH :_SOP+VOA<R2A!ON :D%\Q%>'AOL66.)B4?1I_9Q]D'5ZKK[XG6
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M0:.ZA#1J+))#TQT"+[B# H?K:R7Z!@T7DKJ*+I&)2!XH18X(/7AW&:=S>[%
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M/\F&$+=7%DDB_/?/T>=D62_E^"!KV1GQ55=%7E\ZQL@>%W Y)4/]L!EV$+(
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M)6'Q$..6 (YZ%"#N;+WAO0G#7N0K.=B*69Y+@FNA 8/!R?_UWD-RX\Z9)]J
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M7"*NT@!<KPQ>?[Y*9DE%KW]JSG[ R.Z=\+1\9!C5JVBM55]WG0]"D]C\]"A
M16&/\\)V^-R@4,QX@&K%/&M:$1;,E1IHQ[E*=-<$,)#[AZP("MYX9<KR-@9
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MN2+4:,EA\&R55KJ A'O5W^1:4):=CM\P&@];*!W"SLK>0M&B,HK.4>QK3>V
ME9&7[DIDJ&'67!8=W=FK<FUM(CX',J,Q@6?% -P:(%A+%T6HNW3\C%-KN0U"
M6#I(8R3N0*Y/#J?L7RKDL0-'9APPKY5U9\#A#5B=J%+>L^2;TB=KJ8@?I=P\
M26%S>CS93GD>2Z! H1YY_KIY9 0K>@'=E<$&, 0*1TX3Y8^S%$J5^7; M+T
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M;R86.9VQYT'AN,%(8$M CQ#O&F44\O<T&9/G',]S;DFZ#@' FW?!K76!70.
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M4F%OR<Z3VF3 K6#V\B X5?4"VR_H1+-A7=1(>.ZQ\ <-<>Z4"BXK;OI FN%
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M2&=.)!5P-X9-0][J0007=/U51XXEUF;DU_C."U$OS =HY-#U,:N7,SC6;SV
M4587YY9.8-11EP=CKL74\7*%LUW";(?\#\P.R>-3_7MN+P >866R3-*H8$8&
MNEV*N%.02PL$3J'WT%WS;=>N>9U5<'/5:RY=H'LC>H^'MO7[4_D_,?ZG+U.3
M?!UF_'\0NV^KT-ZTN#Y^A+MP?B5 GIMB/_'Y*IF!?Z(+N[1]CAOAEX9Q@CN:
MD:NR+9RU;^&[B'='T*(:HC"B<H:87L1 78&L.Q1PX?(J=5JQA M%)O*Z-']M
M$43(O0^UJ5#&)7*+JD@.?BW_+ U!)E[)U;MQ,&]I$.-2.YJII:&H4F%VB*\,
M'_&>K_(3>.M0^?@>1B='PT<$U*$8O )*9*6V:T7!,;J_-V)6U%'!U*+'WX90
M*CY^%NR!0N22@G[Y=S]':]7Y@/S=S_9#RO7%UKN>Y<L5*KRZ=["]RI%;?)?&
MP>M7I[;08A>IFY934S.X0>=+LRGRG_!7' "Y-%WOKO,D5JJM<5[/JM!Y=O^1
M ?W;6TZEX3A_CG/T=/LI4O_D@0=T."'O"O1&HOI)SMR.I45+JG_D9$0I(\6:
M:ICLXX<$YADD]Z(Y_+[@BX:'SWG+%#^-S9'!#4TEN91Z"*>+E8WSG= VLDAO
M[ 19SO%9M".[25'=167U4)MGB4:19YA%6T)%4=FX2=F9.$01&"@;)J)78HKA
MEU 9[J28U\L2=8GQOGXEXVM0^).3!A?XE/*J\D'21$F8$PAC0S)N_%0"V4S\
MF%+IUA]TM&E47IJ&"P,0Y))PXE6P@IZ07HW(!%'LK_\E'S]R&-TB%0%1&B)"
M:@;.\T^ASPZASW>=%P;#(/Q3=/.?$Y(H9?1Y&B7+$/-:50'U[')-6N'E2NYT
M\L60KZ(T5J-VU7=3N,3"./D)4NZ4SF=5"%67ZF#) _9E?>IUE*FT?UG(X 7$
M%Y"N6?X>^Z\CFPF::^@=#SD(7EL:QHWHQ"D:RF@DAVYO#E.:%1SD-:2Z4O^0
MI\TZ?+,>'W9MUG]":0F9X?]62[?[L4BB]$%OV4U'+)'\=!7?3.Y8T?[!>4]!
M#YSL%<P;[,U?81;=TISV"795^K:=C_=XC#%,H;HK*IMVQ X[XJCS^)J5@KW.
MFR2N01Q<1NIUE3QHZJN^A)>^L\AC!Q)1^4J::87D-'CP:#Y<V$D+&?QG<]@)
M=/=4%Y&HLI7NEXAARE.!D*U2[H8R46I!2[P(4S7[!L+!6*P$CM05F(;(%T[;
M*%V7B3XQ^D$=+<4.O ^O@X4\<& W-U_9ODSA+J=(4L;NQ ^IXO7'CQR:4TW=
M39<E_9=&8,!,413+Z#4OUIH)M(O.TZ;^:ES1LKS0(IN/'VF5V[*&BIXC>RF_
M5-DQ!1]R>JZ259=09<<0,$+77TMYA*8D^4QA%$)=9VT@79K0@M"XQ5(!6_!M
M;(00OQ08!M15R(+,R\1UA9%5!/<1>'+[,X\?X8?T';RTGVL)E6:Y)9NI<2)4
MEB6( OWW?L^D6>Z> *R-8<IH$$\  I18D";H)RJ0M*WY)WQF./+I!):@<ZA-
MZ1H&AO<-4\-7>1JC8#KL@WPM!%4XY_+ZDY!\>NL97_#%?<L*X?.I0O@ *X3?
M3!7"+R%B.NZ*F/[&^+C@C(63'G"<M+G-XF,S(E"'3HZAS#*3ST6/B^HZ> R%
M&.QH ) !!H46B(@2:-A"@<<&M@+(4R1T(+%T].!3"7&HH.\BRA@3V@3N\0'0
MD!S,&[3JQX?J@Z\_<YN&_%BHSVJ$_N8E1#"HG66B(_.> (^)X)RL4WTK4L!*
M1$N"MY)''0R4NBDP'(R-[$!$DIMQ+0*C=:9STGW/8D@.X!X1%02@34B8:)6O
M9CU!/VBNK=FJ+%BP)'RW&)PJ![H=;W@M+WF1D@"?B>I&AI 6?AH3FJP@(=34
MRMC-R*A97Z(F@'H&8%]C"*[S*8UAX[QA4H:Z6W1LHCZ)L0!.E6IFV&Y8!$-E
M<TYT>PN,"Y-%$ 77A?RK4KASI"/:2(NGHI&TA]YNZ3"]$8VO/0BXJ^F<+/27
M#+L^4("SU%]=FC'%>)&1^S*J+(#9XT<R<):SD4BO@-\<UUK)O>-=M0&&C>UL
M[7@9]"]7%6#!HG57V"B_F"<"1>KX(X\?0>F@U+%9]_N8EX&\(-?]NL;?MUCZ
M!2B@UV*)ZK,0LFJ%+RZ"2NO6E1_*09K;F44[WZ$U@+O4U0OK4\]L:J93C:-G
MB\..@Z&7<E?3BV!)AC=STX1Y$VM8*"$>,1@OQ#*I69MWGI>4A-2F+Q<0+/OQ
MHYX;FC;W?('E%=J>7-  +@LJ7*3B.K*L?$K=[!"(G'2WZ0#&U&3!?[DXE3%D
M523R"BX/K <<EIQWEP"8AWQ)R4WE4=Q9"?8^)I5TV^?GYXA+J6<'P4\'<K3?
M/'GV/-@#=*HZ9^2]/7@GPY29*#@PP,KTX=$^BZZH+$0A# 4ZE#EF4)T+@VMX
MR34=Q-#S5\!SY?Y=JBJD/&, VH0M>F4;X3M/$VI;,/?<UA686V6LQT)JP88W
M9]$2'8X<!S>"TL3T?)?T,<![ _]+AW]KR#<)_#I-\QM[$N@$D.Y6.F-^J77O
MUTR^8 =?T*E6\$HLDBQY.)C$[GU_6H+8>@?&D&OQBQS,$C<*9A%5PM V0;X>
ME)::_$S(O[I#'JNOVR:WTLZ*MM/.,O<.<AO690-[XJS[FQ\LD.Y0E>J7R#"9
MPO<^QJR\N*\-\1^PW+-!RQV<6Y'Y>RJ_6!;@M^(-<VE80+N92)KH9 =CV\'<
MWP[88W?L?+_U[U[W:>??\8K'WBNN@-ZHJME8=E]]Q&VW^[=RMSNBYY,%W+>4
M=L,"I,?_@ 0DG"/!#$_#$=SE ?!<GEE_B$7<4QWPFZD.^ #K@-].=< OPN=M
MJ1UN^3R#)H47L8\]5*7SU*=O]K)!%K>M1XWP&22Y6AA5W$Z-:@74'R"4;5^[
MIV/UWM6G+1.K$=8"33&0Q@A^$@A"NZ?S]-N]U11AW9$I7/F;0G65%\GO$2<
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M[+VO9VDRE_'R7$8VNS(3I&D0Y_.:E/*2;,[LL,076XB%*#"^2+*-5@*/28P
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M4AL*<I]SFQ5;'1MZ$!OE,_%]Y#HYS-4Q<TGJG,'7)&V+HH3-G$J([N]%*K-
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M)C[!= DZV5 (Y^D3O_9[LVJS>XX38.J"SC?E^ N!=&:X+N[+!CLC.&/&"[]
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MC<^:5WPSU-C'TOZ48#<3*Y>#YA*^ Q^,7<6(ZC)@2B*ABS5T&:/@!9VW:NY
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M7-9I+\$W:AT*JJQX@YQNQ=:WG7\'#'TA<>]%RULL$#:+*M.(PBX94E&ZAU2
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M+MS]HJ:NUN"-X8"PTC\CUK2^N.IKSB*>M#JU;^F,]9LYD/C]JOC^[^@ZHJ\
MD^\$HZ\.^V]02P$"% ,4    " !XB!U;P/@IN2T#  #K"P  $
M    @ $     8V=C+3(P,C4P.#(Y+GAS9%!+ 0(4 Q0    ( 'B('5M\HT[
M_0H  '^&   4              "  5L#  !C9V,M,C R-3 X,CE?;&%B+GAM
M;%!+ 0(4 Q0    ( 'B('5N-R!MD7 <  -M7   4              "  8H.
M  !C9V,M,C R-3 X,CE?<')E+GAM;%!+ 0(4 Q0    ( 'B('5LH"D#JH!L
M *Z6   2              "  1@6  !T;3(U,C0V-S)D,5\X:RYH=&U02P$"
M% ,4    " !XB!U;=-I2N%C^  "MJP< %0              @ 'H,0  =&TR
M-3(T-C<R9#%?97@Q+3$N:'1M4$L! A0#%     @ >(@=6T+3.^.:$0  AUP
M !4              ( !<S ! '1M,C4R-#8W,F0Q7V5X-2TQ+FAT;5!+ 0(4
M Q0    ( 'B('5LBM[8JPA4  $%,   6              "  4!" 0!T;3(U
H,C0V-S)D,5]E>#DY+3$N:'1M4$L%!@     '  < S $  #98 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>tm2524672d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cgc-20250829.xsd" xlink:type="simple"/>
    <context id="AsOf2025-08-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001737927</identifier>
        </entity>
        <period>
            <startDate>2025-08-29</startDate>
            <endDate>2025-08-29</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-08-29" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-08-29" id="Fact000004">0001737927</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="AsOf2025-08-29" id="xdx2ixbrl0011">Canopy Growth Corp</dei:EntityRegistrantName>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-08-29" id="xdx2ixbrl0014">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:DocumentType contextRef="AsOf2025-08-29" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-08-29" id="Fact000010">2025-08-29</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-08-29" id="Fact000012">Z4</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-08-29" id="Fact000013">001-38496</dei:EntityFileNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-08-29" id="Fact000015">1 Hershey Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-08-29" id="Fact000016">Smiths Falls</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-08-29" id="Fact000017">ON</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-08-29" id="Fact000018">K7A 0A8</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-08-29" id="Fact000019">855</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-08-29" id="Fact000020">558-9333</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-08-29" id="Fact000021">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-08-29" id="Fact000022">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-08-29" id="Fact000023">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-08-29" id="Fact000024">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-08-29" id="Fact000025">Common     Shares, no par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-08-29" id="Fact000026">CGC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-08-29" id="Fact000027">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-08-29" id="Fact000028">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
